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Subcellular fractionation (together with immunocytochemical localisation studies) showed that
the parasite Trypanosoma brucei brucei possesses a multicatalytic protease complex (MCP-
Tb). This complex is predominantly cytosolic but some activity is also present in the nuclear
fraction. MCP-Tb was isolated from T. b. brucei and compared to the properties of other
proteasomes reported in the literature and to the 20S MCP isolated from bovine red blood cells
(MCP-rbc). The isolation procedure employed four-steps: anion exchange chromatography on
Q-Sepharose, adsorption chromatography on HA-Ultrogel, molecular exclusion
chromatography on Sephacryl S-300 and glycerol density gradient sedimentation.
The molecular mass of intact MCP-Tb was shown to be smaller than that of MCP-rbc.
Separation of the different proteasome subunits by 2D-PAGE showed that MCP-Tb has 12
different polypeptide components compared to the 28 different polypeptide components of
MCP-rbc. The N-terminal sequence of an MCP-Tb subunit showed that this subunit did not
have any obvious sequence homology with the subunits of proteasomes from other cells.
Furthermore, anti-MCP-Tb antibodies (which exhibited the in vitro inhibitory activity of
MCP-Tb) did not cross-react with MCP-rbc showing that MCP-Tb and MCP-rbc are
antigenically distinct.
The basic enzymatic properties of MCP-Tb were fairly typical of other 20S proteasomes.
MCP-Tb had multiple peptidase activities (identified as chymotrypsin-like, trypsin-like and
peptidyl glutamylpeptide hydrolase activities) that are characteristic of proteasomes.
Furthermore, the characteristics of inhibition by a variety of inhibitors were similar to those of
other proteasomes, including MCP-rbc. The activities of 20S proteasomes from most cell
types are activated by endogenous high molecular mass complexes such as the bovine 19S
complex called PA700. These complexes form end-on associations with the 20S proteasome.
However, no endogenous MCP-activator was found in T. b. brucei. Nevertheless, MCP-Tb
was activated in an ATP-dependent manner by bovine PA700. Inhibition of the intrinsic
phosphatase activity of PA700 inhibited the protease enhancing effect of PA700.
Electron microscopic examination of negatively stained MCP-Tb and MCP-rbc showed
particles that were morphologically indistinguishable. However, the MCP-Tb also exhibited
unique end-on associations between individual units forming long (up to 200 nm) ribbon-like
chains. Since access to the active sites of proteasomes occurs through the pores at the end of
the complexes, this end-on association, when coupled to our observation of an apparent lack of
an endogenous activator, suggests that T. b. brucei may have evolved an alternate mechanism
for controlling their proteasome activity.
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The African trypanosome is a unicellular protozoan flagellate that spends part of its life
cycle as a parasite in the blood and other body fluids of its host. It is the causative agent of
a fatal neurological disease, trypanosomiasis, commonly referred to as sleeping sickness in
humans and 'nagana' in animals. The debilitating chronic course of the disease is
characterised by anaemia and severe endocrinal defects (Lomo et al., 1993; 1995).
Trypanosomiasis is endemic in a vast region of Africa defined by the range of the tsetse fly
vector. This insect inhabits over a third of the African continent south of the Sahara and it
exposes about 50 million people to direct risk of contracting trypanosomiasis. Twenty
thousand new cases are reported each year and thousands of other cases go unreported
(Kuzoe, 1993). Perhaps of equal importance to the direct threat to human beings is the fact
that 30% of the estimated 160 million cattle in the tsetse-affected areas are exposed to the
risk of infection (ILRAD report, 1989). The disease makes some four million square miles
of Africa uninhabitable for most breeds of dairy and beef cattle. Having little or no access
to meat or dairy products, much of the human population is malnourished and susceptible
to diseases. Effective control of trypanosomiasis could drastically increase livestock
production in Africa, as well as greatly benefit arable farming on the continent, where
animals provide most of the traction power in agriculture
Various curative and preventive methods of control, including keeping of trypanotolerant
breeds of livestock have been tried, but elimination of the tsetse vector has remained the
method of choice in the control of trypanosomiasis. Before the advent of modern
insecticides, the clearing of vegetation, on which the flies depend for shelter, and the
shooting of wild mammals, on which they primarily depend for food, were widely
practised. The introduction of organochlorine insecticides in the late 1940s was followed
by large scale spraying campaigns in a number of countries. Many of these operations
were effective in reducing the tsetse populations (Jordan, 1995). Nevertheless, there were
problems, namely cost, the logistical difficulties of mounting large-scale ground and aerial
operations, and the realisation that the operation had to be repeated regularly if disease
control was to be maintained. Repeated use of non-biodegradable organochlorine
insecticides resulted in major ecological problems leading to a worldwide ban on the use of
dichlorodiphenyltrichloroethane (DDT). Awareness of the need to conserve the
environment has rendered the earlier methods of vector control such as bush clearing and
killing of wild mammals unacceptable. Furthermore, economies of most countries in the
sub Saharan Africa depend on tourism and game viewing forms a major part of tourist
attraction to these regions.
Alternative, environment-friendly methods of control of tsetse flies are under investigation.
Baited flytraps have been used with considerable success (Putnam, 1993). Another form
of control that has been tried with varying degrees of success is the release of sterile
insects, particularly sterile male insects into the wild (Williams et al., 1983). A further
potential control method is based on the finding that the tsetse fly carries symbiotic
bacteria in the cells of its gut and other tissues. Genetic transformation of these bacteria to
produce a lectin protein or antibody fragment known to kill trypanosomes before leaving
the insect gut was tried with little success (Aldhous, 1993).
Only a very limited number of drugs are available for chemotherapy of African
trypanosomiasis. Treatment of this disease in humans is currently dependent upon four
drugs: suramin, pentamidine, a-DL-difluoromethylornithine (DFMO) and melarsoprol
(Kuzoe, 1993). In cattle, sheep and goats, three compounds (homidium, diminazene and
isometamidium) are used to treat nagana (Kinabo, 1993). Regrettably, all these drugs are
plagued by various problems ranging from adverse side effects, oral inabsorption, short
duration of action, and low efficacies to the emergence of drug resistant strains of
trypanosomes (Wang, 1995). In view of the inadequency of the available drugs and
considering the dramatic outbreaks of trypanosomiasis in different areas on the African
continent, there is a need to identify alternative methods of control. The rational approach
is to identify unique biochemical and molecular features of trypanosomes that could be
potential chemotherapeutic targets for effective drug design. Thus, it becomes necessary to
understand the biological features of the trypanosome.
1.2 Classification of African trypanosomes
The causative agents of African trypanosomiasis are unicellular eukaryotic organisms
belonging to the family Trypanosomatidae (Fig. 1.1). African trypanosomes share with
other Sarcomastigophora the characteristic mode of locomotion by flagella. They are also
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classified in the superclass Mastigophora that contains those protozoans which move by
flagella only. Since they do not possess chlorophyll, African trypanosomes are placed in
the class Zoomastigophorea. They fall into the order Kinetoplastida because they possess
a kinetoplast, a dense organelle at the base of the flagellum, which contains the
mitochondrial DNA. The suborder Trypanosomatina is composed of Kinetoplastida with
only one flagellum and all members appear to be parasitic. African trypanosomes belong
to the genus Trypanosoma consisting of mammalian-infective species of trypanosomes
divided into two groups (stercoraria and salivaria). These two groups differ according to
the site where the parasite develops in the vector and the mode of transmission of the
infection (Hoare, 1972).
The stercoraria group consists of parasites whose developmental cycle is completed in the
"posterior of the vector" and where transmission occurs via the faeces of the vector
through skin wounds in the host. Trypanosoma cruzi, the South American trypanosome
that causes Chaga's disease is the best known species in this section. Reproduction in the
animal is discontinuous and usually takes place in the amastigote or epimastigote stage.
Stercorarian trypanosomes are not the subject of this thesis and will not be discussed
further.
Within the salivarian group of trypanosomes are genera whose developmental cycle in the
vector is completed in the anterior {e.g. in the salivary gland) of the vector. Transmission
from vector to host occurs by the inoculation of the metacyclic stage when the insect bites
the new host. The flagella of trypanosomes are attached to the body by means of an
undulating membrane but may extend beyond the body of the parasite where the flagella is
said to be free. The kinetoplast is relatively small and may be terminal or subterminal. The
posterior extremity of the parasite cell body is often blunt. Cell division in the host is
continuous in the trypomastigote stage.
In Africa T. vivax, T. congolense, T. evansi, T. equiperdum and T. brucei are major animal
pathogens. T. vivax, T. congolense and T. brucei are generally transmitted by tsetse flies
(Glossina species), in which they undergo a strict developmental cycle. However, they can
also be directly transmitted by other bloodsucking flies, or by the ingestion of infected



































DUTTONELLA NANNOMONAS TRYPANOZOON PYCNOMONAS
T. (D.) vivax T. (N.) congolense T. (T.) equiperdum T. (P.) suis
T. (D.) uniforme T. (N) simiae T. (T.) brucei
T. (T.) evansi
B: SALIVARIA
T. (T.) b. brucei
T. (T.) b. rhodesiense
T. (T.) b. gambiense
Figure1J. Classification of African trypanosomes adapted from Hoare, 1972; Baker et aL, 1978
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Human sleeping sickness is caused by 'subspecies' of T. brucei designated T .b.
rhodesiense and T. b. gambiense. The former is found in Eastern Africa and causes acute
illness, whereas T. gambiense is found in Western Africa and causes a more chronic
disease. T. b. brucei is morphologically identical to these two subspecies in all phases of
its developmental cycle, but is confined to wild and domestic ungulates and carnivores. It
is not generally considered to be infective to man.
1.3 Anatomy of African trypanosomes
The generalised fine structure of T. brucei is shown in Fig. 1.2. This parasite is a
unicellular organism with a flagellum that stretches along (and may extend beyond) the
body of the parasite. The cell body of the trypanosome is bounded by a unit membrane
which is coated on its outside by a thick layer of variant surface glycoproteins (VSG).
Beneath the limiting membrane run the pellicular microtubules in a longitudinal direction
from the anterior to the posterior end of the parasite. The microtubular skeleton maintains
the shape and stability of the cell (Hemphill et al, 1991). In addition, T. brucei has a
precisely ordered microtubule cytoskeleton whose morphogenesis is central to cell cycle
events such as organelle positioning, segregation, mitosis and cytokinesis (Robinson et al,
1995).
The flagellar pocket of an African trypanosome is a flask-like invagination at the posterior
end of the cell body where the flagellum leaves the surface of the parasite, and enters into
the main body of the cell. The flagellar pocket membrane is devoid of subpellicular
microtubules. The flagellar pocket constitutes 0.2-1% of the total cell volume (Webster
and Fish, 1989), has an inner surface of about ljam2 (Coppens et al, 1988) and is
considered to be an important site of endocytosis (Langreth and Balber, 1975; Webster and
Russel, 1993). There is also evidence, from freeze-fracture analysis of the
trypanosomatidae Leptomonas collosoma (Fig. 1.1), for a role of the flagellar pocket in
exocytosis (Linder and Staehelin, 1979). The plasmalemma of the cell body is continuous
with that of the flagellum through the flagellar pocket.
The trypanosome flagellum begins from a structure called the basal body or kinetosome
found below ̂ he floor of the flagellar pocket. The flagellum contains two major structural
components: the axoneme and the paraflagellar rod (Schlaeppi et al., 1989). The axoneme
is formed by the characteristic 9+2 associated microtubular structures. It consists of nine
doublet microtubules held in a ring by interdublet linkages termed nexin links. This ring
surrounds a central core of two singlet microtubules. The flagellum forms an undulating
membrane that runs along the pellicle and is attached to the trypanosome along the whole














Figure 1.2. Schematic diagram of bloodstream form of Trypanosoma brucei illustrating the major
organelles (adapted from ILRAD 1989 Annual Report)
At the opening of the pocket where the flagellum emerges from the cell body, there is a
thickening of the flagellum and the appearance of 'hemidesmosomaF junctions within the
flagellum and the opposing region of the cell body. These regions are thought to limit the
access of materials to the lumen of the pocket area or act as anchor points for the flagellum
to the cell body (Webster and Russel, 1993). The flagellum may terminate at the anterior
end of the cell body (T. congoleme) or it may extend beyond the cell body when it is said
to become "free" (T. brucei). In bloodstream forms, in the vertebrate host, the flagellum is
responsible for movement while in the invertebrate it plays a dual role; locomotion and
attachment.
The main body of the parasite contains various intracellular organelles analogous to those
in other cells. The mitochondrion of T. brucei is unusual in that it is a single elongated
tubular structure that extends along the length of the cell (Hoare, 1972). The
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mitochondrion is more developed in the tsetse fly stages and less developed in the
bloodstream form stages, where energy is readily available in the form of glucose in the
blood of the host (Vickerman et al, 1988). The mitochondrial genome is not distributed
throughout this single mitochondrion, but instead exists within the mitochondrion as a
discrete physical structure called the 'kinetoplast'. The kinetoplast DNA (kDNA) consists
of maxicircle and minicircle components. The maxicircle components play a role in the
cycle of mitochondrial activation and repression and are considered the true mitochondrial
DNA encoding several respiratory enzymes. The more numerous minicircles, which
appear to hold the maxicircles together in a network, are thought to serve as guides for
RNA editing or the transcripts of the mitochondrial genome (Stuart, 1991).
The nucleus of trypanosomes may be spherical or slightly ovoid and it may be situated in
one of the several different parts of the parasite body. In bloodstream form parasites, it is
normally situated in the centre of the anterior half of the cell (Hoare et al, 1972). As in all
other eukaryotes the nucleus is bound by a double membrane envelope with pores. The
outer nuclear membrane is continuous with the rough endoplasmic reticulum which is
associated with the Golgi apparatus, subpellicullar microtubules and mitochondrial
network (Hemphill et al, 1991). The nucleolus lies in the center of the nucleus and the
condensed chromatin is found in the nucleoplasm especially immediately beneath the
nuclear envelope.
Trypanosomes possess unusual organelles called glycosomes. These contain glycolytic
enzymes normally located in the cytosol in other eukaryotic cells (Opperdoes et al, 1987).
Glycolysis is essential for African trypanosomes living in the bloodstream of the
mammalian host because it Is their sole source of energy. They lack a functional Kreb's
cycle and mitochondrial ATP-synthesising respiratory chain and therefore entirely depend
on the aerobic conversion of glucose to pyruvate (Bowman and Flynn, 1976). Pyruvate is
excreted as a metabolic end product into the bloodstream.
The endosomes and lysosomes of trypanosomes are specialised structures, similar to
mammalian endosomes and lysosomes that contain hydrolytic enzymes (including
proteases and phosphatases) that break down endocytosed molecules (Lonsdale-Eccles and
Grab, 1987). Newly formed intracellular vesicles that have detached from the flagellar
pocket membrane travel into the cell where they fuse with endosomes and deposit their
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ingested material. This ingested material passes through the endosome [where protein
sorting is also thought to occur (Webster and Fish, 1989)], into lysosomes where the
intracellular digestion is completed. Proteases such as trypanopain-Tc from T. congolense,
which have been localised in lysosome-like organelles, are thought to digest endocytosed
materials (Lonsdale-Eccles and Grab, 1987; Mbawaetal., 1992). The breakdown products
such as amino acids then pass through the lysosomal membranes into the cell's cytoplasm,
where they can be used to synthesise new proteins (Ferguson and Williams, 1988).
Other cytoplasmic membrane systems include the Golgi apparatus, which is found between
the nucleus and the flagellar pocket, where glycosylation and packaging of the newly
synthesised proteins (including hydrolytic enzymes) occur (Bangs et al., 1986; Ferguson et
al., 1986). The endoplasmic reticulum may be rough containing attached ribosomes or
smooth without the associated ribosomes. These play a similar role as in other eukaryotes,
transporting proteins to the Golgi apparatus (Webster, 1989; Clayton et al., 1995).
1.4 Life cycle of African trypanosomes
Development in the insect vector
Trypanosomes, like many other parasites, assume different forms at different stages of
their complex developmental cycle (Fig. 1.3) (Vickerman, 1985; Vickerman et al., 1988).
The parasite shape, the position of the kinetoplast in relation to the nucleus, and the extent
of the flagellar apparatus identify the distinct morphological stages. For example, the
trypomastigote (trypanosome) stage has a post-nuclear kinetoplast and body-attached
flagellum, while the epimastigote (crithidial) stage has a prenuclear kinetoplast and similar
fiagellum, and the rounded immobile amastigote (leishmanial) stage lacks an emergent
flagellum. In T. brucei, two distinct morphological forms of trypanosomes are seen in the
bloodstream. Slender (dividing) forms predominate early in the infection while stumpy
(non dividing) forms are seen at declining parasitaemia (Vickerman, 1965; Hecker et al.,
1973)
The life cycle of T. brucei may be arbitrarily considered to begin when trypanosomes are
ingested by a feeding tsetse fly. The ingested parasites lodge in the fly's midgut, where the
stumpy trypanosomes (which are insect infective) transform into the so-called procyclic
stage. The slender forms die or change into stumpy forms in the anterior midgut.
Transformation to procyclic forms takes place in the posterior part of the midgut in the
endoperitrophic space. Morphological transformation is accompanied by an increase in
body length, elongation of the post-kinetoplastic portion of the body and repositioning of
the mitochondrial genome (Mathews et al., 1995). Concomitantly, glycosomes change
from spherical to bacilliform structures. The coat of variable antigen is progressively lost
and endocytosis diminishes (Steiger, 1973).
Figure 1.3. Schematic diagram showing the life cycle of T. brucei (adapted from Vickerman, 1985)
Procyclic development is associated with a switch from the use of glucose to that of
proline as the principal energy source. Interestingly, the tsetse itself uses proline as an
energy source for flight (Bowman and Flynn, 1976). The procyclic trypomastigote forms
migrate to the salivary glands where they become anchored by their flagella to the tsetse
fly epithelial cells. Here they multiply as a distinct morphological stage called the
epimastigote. These epimastigote forms have no obvious surface coat, and can divide.
After cessation of division, the epimastigote starts to express the variant surface
glycoprotein (VSG) coat once more (Tetley et al, 1987). This expression leads to
detachment and maturation as nondividing, infective, metacyclic trypomastigotes. The
VSG coat is a unique feature that facilitates the survival of the trypanosomes in their
mammalian host and will thus be discussed further in the subsequent section.
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Development in the mammalian host
When an infected tsetse fly feeds, it injects metacyclic trypomastigotes into the dermal
tissues of the host. Here a local inflammatory reaction, the 'chancre', develops (Roberts et
al, 1969). From the chancre the parasites migrate to the lymphatic system and the
bloodstream. They may traverse into connective tissues through the walls of blood and
lymph capillaries. Eventually, they cross the choroid plexus into the brain and
cerebrospinal fluid. In all these sites they multiply by binary fission with a doubling time
of about 6 hours in the case of T. b. gambiense (Seed, 1978). Because of the growth
characteristics of the parasites, and because of their interplay with the host's immune
system, parasitaemia fluctuates in a cyclical manner that corresponds to the growth of
different antigenic variants of the parasites. During ascending parasitaemia, parasites with
a particular antigenic type (called the 'homotype') form the major part of the population
(Van Meirvenne et al., 1975). When the host mounts an IgM response to the homotype,
parasitaemia goes into remission as trypanosomes of that variable antigenic type (VAT) are
killed (Seed, 1977)
In the case of T. brucei, the rapidly dividing bloodstream forms of the parasites are long
and slender. During the latter stages of a parasite growth-curve, the parasites stop dividing
and become short and stumpy. At this point parasitaemia goes into decline. It is believed
that short stumpy trypomastigotes can only continue the life cycle in the vector.
In addition to the homotype VAT, trypanosome populations contain minor VATs or
'heterotypes' that continue to multiply during remission (Van Meirvenne et al., 1975).
One of these VATs overgrows the others to give rise to a recrudescence of parasitaemia in
which it becomes the homotype. Again, parasitaemia peaks and goes into remission, and
so the process continues, to give the chronic, cyclic infection characteristics of African
trypanosomes.
1.5 Antigenic variation y
 r !
The key to the trypanosome's success is its ability to circumvent the mammalian immune
system. A mammal ordinarily defends itself against viruses, bacteria or protozoa such as
trypanosomes by producing specific antibodies directed against antigens it recognises on
the surface of the foreign organism. The antibodies bind to the antigens and either
neutralise the effects of the invading organisms or help to destroy them. Some antibody-
producing cells persist in the bloodstream and provide lasting immunity. A vaccine that
mimics a natural infection can also elicit such immunity. A humoral response is thought to
be more effective against organisms that invade the bloodstream as in malaria or African
trypanosomiasis, whereas cell-mediated immunity is the effective immune response against
parasites that grow within tissues (e.g. cutaneous Leishmaniasis or T. cruzi infection)
(Taylor, 1998).
Trypanosomes evade the host's specific immune response by changing their surface
glycoprotein. These variant surface glycoproteins or VSGs, form a 15 nm coat which
overlays the plasma membrane of the cell body and the flagellum of the bloodstream (and
metacyclic) forms of the parasites (Vickerman, 1969). The change in VSG coat, termed
antigenic variation, is a process that involves sequential synthesis and surface expression
of different VSGs during the course of infection (Cross, 1990; Vickerman, 1978). By the
time the immune system has made new antibodies to bind to the new antigens, some of the
trypanosomes have shed their coat and replaced it with yet another that is antigenically
distinct. Eventually, the host's overworked immune system becomes unable to cope with
this or other infections and the host succumbs.
Each VSG is encoded by a separate gene (Steinert and Pays, 1985). Changes of the VSG
coat are initiated by transcriptional activation of a new VSG gene (Pays et al, 1994). The
VSGs are synthesised in the rough endoplasmic reticulum, a process that takes 6 to 8 min
(Grab et al, 1984). The VSGs are then glycosylated and a glycosylphosphatidyl-inositol
(GPI) anchor added (Cross, 1990; Furguson and Williams, 1988). The VSGs are
transported to the Golgi apparatus and finally to the cell surface. The whole process takes
about 45 min (Bangs et al, 1986; Ferguson et al, 1986).
The expression of VSG is not only regulated throughout the life cycle of the parasite, but it
is also modulated during trypanosomal development in the blood. For example, non-
dividing trypanosomes (e.g. stumpy forms) do not undergo antigenic variation (Vickerman,
1985). Trypanosomes expressing different VSGs appear successively during chronic
infection. Although the repertoire of the VSGs appears unlimited, the timing of its
expression is not entirely random. Some VSGs are usually observed early in the infection,
while others emerge only later.
Two forms of VSG have been isolated; a membrane-form (mfVSG) (Cardoso de Almeida
and Turner, 1983) and a hydrophilic, water-soluble form (sVSG) (Cross, 1975). The
mfVSG is readily converted to sVSG, during extraction procedures, by a hydrolytic
process catalysed by mfVSG hydrolase, an endogenous phospholipase C-like enzyme
(Bulow and Overath, 1985). The conversion of mfVSG to sVSG is stimulated upon
parasite lysis, by Ca2+ in the presence of ionophores or benzyl alcohol (Jackson et al,
1985). However, mfVSG is not hydrolysed to sVSG so long as membrane integrity is
maintained. Interestingly, a localisation study indicated that the GPI-specific
phospholipase C in trypanosomes is found on the cytosolic face of vesicles and not at the
cell surface, and as such may not be directly responsible for VSG release in vivo (Bulow et
al, 1989).
Curiously, in order to purify mfVSG, protease inhibitors e.g. 1 mM tosyl-lysyl-
chloromethyl ketone (TLCK) and 0.2 mM phenylmethyl sulfonyl fluoride (PMSF) are
required to stop conversion of mfVSG to sVSG (Cardoso de Almeida et al., 1984). Since
these reagents are potent inhibitors of trypsin-like and chymotrypsin-like activities, it is
likely that proteases play a role in this conversion. Indeed, studies on the release of VSG
indicates that proteolysis is involved (Ziegelbauer et al, 1993).
1.6 Pathophysiological role of proteases
Proteases are important constituents of all eukaryotic organisms. In the case of protozoan
parasites, some of these enzymes are thought to assist the parasites by helping them to
evade the host immune system; for example, by degrading the antibodies directed against
the parasite (Russo et al., 1993, 1994; Donelson et al., 1998). They may also help the
parasites to invade host tissues or cells e.g. T .cruzi invasion of fibroblasts (Burleigh and
Andrews, 1995).
Since African trypanosomes are generally considered to be extracellular parasites, their
proteases are unlikely to be involved in cell invasion processes, although they may well
play roles in the penetration of different tissues. Indeed, there is evidence that African
trypanosomes release proteases into the host's bloodstream. Here the proteases may
adventitiously induce pathology by degrading host proteins and peptidyl hormones
(Nwagwu et al, 1988; Boutignon et al, 1990; Troeberg et al, 1996). In some cases, these
proteases are rapidly inhibited by endogenous protease inhibitors in the blood (e.g. the
trypanosome-released lysosomal cysteine proteases by cystatins) but in other cases they are
not (e.g. the trypanosome-released cytosolic serine endopeptidase called OP-Tb by serpins)
(Troeberg et al., 1996). Thus, unihibited, released proteases such as OP-Tb may play
important roles in disease pathology. However, such actions are probably secondary to
their nutritional and intracellular maintenance functions within the parasites themselves.
One proteolytic system that has been shown to be essential to the proliferation and cell
cycle transformation of trypanosomes, is the proteasome. Proteasome activity is required
for the transformation of T. cruzi trypomastigotes (non-replicative bloodstream forms) into
amastigotes (obligate intracellular replicative forms) since lactacystin or peptide aldehyde
MG132, both of which are inhibitors of the proteasome activity, prevents the intracellular
stage-specific transformation of these parasites (Gonzalez et al, 1996). Similarly,
inhibition of proteasome activity also blocks cell cycle progression in bloodstream and
procylic forms of T. brucei (Mutomba et al., 1997). Thus, it appears that proteasome-
mediated proteolysis is essential for the transformation and proliferation of trypanosomes.
Indeed, the two events may be tightly linked by proteasome activity. One possible
explanation of these observations is that the proteasome regulates cell division through
degradation of cyclins that act in different phases of the cell cycle (Glotzer et al., 1991;
Affranchino et al., 1993).
1.7 Characterisation and classification of proteases
Proteases are ubiquitous enzymes that catalyse the degradation of peptide bonds in
peptides or proteins. Their active sites consist of a catalytic site and substrate-binding
subsites. The latter are located on either sides of the point of cleavage of the substrate in
the active site cleft (Schechter and Berger, 1967). By convention, these specificity subsites
are numbered Si, S2, S3....Sn, away from the catalytic site towards the N-terminus of the
substrate, and Si', S21, S3'...Sn' towards the C-terminus (Fig. 1.4). The corresponding amino
acid residues of the substrate fitting into these pockets are designated as Pi, P2, P3 ....Pn on
the N-terminal and Pi', P2', P3'....Pn' on the C-terminal of the peptide bond being cleaved,
respectively.
There are two major types of proteases (peptidases): endopeptidases and exopeptidases
(Barrett and Rawlings, 1991). Endopeptidases are also known as proteinases and catalyse
the cleavage of an internal peptide bond within a protein. Exopeptidases catalyse the
cleavage of one or two amino acids from the extreme amino terminus (aminopeptidases) or
carboxyl terminus (carboxypeptidases) of a protein or peptide.
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Figure 1.4. Schematic diagram of the subsite specificity of a protease.
Pi Pi' are the side chains of six substrate amino acids, and Si ...S2' are the corresponding subsites on the
enzyme (Schechter and Berger, 1967)
Typically proteases are classified into five distinct groups on the basis of the chemical
groups that are responsible for their catalytic activity (Fig. 1.5). They are the serine,
cysteine, metallo-, aspartic, threonine and serine proteases (Barrett and Rawling, 1991;
Seemuller et al, 1995). These groups of proteases are most easily distinguished by
appropriate type-specific inhibitors. The endopeptidases in each of these five groups are
further categorised into families on the basis of'evolutionary line'.
The term 'family' refers to a group of peptidases in which the amino acid sequence of the
part of the protein responsible for catalytic activity shows a statistically significant
relationship to that of at least one other member (Barrett and Rawling, 1995). Members of
the same family are homologous and are believed to have a single evolutionary ancestor.
Such indications come primarily from the linear order of catalytic site residues in the











Calpain Papain Pepsin Retropepsin Chymotrypsin Subtilisin
I I I
Chymotrypsin-like Trypsin-like Elastase-like enzyme
Figure 1.5. Scheme of nomenclature of proteases adapted from Barrett and Rawling, 1991 and
Seemuller et al, 1995
1.7.1 Metalloproteinases
The metalloproteinases are widespread in bacteria, fungi, and in higher organisms. Their
active site clefts contain a metal ion that plays a key role in substrate binding and catalysis.
For example, in thermolysin (from Bacillus thermoproteolyticus) a zinc atom held in
position by two closely spaced histidine side-chains, and a more remote glutamate residue
(Bode et al, 1992) are crucial for catalytic activity. Thermolysin also has four binding
sites for Ca2+, but this ion is important for enzyme stabilisation rather than catalytic
activity.
The catalytic activity of metalloproteinases is usually inhibited by metal ion chelators such
as EDTA. These enzymes typically show maximal activity at about pH 7.0. They seldom
cleave bonds other than true peptide bonds between amino acid residues. These residues
typically have non-polar side chains, and often a bulky hydrophobic residue such as
leucine or phenylalanine is favoured in Pi. Many of the mammalian metalloproteinases are
secreted from cells as zymogens that can be activated by limited proteolysis. Most
families of metalloproteinases have a conserved -His-Glu-Xaa-Xaa-His (or 'HEXXH)
sequence that is thought to be involved in binding zinc at the active site cleft (Becker and
Roth, 1992). Included in this group are carboxypeptidase A and B from mammalian
pancreas, astacin from the crayfish digestive gland, membrane-bound metalloproteinases
of Leishmania (Etges and Bouvier, 1993) and African trypanosomes (El-Sayed and
Donelson, 1997). The membrane-bound metalloproteinases may be involved in
extracellular digestion of host proteins for parasite nutrition or to assist in the penetration
of host cells and tissues e.g. penetration of the walls of blood and lymph capillaries by the
trypanosomes.
1.7.2 Aspartic proteinases
Aspartic proteinases have been found in all studied organisms. However, they are scarce
in bacteria. Most of the fungal and mammalian aspartic proteinases have pH optima
between 2.5-4.5. The important catalytic site residues of these enzymes are two carboxyl
groups contributed by a pair of aspartic acid residues. The aspartic proteinases act best on
peptide bonds between bulky hydrophobic amino acid residues such as Leu-Tyr, Tyr-Leu,
Phe-Phe and Phe-Tyr bonds. The fungal aspartic proteinases have been reported to have
relative molecular masses in the range of 30 000-45 000 and isoelectric points below pH
5.1 (North, 1982). There are two major groups of aspartic proteinases: the pepsin and
retropepsin families.
1.7.2.1 Pepsin family
The pepsin family includes pepsin and chymosin found in the mammalian stomach, plasma
renin whose protein substrate is angiotensinogen, and the lysosomal cathepsins D and E.
The gastric proteinases of higher animals are secreted as zymogens that are converted to
active enzymes by proteolytic cleavage of an N-terminal extension of the propolypeptide
chain. The limited proteolysis is initiated at acid pH by the zymogens themselves. Pepsin
A is irreversibly inactivated at and above neutral pH (i.e. when it leaves the stomach and
enters the small intestine). Enzymes of the pepsin family are bilobed molecules with the
active site cleft located between the lobes and each lobe contributing one of the pair of
aspartie (Asp32 and Asp215) residues that is responsible for catalytic activity (Rawlings and




In contrast to pepsin, retropepsin consists of a single lobe and carries only one catalytic
aspartic acid residue, so that formation of the active enzyme requires the formation of a
non-covalent homodimer. The retropepsin family includes the retroviral endopeptidases
such as those of the human immunodeficiency virus (HIV). These enzymes play an
essential part in the viral life cycle. For example, an aspartyl proteinase, HTV-1 PR is
required for proper protein processing and production of infectious virions (Seelmeier et
ai, 1988). Recently, protease inhibitors have been introduced as a part of the regimen for
the treatment of HIV-infected patients. Among the parasitic protozoa, aspartic proteases
has been reported in Plasmodium falciparum (Vander jagt et al., 1989). The acid pH
optimum implies a lysosomal localisation of aspartic proteases in parasitic protozoa. Thus
aspartic proteases may be involved in the lysosomal intracellular degradation of proteins in
the parasite but this has not been demonstrated.
1.7.3 Cysteine proteinases
Cysteine proteinases are found in bacteria, eukaryotic microorganisms, higher plants and
animals. Many occur within the intracellular vacuoles of plant cells and lysosomes of
animal cells. Cysteine proteinases are recognized by their sensitivity to inhibition by thiol
blocking agents. Although trans-Epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64)
(Sreedharan et al., 1996) is generally regarded as the definitive cysteine proteinase
inhibitor, many inhibitors of peptidases of other catalytic types can also inhibit cysteine
proteinases. These inhibitors include organomercurial compounds, leupeptin, chymostatin
and antipain (Bontempi et al., 1984). There are two superfamilies of cysteine proteinases:
papain-like and calpains.
1.7.3.1 Papain family
Papain is the standard against which most cysteine proteases are compared. It is a cysteine
proteinase from the latex of the plant Carica papaya. There are two branches of the papain
superfamily; one branch includes mammalian cathepsins L and H, and the plant
proteinases; the other branch contains mammalian cathepsin B and cysteine proteinases
thus far found in helminths (Rawlings and Barrett, 1993). The enzymes range in size from
212 amino acid residues (papain, 23.4 kDa) to 252 amino acid residues (cathepsin B, 29.0
kDa). Cysteine proteinases contain a thiol-imidazolyl system within the active site. The
active site residues involved in catalysis are Asn157, Cys25 and His159 (papain numbering).
Catalysis proceeds via a thiol ester formed transiently between the substrate and Cys25.
Side chains of adjacent residues, including His159 facilitate ester bond formation. Cysteine
proteinases tend to have a broad specificity with respect to protein and peptide sequences,
but may show a preference for arginine at the Pi position and an arginine or a hydrophobic
residue at the P2 position.
Cysteine proteinases with cathepsin L-like activity have been studied in a number of
parasitic protozoa including Entamoeba histolytica (Reed et al, 1989), Leishmania
mexicana (Coombs et al, 1991), Plasmodium spp. (Rosenthal et al, 1991) and
epimastigotes of T. rangeli (Labriola and Cazzulo, 1995). In bloodstream trypomastigotes
of T. brucei (Lonsdale-Eccles, 1991; North, 1991), a cathepsin L-like activity has been
reported to play a role in degradation of internalised anti-VSG antibodies (Mbawa et al,
1991a; Russo et al, 1993). Like most cysteine proteinases, trypanopain-Tc from T.
congolense is most active at slightly acid or neutral pH. For maximum activity in vivo it
requires the presence of reducing agents such as dithiothreitol (Mbawa et al, 1991a, 1992).
Micromolar concentrations of peptidyl cysteine proteinase inhibitors arrest parasite
replication and trypomastigote-amastigote differentiation (Ashall, 1990; Mereiles et
al. 1992; Harth et al, 1993; Scory et al, 1999; Troeberg et al, 1999). In addition, cysteine
proteinase inhibitors prevent the normal autocatalytic processing and trafficking of a
cysteine proteinase within the Golgi apparatus in T. cruzi (Engel et al, 1998). Thus,
cysteine proteinases of trypanosomes are potential targets for chemotherapy in
trypanosomiasis.
1.7.3.2 Calpain family
The calpain family of cysteine proteinases is comprised of calcium-dependent cysteine
proteinases that show maximal activity at about pH 7.8. They are widely distributed in
invertebrate and vertebrate animals where they occur mainly in the cytosolic fraction of
cells. The calpains exist as heterodimers comprising two subunits of 80 and 30 kDa. The
large subunit is homologous to papain and contains a segment (towards the N-terminus)
responsible for the proteolytic activity of the molecule. The 30 kDa subunit plays a
regulatory function. The C-terminal segments of both subunits show homology with the
calmodulin family of calcium-binding proteins, containing calcium-binding sites similar to
those of the calmodulins. The Ca2+ in the calpains is thought to
function by mediating a conformational change in the active site as opposed to the Zn2+
atom in metalloproteinases that function directly in the catalytic mechanism. Calpains are
specifically inhibited by calpastatin. Calpastatin is thought to inhibit the activity of calpain
by chelating the Ca2+ ion. Although a protease of the calpain family has not been isolated
from trypanosomes, a conserved sequence has been reported suggesting the presence of a
calpain-like molecule in T. b. rhodesiense (El-Sayed, etal, 1995).
1.7.4 Serine proteases
Serine proteinases are the most numerous, diverse and widely studied endopeptidases.
They are found in prokaryotic and eukaryotic microorganisms, and in vertebrate and
invertebrate animals. They are so named for the amino acid serine, whose hydroxyl group
is involved in the binding and catalysis of the substrates. The active site of serine
proteinases consists of a catalytic triad comprising an aspartate, a histidine and a serine
residue. There are two major families of serine endopeptidases, the chymotrypsin and
subtilisin families (Barrett and Rawlings, 1995). Serine proteases are readily inhibited by
both natural and synthetic inhibitors such as a.2- macroglobulin, ai-antichymotrypsin, cci-
antitrypsin, aprotinin, chymostatin, leupeptin, antipain and chloromethylketones.
However, a diagostic test for serine proteinases is the inhibition by DFP that inhibits the
enzyme by affinity labelling the serine residue at the active site.
1.7.4.1 Chymotrypsin family
The catalytic triad in chymotrypsin-related proteinases is arranged in the order His/Asp/Ser
and they are inhibited by diisopropylfluorophosphate (DFP). The chymotrypsin-related
enzymes can be grouped into three categories on the basis of their primary subsite
specificity: chymotrypsin-like, trypsin-like, and elastase-like enzymes (Rawlings and
Barrett, 1993; Barrett and Rawlingss, 1995). Chymotrypsin-like enzymes primarily
hydrolyse peptide bonds at the carboxyl group of hydrophobic amino acid residue (e.g.
tryptophan or phenylalanine). Trypsin-like enzymes have specificity for basic side chains
(e.g. arginine and lysine) in the Pi position and elastase-like enzymes exhibit a preference
for small aliphatic residues (e.g. alanine) in the Pi position. An example in this group is
trypsin-like oligopeptidase (OP-Tb) that has recently been isolated from T. brucei
(Kornblatt et al, 1992; Morty et ai, 1998). It has been demonstrated that T. brucei
releases OP-Tb, and it has been postulated that this enzyme may induce pathology during
infection by degrading host peptidyl hormones (Troeberg et al, 1996) because the protease
inhibitors normally present in blood (serpins) fail to inhibit the activity of OP-Tb.
1.6.4.2 Subtilisin family
Members of the subtilisin family are widely distributed in microorganisms, plants and
higher animals. The subtilisins have the same triad of catalytic residues as the
chymotrypsin family but in the order Asp/His/Ser in the polypeptide chain (Barrett and
Rawlings, 1991, 1995). However, the tertiary structures of chymotrypsin and subtilisin
families have quite different folding patterns. Typical bacterial subtilisin contains no
cysteine, and thus no disulfide bonds. Thermitase from Thermoactinomyces vulgaris
contains a single cysteine residue close to the catalytic histidine. This is retained in many
eukaryotic homologues such as proteinase K and yeast proteinase B (Moehle et al, 1987).
This thiol group can react with some thiol-reactive reagents, so that the enzymes are
inhibited, much as if they were cysteine endopeptidases. Most subtilisins require Ca2+ions
for activation and stabilisation. Subtilisin homologues from yeast to man function in the
processing of precursor proteins. For example, the cleavage at paired basic residues that
occurs in the maturation of numerous mammalian proteins including insulin and the
adrenocorticotropic hormone (ACTH)-related hormones. There are no reports available on
proteases of the subtilisin family among the parasitic protozoa.
1.6.5 Threonine proteinases
The catalytic mechanism of the proteasome (Lowe et al, 1995; Seemuller et al., 1995) is
distinct and different from the typical 'serine', 'cysteine', 'aspartic' and 'metallo'-
proteinases (Barrett, 1980). Active site-directed mutagenesis experiments with a
recombinant proteasome from Thermoplasma have shown that the proteasome represents a
new class of proteases referred to as 'threonine' proteases (Seemuller et al, 1995). The
protease is a high molecular mass multicatalytic protease complex (MCP) that forms an
essential component of the intracellular, ATP-dependent proteolytic pathway. The term
'proteasome' was proposed by Arrigo et al. (1988) to indicate the proteolytic and
paniculate nature of the protein. The proteasome is responsible for the degradation of
most cellular proteins (Rock et al, 1994) and is necessary for cell viability (Tanaka, 1995).
This particle is the major neutral proteolytic activity in mammalian cells and constitutes up
to 1% of the cell protein (Tanaka et al, 1986). However, its concentration varies
considerably among cell types and is greater in organs (e.g. liver) in which average rates of
protein breakdown are higher than in other tissues such as muscle (Tanaka et al, 1986).
Proteasomes are present in the nuclei, microsomes and cytosol of all eukaryotic cells
examined (Rivett et al, 1992; Peters et al, 1994). Specific examples are Saccharomyces
cerevisiae (Groll et al., 1997), Entamoeba histolytica (Scholze et al, 1996) T. cruzi
(Gonzalez et al, 1996) and in T. brucei (Hua et al, 1996; To and Wang, 1997; Lomo et
al, 1997). Some particles are also found associated with the endoplasmic reticulum
(Palmer et al, 1996). The proteasome has been reported in prokaryotic cells including
Rhodococcus erythropolis (Tamura et al, 1995) and Thermoplasma acidophilum
(Seemullere/a/., 1995).
There are two distinct forms of the particle, the 20S (700 kDa) and the 26S (2000 kDa)
proteasome complexes. These forms of the proteasome may be distinguished by the ability
of 20S proteasome to degrade certain denatured or oxidized proteins in the absence of ATP
in vitro, whereas the 26S complex requires ATP for activity (Tanaka, 1998). Structurally,
the larger 26S complex consists of the 20S proteolytic core and approximately 20
additional polypeptides found in a distinct complex called the 'PA700 proteasome
activator', or the '19S complex' (Chu-Ping et al, 1994). These individual complexes will
now be considered in greater detail in the subsequent sections.
1.7.5.1 20S Proteasome
The 20S proteasome is a cylinder-shaped particle composed of four stacked rings. It has a
diameter of approximately 11 nm, a length of about 15 nm and an internal cavity (Lowe et
al, 1995; Groll et al, 1997). This particle contains multiple subunits ranging in size
between 20-35 kDa and has a molecular mass of 700 kDa. The 20S proteasome of
archaebacterium, Thermoplasma strongly resembles the eukaryotic 20S proteasome in its
quarternary structure. However, the proteasome from Thermoplasma contains only two
distinct types of subunits, a and p (Koster et al, 1995) (Figure 1.6). Electron microscopic
and X-ray crystallographic analyses have shown that its two outer rings contain only a
subunits, and its two inner rings only P subunits (Lowe et al, 1995). The particle has 7
subunits per ring arranged in the order a7P?P7a7 (Coux et al, 1996). A recent report (Groll
et al, 1997) shows that the yeast (S. cerevisiae) 20S proteasome is similar in size and
shape to the archaebacterial proteasome. However, it is much more complex having seven
different a-type and seven different P-type subunits arranged in four stacks in the order
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(ai...a7, pi...p7)2 The proteasomes from eukaryotes are even more complex. Their
subunit pattern consists of multiple a and (5 type subunits related to either a or (5 subunits
of the Thermoplasma proteasome (Tanaka, 1998).
Figure 1.6. Structure of a- and (3- subunits of Thermoplasma acidophilum proteasome.
The active site residues of the P- subunits Thr 1, Glu 17 and Lys 33, are shown in ball- and -stick (yellow)
representation. Helices are shown in red, (3-Strands and loops are blue (Baumeister et al. 1997).
The subunit compositions of the 20S proteasome of eukaryotic cells can vary in a given
species and are subject to precise regulation. For example, y-interferon treatment of cells
induces the replacement of three P subunits by distinct, newly synthesised subunits, the
LMP1, LMP2 and MECL1 subunits (Brown et al, 1993; Akiyama et al, 1994). These
alter the activity of the proteasome to favour antigen presentation over other functions
(Gaczynska et al., 1993).
Nearly all a and P subunits contain several glycine residues and a common GXXXD motif.
However, the amino acid sequences of a and P families differ in several respects. The a
subunits are more conserved than the P, both within a given species and between species
(Coux et al, 1994). The main difference between a- and P-type subunits lies in a highly
conserved N-terminal extension of the a-type subunits, part of which (residues 20-30)
forms an a-helix across the top of the central (5 sandwich (Fig. 1.6). All a subunits contain
an RPXG motif. Several of the a subunits contain nuclear localization signals (NLS), as
well as putative motifs that are complementary to the NLS (cNLS) that regulate nuclear
localization (Nederlof et al, 1995). Phosphorylation is thought to regulate proteasome
translocation across the nuclear membrane by inducing conformational changes that
modulate its binding to the NLS receptor on the nuclear pore (Castano et al, 1996).
The a subunits by themselves have the capacity to form rings, but the P-subunits do not.
Thus, the assembly of the a-rings is a prerequisite for the formation of the P-rings (Zwickl
et al, 1994). The a subunits constitute a physical barrier that limits the access of cytosolic
proteins into the inner proteolytic chamber (Lowe et al, 1995). The unfolded polypeptide
substrates wind their way through the outer cavities (by unknown mechanism) to the
proteolytic active site cleft in the central cavity. The polypeptides are then degraded to
peptides of narrow size range (4 to 10 residues) (Wenzel et al, 1994; Ehring et al, 1996).
In vertebrates, the focused product length of the proteasome has been exploited by the
immune system for production of peptides displayed by the class 1 major
histocompatibility complex (MHC I) (Rock et al, 1994; Heemels and Ploegh, 1995).
1.7.5.2 Mechanism of action
The proteasome fold is prototypical of a new family of proteins called the N-terminal
nucleophile (Ntn) hydrolases which have a unique, "single-residue" active site (Brannigan
et al, 1995, Duggleby et al, 1995). In Thermoplasma proteasome, the single-residue is
the N-terminal Thr of the P subunit which serves both as the catalytic nucleophile and the
primary proton acceptor (Lowe et al, 1995; Seemuller et al, 1995). The nucleophilic
attack is initiated when the free N-terminus (the primary proton acceptor) removes the
proton from the catalytic residue's side chain (the nucleophile). This transfer, at least in the
proteasome and penicillin cyclase, involves an intermediate water molecule (Fig. 1.7).
Three different N-terminal residues can act as the nucleophile in Ntn hydrolases: serine
(penicillin acylase), cysteine (glutamine PRPP amidotransferase), or threonine (the
proteasome) (Brannigan et al, 1995; Lupas and Baumeister, 1998). In all Ntn hydrolases,
the amide backbone group of a residue at the C-terminal end of Strand P4 (Gly 47 in
Thermoplasma p subunit) is involved in forming the oxyanion hole. Besides the N-
terminal threonine, the proteasome requires two further residues for activity (Seemuller et
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al., 1995, 1996): a lysine residue (Lys 33 in Thermoplasma 3 subunit) and a glutamic acid
residue (Glu 17 in Thermoplasma P subunit). The exact role of Lys 33 and Glu 17 is yet to
be clarified. However, they form a salt bridge across the bottom of the active site. This
may lower the pKa of the N-terminus by electrostatic effects, thus facilitating its function
as a reversible proton acceptor, or it may actually participate in the delocalisation of the















Figure 1.7. Putative catalytic mechanism of the 20S proteasome
Panel A shows the general mechanism of Ntn hydrolases and panel B the potential involvement of 0Lys33
and PGlu 17 as a charge relay system in the delocalization of the (3Thrl side-chain proton (after Lupas and
Baumeister, 1998)
A third residue (Asp 166 in Thermoplasma (3 subunit) may also be involved in formation
of the active site, possibly via electrostatic effects, as its mutation in Thermoplasma
inactivates the proteasome (Seemuller et al., 1996)
1.7.5.3 26S Proteasome
The 26S proteasome is a very large protease complex with a molecular mass of
approximately 2000 kDa (Koster et al, 1995). It is formed by a central 20S core complex
and two 19S cap complexes that associate with the two termini of the core in an energy
dependent manner (Chu-Ping et al, 1994). The PA 700 (or 19S cap) complexes are
composed of 18 different subunits that range in molecular mass from 25 to 110 kDa. PA
700 is thought to function as the 'mouth' of the proteolytically active 20S core. It provides
components necessary for the selective degradation of ubiquitinated proteins. These
include binding sites for Ubiquitin (Ub)-chains (Deveraux et al, 1994), isopeptidase
activity and many ATPases, as well as the capacity to activate the peptidase activities of
the 20S particle.
The structure of the 26S complex is shown in Figure 1.8. It is a labile structure that is
stabilized in vitro by glycerol and ATP. In contrast to the 20S proteasome which degrades
unfolded proteins in an energy-independent manner (Hilt and Wolf, 1996), degradation by
the 26S complex is ATP-dependent and directed towards ubiquitinated and certain non-
ubiquitinated proteins. The polypeptides comprising the 19S regulatory component of the
26S complex consist of ATPase and non-ATPase subunits. These ATPase subunits are
thought to be responsible for the unfolding and transport of substrate proteins into the 20S
core. The non-ATPase subunits do not belong to the ATPase family and lack the capacity
to bind ATP (Dubiel et al., 1992). These subunits are thought to serve diverse functions
such as allowing association and activation of the 20S particle, capture of substrates,
release and disassembly of the poly-ubiquitin chains, maintenance of the particle's
structure, and delivery of the substrate into the 20S particle (Koster et al., 1995; Coux et
al, 1996;Baumeisterefa/., 1997, 1998).
In eukaryotic cells, degradation of many proteins proceeds via a polyubiquitination
process. This involves an initial modification of the protein by conjugation to ubiquitin
(Hochstrasser, 1996). This is a complex process involving the formation of a thioester
bond at the C-terminus of ubiquitin. This reaction is catalysed by the ubiquitin activating
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enzyme El. Ubiquitin is then transferred to the active cysteine group of the soluble
ubiquitin carrier protein E2. The E2 transfers the attached ubiquitin to the £-amino groups
of lysine residues of a protein substrate. This process in some cases needs cooperation
with a ubiquitin protein ligase E3 (Hochstrasser, 1996). After its poly-ubiquitination, the
protein substrates are recognized by the 26S proteasome and rapidly degraded into
peptides.
s
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Figure 1.8. Contour plot of the 26S proteasome complex with putative functions assigned to parts of
the complex (Koster et aL, 1995)
The eukaryotic proteasome was originally defined as a proteinase containing three active
sites capable of cleaving peptide bonds after hydrophobic, basic and acidic amino acid
residues. Thus the proteasome was considered to have chymotrypsin-like, trypsin-like and
peptidylglutamyl peptide bond hydrolysing (PGPH) activities (Cardozo et al, 1993). On
the basis of studies with small synthetic peptides and protease inhibitors, as many as five
distinct proteolytic activities have been assigned to the eukaryotic proteasome (Orlowski et
al, 1993). The newer activities were termed "branched chain amino acid preferring" or
BrAAP and "small neutral amino acid preferring" or SnAAP. Pereira (1992a) also
defined a distinct catalytic activity responsible for the initial degradation of P-casein,
termed 'caseinolytic". These activities appear to be catalyzed by distinct active sites.
Point mutations in P subunits, or changes in subunit composition (e.g. after y-interferon
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Point mutations in P subunits, or changes in subunit composition (e.g. after y-interferon
treatment) alter these activities differentially (Hilt and Wolf, 1995). These activities are
inactivated by 3,4-dichloroisocoumarin (DCI) (Cardozo et al, 1992) whereas the activities
of BrAAP and SnAAP appear to be stimulated (Orlowski et al, 1993). The proteasomes
of Thermoplasma and Rhodococcus have only one major "chymotryptic"activity
(Dahlmann et al, 1992; Tamura et al, 1995), in accordance with the fact that they have
only one type of active site.
Three energy-independent large protease complexes have been described, which are
traversed by a channel that widens into a large cavity. These are bleomycin
hydrolase/Gal6 (Joshua-Tor et al, 1995), the tricorn protease (Tamura et al, 1996) and a
giant protease (Geier et al, 1999). Bleomycin hydrolase is a papain type cysteine protease.
However, the active sites of the tricorn protease or the giant protease have yet to be
defined.
1.7.5.4 Regulation of proteasome proteinase activities
Precise regulatory mechanisms must have evolved to allow selective protein breakdown in
the cytosol and nucleus while preventing generalised proteolytic damage to the cell. Two
structural features of the proteasome, the inclusion of its proteolytic sites within the
internal chamber, and the restricted opening of the a-rings, reduce the chances of non-
specific digestion of cell constituents (Baumeister et al, 1998). In eukaryotes the
requirement for ubiquitination of substrates and the machinery of the 19S complex
probably evolved to ensure further selectivity. In addition, certain inherent regulatory
properties and cellular inhibitory factors appear to help maintain the proteasome in an
inactive form. The activity of the 20S proteasome is latent in freshly prepared extracts or
when isolated by gentle methods. These proteasomes are inactive against protein
substrates and degrade peptide substrates only slowly. Glycerol helps maintain the particle
in a latent state (McGuire et al, 1989) and presumably preserves the 20S and 26S
complexes in their most physiological forms (Dahlmann et al, 1992).
Dramatic stimulation of proteasome activities can be induced by various treatments of the
crude proteasome containing extract, for example: by performing purification in the
absence of glycerol, by incubation at 37°C, by heating at 55°C, by dialysis against water
and by incubating with basic polypeptides, SDS, guanidine hydrochloride, or fatty acids
(Rivett, 1993). Most treatments that activate the 20S particle are known to disturb protein
conformation. Thus, activation presumably involves either a conformational change in the
P subunits that enhances catalytic activity, or an alteration in the a ring that facilitates
substrate entry. Such modulatory effects may be mediated in vivo by specific endogenous
activators or protein inhibitors. Several different endogenous inhibitors have been
identified including a 200 kDa protein composed of identical 50 kDa subunits (Li and
Etlinger, 1992); a 240 kDa protein (a hexamer of a 40 kDa subunit) (Guo at al, 1994); and
a 60 kDa inhibitor protein (a dimer of a 31 kDa subunit) (Chu-Ping et al, 1992).
Protein complexes that associate with the eukaryotic 20S proteasome, and dramatically
enhance its activity, have also been characterised. One is PA 700 (Chu-Ping et al, 1994).
This is the 19S complex that combines with the 20S proteasome in an ATP-dependent
reaction to form the 26S complex. Another activator is PA28 (Chu-Ping et al, 1992;
Kuehn and Dahlmann, 1996). This is the US regulator that associates with the 20S
proteasome in the absence of ATP (Kania et al, 1996). Interestingly, a recent report
indicates that the 20S proteasome can bind both PA700 and PA28 simultaneously to form
an even larger ternary complex (Hendil et al, 1998), but the significance of this is not
clear.
Proteasome activities are inhibitable by specific peptide aldehydes. Thus, acetyl-Leu-Leu-
norleucinal (also called calpain inhibitor 1) and chymostatin reversibly inhibit the
chymotrypsin-like activity, while leupeptin inhibits the trypsin-like activity (Wilk and
Pereira, 1993). Cbz-Leu-Leu-leucinal (MG132), is a potent inhibitor of the chymotryptic,
postglutamyl, and BrAAP activities (Jensen et al, 1995). Since MG132 readily enters
cells (Reed et al, 1995) it may prove to be useful for intracellular studies. A similar, but
less potent inhibitor is Cbz-Leu-Leu-norvalinal (MG115) (Rock et al, 1994). It may also
prove to be a useful probe. A specific proteasome inhibitor that is not known to inhibit any
other protease is the natural product lactacystin (Fenteany et al, 1995). Lactacystin is
converted in aqueous solution to lactone, which modifies N-terminal threonine residue
involved in the catalysis by proteasomes (Dick et al, 1996). The serine protease inhibitor
DCI can also block multiple activities of the proteasome (Cardozo et al, 1992) by reacting
with the N-terminal threonine residues of the P subunits. However, DCI is much less
specific and, under certain conditions, activates the proteasome (Cardozo et al, 1992).
Hence, it may not be useful for studies in intact cells.
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Some of these agents block up to 90% of proteolysis in cultured mammalian cells,
including the degradation of highly abnormal proteins, as well as the short- and long-lived
normal proteins (Rock et al, 1994). Thus, the proteasome may be implicated as the
primary site for breakdown of most proteins in growing cells. However, other proteolytic
systems (e.g. lysosomal proteolysis) can be important in non-growing cultures and in
specialised cells (Gronostajski et al., 1984; Scory et al. 1999).
1.7.5.5 Cellular functions of the proteasome
The primary function of the proteasome is to catalyze the breakdown of proteins into small
peptides, most of which are then hydrolysed to amino acids. The proteasome may also be
important in removal of abnormal proteins (Hilt and Wolf, 1995). The ubiquitin-
proteasome pathway has been shown to catalyse the regulated proteolytic processing of a
large, inactive precursor into an active protein, NF-KB (Palombella et al., 1994). NF-KB is
a transcriptional regulator for the excretion of various proteins critical in immune and
inflammatory responses, including cytokines and adhesion molecules (Read et al., 1995).
One of its subunits, p50, is generated by proteolytic processing of an inactive 105 kDa
precursor. The p50 is then maintained in the cytosol together with the p65 subunit in an
inactive complex that is bound to an inhibitory protein IKBCX. Inflammatory signals (e.g.
TNF-oc) activate NF-KB by signalling the complete degradation of the inhibitor, lkfia, and
stimulating the proteolytic processing of the pl05 precursor, catalysed by the 26S
proteasome (Palombella et al., 1994).
In higher vertebrates, the proteasome is thought to generate the peptides presented by
MHC class I molecules of circulating lymphocytes (Rock et al, 1994; Dick et al., 1996).
In this process, peptides generated during protein breakdown are transported into the
endoplasmic reticulum via TAP1/TAP2 transporter. Here they are bound to MHC class I
molecules before delivery to the cell surface. The presentation of these peptides enables
the immune system to screen for and destroy, cells expressing viral or other unusual
polypeptides. Indeed, the proteasome-specific inhibitor lactacystin blocks the generation
and presentation of antigens by human and murine MHC class 1 molecules to cytotoxic T
lymphocytes (Rock et al, 1994, Cerundolo etal, 1997).
The proteasome also play a key role in cell-cycle regulation. Eukaryotic cell division is
controlled by cyclin-dependent protein kinases (CDKs). The appearance and
disappearance of active kinase complexes during different phases of the cell cycle is
regulated by synthesis and proteolytic degradation of specific cyclins (Yaglom et al,
1995). There is evidence that the proteasome might be important for cell cycle regulation
by degrading cyclins that act in different phases of the cell cycle (Glotzer et al, 1991).
Further, proteasome-mediated proteolysis has been implicated in apoptotic cell death
(Drexler, 1997)
Finally, the proteasome also functions in the regulation of various metabolic adaptations.
For example, the 26S complex degrades ornithine decarboxylase (ODC) in a ubiquitin-
independent manner (Hershko and Ciechanover, 1998). This is a short-lived, rate-limiting
enzyme in polyamine biosynthesis. Because polyamines are toxic in high levels, cells have
evolved negative feedback mechanisms to inactivate and rapidly degrade ODC.
Accumulation of polyamines induces the specific inhibitory protein, antizyme (AZ)
(Hayashi and Murakami, 1995). AZ binds to ODC, inactivates it and triggers its
degradation. When associated with AZ, ODC is rapidly hydrolyzed by the ATP-dependent
26S complex.
1.8 Objectives of the current study
Proteases play diverse functions in the parasite life cycle and pathology of parasitic
infections (Lonsdale-Eccles, 1991; North, 1991). So far different classes of proteases have
been identified and characterised in parasitic protozoa, including cysteine proteases from
T. brucei (Mottram et al, 1989; Troeberg et al, 1996), T. congolense (Mbawa et al,
1991b), T. cruzi (Engel et al, 1998), a trypanosome-released cytosolic oligopeptidase
(Morty et al, 1998) and membrane-bound metalloproteinases of T. brucei (El-Sayed and
Donelson, 1997) and Leishmania (Etges and Bouvier, 1993). Whereas MCP is ubiquitous
and has been studied extensively in archaebacterium Thermoplasma and eukaryotic cells
(reviewed by Coux et al, 1996; Tanaka, 1998), there is a dearth of information on MCP
from parasitic protozoa.
MCP is the major non-lysosomal proteolytic system that plays a central role in cytosolic
and nuclear proteolysis (Section 1.7.5.5). The physiological role of the MCP has been
shown to be necessary for cell viability. Considering that the MCP plays a central role in
key processes in the parasite, together with the established role of proteases in
pathogenesis of parasitic diseases (Section 1.5), a better understanding of the structure and
function of MCP may be essential for designing drugs or vaccines targeting the parasite
MCP or MCP components.
The objectives of this study were to characterise a multicatalytic protease complex from T.
brucei (MCP-Tb) and compare its biochemical and structural properties with the well-
characterised MCP from bovine host (MCP-rbc). To achieve this, MCP-Tb and MCP-rbc
were purified from T. brucei and bovine red blood cells respectively (Chapter 3). A
number of the fundamental characteristics of the enzymes were investigated, including
substrate specificity, inhibition and pH profiles (Chapter 3).
Once purified, structural studies on MCP-Tb and MCP-rbc were carried out by electron
microscopy as described in Chapter 4. The N-terminal sequence of a subunit of MCP-Tb
was determined for comparison with the primary structures of other proteasomes. The
need to study the possible role of MCP-Tb in post-translational processing of VSG
necessitated purification of VSG from T. brucei. Antibodies were raised against both VSG
and MCP-Tb in chickens. The anti-MCP-Tb antibodies were used to assess antigenic
similarities between the parasite MCP-Tb and the host MCP-rbc and to study the effect of
the antibody on the catalytic activity of MCP-Tb (Chapter 4).
MCP-Tb was localised in the parasite using biochemical and immunocytochemical
methods (Chapter 5). The antibodies raised against MCP-Tb and VSG were used for the
immunolocalisation studies. Considering that trypanosome proteases may be actively or
constitutively secreted, or simply released into the host bloodstream upon complement
mediated lysis, the possible interaction between the parasite MCP-Tb and the host
regulatory molecule, proteasome activator PA700 was investigated. Proteasome activator
PA700 was purified from bovine red blood cells and its effect on MCP-Tb activity was
tested in vitro (Chapter 6).
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Chapter 2
General materials and methods
2.1 Introduction
The experimental techniques used in this study mostly involved protein purification and
characterisation, and immunochemical protocols. For convenience, this chapter presents the
basic techniques common to the different areas covered in this study. In order to maintain the
logical sequence of information presented, those techniques pertaining to specific areas of study
will be described in the relevant chapters.
2.2 Materials
Common chemicals used in this study were from Sigma, BDH or Boehringer Mannheim, and
were of analytical grade or purer. Lowicryl K4M resin was from Electron Microscopy Sciences,
Fort Washington, PA, USA. DEAE-cellulose (DE-53) was from Whatman Biochemical
Systems, Maidstone, U.K. Sephacryl S-300 and molecular mass markers were from Pharmacia,
Uppsala, Sweden. Ampholytes (Servalyt), Serva Blue G, acrylamide, and N,N,N',N'-
tetramethyl-ethylenediamine (TEMED) were from Serva, Heidelberg, Germany. Nitrocellulose
transfer membrane for Western blot was from Micron Separations Inc., MA, USA. Immobilon-
PSQ transfer (PVDF) membrane for microsequencing was from Millipore Corporation, Bedford,
MA, USA. Percoll®, HA-Ultrogel, Q-sepharose, protease inhibitors, Leu-Leu-Glu-|3NA,
hypoxanthine, sodium orthovanadate, ouabain, P-casein, rabbit anti-chicken IgG-alkaline
phosphatase conjugate, and Sigma Fast® 5-bromo-4-chloro-3-indolyl phosphate/nitro blue
tetrazolium (BCIP/NBT) substrate were purchased from Sigma Chemicals Co., St. Louis, MO,
USA. All other peptide substrates used were from Bachem Feinchemikalien, Bubendorf,
Switzerland. Horseradish peroxidase (HPRO) was from Seravac South Africa. Freund's
complete and incomplete adjuvants were purchased from Gibco Laboratories, Life
Technologies, Inc., OH, USA. 2,2 Azino-di-[3-ethylbenzthiazoline sulphonate (6) ] (ABTS)
was from Boehringer Mannheim, SA. Microtitre plates Nunc-Immuno Plate MaxiSorp™ used
in enzyme-linked immunosorbent assays (ELISA) and FluoroNunc™ MaxiSorp plates used for
fluorescence assays were from AEC-Amersham, South Africa.
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2.3 Parasite Isolation
Trypanosoma brucei brucei clone ILTat 1.1 (originally derived from East African
Trypanosomiasis Research Organization, stock EATRO 795) was used in this study.
Bloodstream forms were grown in 4-month-old Sprague Dawley rats. Trypanosomes were
separated from blood cells and platelets by passing infected blood from infected rats through
the anion exchanger DEAE-cellulose (Lanham and Godfrey, 1970). Separation depends on the
difference between the surface charge of blood cells and that of parasites. The more negatively
charged blood components adsorb to the DEAE-cellulose while the less negatively charged
parasites are eluted.
Although surface charge differs between species of salivarian trypanosomes (Lanham and
Godfrey, 1970) it is usually sufficiently different from that on the rodent blood cells and
platelets for successful separation under standard conditions of pH and ionic strength.
However, the negative charge density on the erythrocytes also varies with mammalian species.
Those with the lowest level of charges may be eluted from DEAE-cellulose under the standard
buffer conditions, so that separation from trypanosomes may not occur. Although such blood
cells could be adsorbed, by lowering the ionic strength of the buffer, too great a reduction may
cause adsorption of the infecting trypanosomes. The ionic strength of the phosphate saline
glucose (PSG) recommended for the isolation of trypanosomes from rat blood is 0.217. In
each case, separations were carried out at pH 8.0 (Lanham and Godfrey, 1970).
2.3.1 Reagents
Percoll solution [2% (m/v) glucose. 250 mM sucrose. 100% (v/v) Percoll®. pH 7.4]. Glucose
(2.0 g) and sucrose (8.55 g) were dissolved in Percoll® (100 ml) and adjusted to pH 7.4 by
addition of solid HEPES.
Phosphate saline glucose (PSG). pH 8.0. Na2HPO4 (8.088 g), NaH2PO4.2H2O (0.467 g), NaCl
(2.5 g), and glucose (10.0 g) were dissolved in 950 ml of dist. H2O, adjusted to pH 8.0 and
made up to 1 litre.
Sodium citrate -PSG [0.5% (m/v) Na-citrate] Sodium citrate (0.5 g) was dissolved in 100 ml
PSG 6:4, pH 8.0.
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2.3.2 Procedure
The blood parasites were isolated on the fifth day after inoculation (at peak parasitaemia). Rats
were anaesthetised using chloroform, blood was obtained by cardiac puncture and collected
into 0.5% citrate (0.5 ml). The samples were mixed and kept on ice. Trypanosomes were
separated from blood cells by a combination of centrifugation on isopycnic Percoll® gradients
(Grab and Bwayo, 1982) and chromatography on DEAE-cellulose (Lanham and Godfrey,
1970). Blood was mixed with Percoll® in the ratio 1:1 (v/v) and centrifuged (17 000 x g, 15
min, 4°C). After centrifugation, trypanosomes floated as a single band on top of the Percoll®-
sucrose-glucose gradient, while platelets were found in the middle layer and red blood cells
pelleted at the bottom of the centrifuge tube. The band of trypanosomes was removed by
aspiration and mixed with 3 parts PSG, pH 8.0 containing 0.1 mM hypoxanthine (PSGH)
(Lonsdale-Eccles and Grab, 1987) and centrifuged in a microfuge (421 x g, 15 min; 25°C).
Pelleted trypanosomes were resuspended in a minimum volume of PSG and the pH adjusted to
8.0 by addition of solid Tris base. The parasite preparation was then layered on DEAE-
cellulose exchange resin equilibrated in PSGH, pH 8.0 in a Biichner funnel.
Parasites were eluted from the column using PSG into a beaker containing 200 ml PSGH, pH
7.4. The cells were pelleted, washed three times in PSGH buffer, pH 7.4 (1 000 x g, 15 min,
4°C) and resuspended in the same buffer. Cell numbers were determined in a hemocytometer
when necessary. Pelleted cells were usually frozen and stored at -80°C for subsequent enzyme
purification. No appreciable loss of enzyme activity was observed.
2.4 Protein assay
The Bradford dye-binding assay (Bradford, 1976) as modified by Read and Northcote (1981)
was routinely used for protein determination, since it is a rapid and very sensitive protein
quantitation technique. The method is unaffected by most laboratory reagents except high
concentrations of detergents (e.g. 1% Triton X-100). Under acidic conditions, the Coomassie
Blue G-250 dye (Bradford reagent) specifically binds to Arg and Phe residues in protein
molecules, forming a blue complex that can be monitored at 595 nm (Bradford, 1976). The
assay used in this study followed the original Bradford method, but using Serva blue G dye
(Read and Northcote, 1981). The modified assay, minimizes the protein-to-protein variability
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in dye binding and increases the sensitivity of the assay (Read and Northcote, 1981). This
micro-assay method was used to quantify protein in the 1-5 ug range.
2.4.1 Reagents
Dye Reagent. Serva blue G dye (50 mg) was dissolved in 88% (v/v) phosphoric acid (50 ml)
and 99.5% (v/v) ethanol (23.5 ml). The solution was made up to 500 ml with dist.H2O and
stirred for 30 min on a magnetic stirrer. The resulting solution was filtered through Whatman
No. 1 filter paper and stored in an amber coloured bottle. The solution could be stored for up
to 6 months. Visual checks were made before use and if precipitation was visible, the reagent
was filtered and re-calibrated.
Micro-assay. Standard protein (0-50 (j.1 of a 0.1 mg/ml standard ovalbumin solution) or sample
was diluted to a final volume of 50 u,l with dist.H2O, or buffer, in 1.5 ml microfuge tubes. Dye
reagent (950 ul) was added, and the content of the tube mixed by inversion of the tube. The
colour was allowed to develop for 2 min after mixing and the absorbance read at 595 nm.
Assays for construction of a standard curve were carried out in triplicate at 5 concentrations of
ovalbumin. Results were calculated by linear regression analysis of the standard curves, for
each assay type and for every batch of dye reagent made up.
2.5 Concentration of Samples
It was often necessary to concentrate protein samples (e.g. before proceeding to the subsequent
step of purification, or for gel electrophoretic analyses, or for inoculation into experimental
animals for antibody production). The use of commercial polyethylene glycol (PEG) was found
to be a simple and efficient method of concentrating protein samples. The high Mr (20 000)
form of PEG was used so that it was excluded by Mr 12 000 cut-off dialysis tubing.
Concentration by dry, highly soluble polymers such as PEG or sucrose is based on the principle
of movement of water along a concentration gradient out of the dialysis bag to dissolve the dry
polymer. Dialysis against sucrose was not desirable because of the presence of variable
amounts of sucrose in the concentrated protein sample which diffuse into the dialysis bags.
Ultrafiltration on the other hand has been found to denature certain proteinases such as rabbit
cathepsin L (Mason et al, 1984). Further, high glycerol requirement (20%) by MCP-Tb in the
buffers made the samples too viscous to concentrate in good time by ultrafiltration.
2.5.1 Dialysis against PEG
When a protein solution needed to be concentrated, the sample was sealed in a dialysis bag (Mr
12 000 cut-off limit), which was placed onto a thick layer of PEG (Mr 20 000) in a plastic tray
at 4°C. Once the sample was sufficiently concentrated (5-10 fold), the bag was briefly rinsed in
dist.H2O (to remove adhering PEG). The bag was then cut open and the sample squeezed out.
Rubber gloves were worn at all times during this procedure to prevent contamination of the
protein samples (e.g. by skin cells).
2.6 Polyacrylamide gel electrophoresis
Gradient polyacrylamide gel electrophoresis under non-denaturing conditions was used to
assess the homogeneity of the purified multimeric protein samples. The molecular mass of the
native protein was estimated by comparison with high molecular mass markers separated on the
same gradient gel as the protein of interest (Laemmli, 1970). This technique was used together
with western blotting (Section 2.11.) to identify proteins, and to assess the specificity of
antibodies raised against the purified proteins. Because many proteases retain their catalytic
properties after electrophoresis on non-denaturing polyacrylamide gels, the activity of such
proteases can be detected as the clear sites remaining from digestion of gelatin or fibrinogen
that has been copolymerized with the polyacrylamide gel (Heussen and Dowdle, 1980;
Lonsdale-Eccles and Mpimbaza, 1986). In the present study, zymogram profiles were obtained
on gelatin-containing polyacrylamide gels (Section 2.7).
The purified multicatalytic protease (Section 3.2) was found to be susceptible to denaturation
by anionic detergents such as SDS. SDS-PAGE under either reducing or non-reducing
conditions was thus used only for the characterisation of the purified protein, especially the
determination of the relative molecular mass value of its subunits. Ideally, SDS interacts with
most proteins producing negatively charged rod-like SDS-protein complexes. The length of
these complexes corresponds to the molecular mass of the protein. If additionally the protein is
treated with a reducing agent, such as 2-mercaptoethanol, the protein will be reduced to its
constituent subunits, resulting in improved binding of SDS, giving a more accurate estimation
of molecular mass. The negatively charged protein-detergent complexes with similar charge-
to-mass ratios migrate anodally in an electrical field. The inverse relationship between the
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distance migrated in a gel by a protein and the logarithm of its molecular mass, allows the
construction of a standard curve for Mr determination. This is done by running standard
proteins of known Mr alongside the proteins to be characterised.
2.6.1 Reagents
Solution A :Monomer Solution [30% (m/v) acrylamide. 2.7% (mM N.N' methylene
bisacrylamide]. Acrylamide (73 g) and N,N' methylene bisacrylamide (2 g) were dissolved and
made up to 250 ml with dist. H2O and stored in an amber coloured bottle at 4°C.
Solution B :4 x Running Gel Buffer (1.5 M Tris-HCl. pH 8.8V Tris (18.16 g) was dissolved in
approximately 70 ml of dist. H2O, adjusted to pH 8.8 with HCl and made up to 100 ml.
Solution C :4 x Stacking Gel Buffer (0.5 M Tris- HCl. pH 6.8). Tris (6.06 g) was dissolved in
70 ml dist. H2O, adjusted to pH 6.8 with HCl and made up to 100 ml. This buffer was made
freshly each week. This was because of its poor buffering capacity at 2.1 pH units below the
buffer's pKa at 4°C, which results in pH drift and anomalous running patterns in non-reducing
polyacrylamide gel electrophoresis.
Solutions A, B, and C were filtered through Whatman No.l filter paper before storage.
Solution D :10% (m/v) SDS. SDS (10.0 g) was dissolved in 100 ml dist. H2O with gentle
heating if necessary.
Solution E :Initiator [10% (m/v) ammonium persulfate (APS)]. Ammonium persulfate (0.05 g)
was made up to 0.5 ml just before use.
Solution F :Tank Buffer T25 mM Tris-HCl. 192 mM glvcine. 0.1% (m/v) SDS. pH 8.81. Tris
(12.0 g) and glycine (57.6 g) were dissolved and made up to 4 litres with dist. H2O. For
denaturing SDS-PAGE, 40 ml of 10% SDS Stock (Solution D) was added to 4 litres of
Solution F for use in the Biorad Protean II xi Electrophoresis Cell.
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Solution G :Reducing Treatment Buffer [125 mM Tris- HC1. 4% (m/v) SDS. 20% (v/v)
glvcerol. 10% (vM 2-mercaptoethanol. pH 6.81. Buffer C (2.5 ml), 10% SDS (4.0 ml)
(Solution D), glycerol (2.0 ml) and 2-mercaptoethanol (1.0 ml) were made up to 10 ml with
dist. H2O.
Solution H :Non-reducing Treatment Buffer [125 mM Tris-HCl. 4% (m/v) SDS 20% (v/v)
glvcerol. pH 6.8]. Buffer C (2.5 ml), 10% SDS (4.0 ml) (Solution D) and glycerol (2.0 ml)
were made up to 10 ml with dist. H2O.
Solution I :Non-denaturing Treatment Buffer [125 mM Tris-HCl 20% (v/v) glvcerol. pH 6.81.
Buffer C (2.5 ml) and glycerol (2.0 ml) was made up to 10 ml with dist. H2O.
Stain Stock Solution [1% (m/v) Coomassie blue R-250], Coomassie blue R-250 (1.0 g) was
dissolved in 100 ml of dist. H2O mixed by magnetic stirring for 1 h at room temperature. The
solution was filtered through Whatman No. 1 filter paper.
Staining Solution [0.125% (m/v) Coomassie blue R-250. 50% (v/v) methanol. 10% (v/v)
acetic acid]. Stain stock (62.5 ml) was mixed with methanol (250 ml) and acetic acid (50 ml)
and made up to 500 ml with dist. H2O.
Destaining Solution I [50% (v/v) methanol. 10% (v/v) acetic acid]. Methanol (500 ml) was
mixed with acetic acid (100 ml) and made up to 1 litre with dist. H2O.
Destaining Solution II [7% (v/v) acetic acid. 5% (v/v) methanol]. Acetic acid (70 ml) was
mixed with methanol (50 ml) and made up to 1 litre with dist. H2O.
2.6.2 Procedure
Non-denaturing PAGE was performed in a Biorad Protean II Slab Cell assembled as described
in the manufacturer's instruction manual. The mixed running gel solution (Table 1.1) was
carefully poured into the space between the plates to a depth 1-2 cm from the top of the glass
plate and overlayered with dist. H2O to prevent inhibition of polymerization by oxygen. Once
the gel had polymerized, usually about 45 min to 1 h, the water was removed with a syringe.
Stacking gel monomer solution was poured in to cover a 10 well comb inserted to form the
sample application wells. Once this gel polymerized (about 45 min) the comb was removed,
and the wells rinsed with sample treatment buffer.
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Polyacrylamide gradients (4.5-10%) were made with an external gradient former and
introduced into the Protean II xi gel-sandwich assembly using a peristaltic pump.




















































"The (3.0%) stacking gel was used in non-denaturing 4.5-10% gradient gels, whereas the 4.0% stacking gel
was used in combination with 12.5% running gels in non-denaturing and reducing SDS-PAGE.
The upper and lower electrode compartments were filled with Tank buffer (Solution F).
Samples for non-reducing SDS-PAGE were combined with half their volume of non-
reducing treatment buffer (Solution H) before loading onto the gel. For reducing SDS-
PAGE, samples were combined with an equal volume of reducing treatment buffer
(Solution G) and incubated in a boiling water bath for 2 min before loading. Non-reducing
samples were also subjected-to boiling except when enzyme activity needed to be retained
in substrate gels (Section 2.7). A marker dye, bromophenol blue, which migrates with the
buffer front, was added to each sample before loading into the gels. Suitable amounts of
samples (about 3 p.g) were pipetted into the wells. The gels were run at 40 mA per slab gel
(Protean II xi apparatus) or 18 mA per mini gel (in Biorad mini gel apparatus) until the
bromophenol blue tracker dye was about 0.5 cm from the bottom of the running gel. The
gel was removed and placed into staining solution for 4 h. The gel was rinsed with dist.
H2O and placed in destaining solution I overnight, followed by soaking in destaining
solution II to effect complete destaining. The gels were stored in polythene zip-seal bags
and kept hydrated until photographed.
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2.6.3 Silver Staining
Protein bands on polyacrylamide gels were silver-stained when a high degree of sensitivity
was necessary for their detection. Silver staining is a method based on the reduction of
silver ions to metallic silver and is capable of detecting as little as 100 ng protein per band
(Blum et al, 1987). The method of Blum et al. (1987) differs from previous methods in
that it incorporates thiosulfate that not only increases sensitivity, but also complexes
insoluble silver salts from the surface of the gels, resulting in clear background.
2.6.3.1 Reagents
Fixing solution [50% (v/v) methanol. 12% (v/v) acetic acid. 0.05% (v/v) 37% (v/v)
formaldehyde]. Methanol (50 ml), acetic acid (12 ml) and 37% (v/v) formaldehyde (50 u.1)
were made up to 100 ml with dist. H2O.
Thiosulfate solution [0.02% (m/v) sodium thiosulfate]. Na2S2O3.5H2O (40 mg) was
dissolved in dist.H2O (200 ml).
Silver nitrate solution [0.2% (m/v) AgNCh. 0.075% (v/v) 37% (v/v) formaldehyde],
AgNO3 (200 mg) was dissolved in 80 ml dist.H2O, 37% (v/v) formaldehyde (75 u.1) added
and volume adjusted to 100 ml with
Developing solution \6% (m/v) Na2CO2. 0.05% (v/v) 37% (v/v) formaldehyde. 0.0004%
(m/v) Na2S2O2i. Na2CO3 (6 g) was dissolved in 80 ml of dist.H2O, 37% (v/v)
formaldehyde (50 JJ.1) and Na2S2O3.5H2O (2 ml of thiosulfate solution above) added and
the volume adjusted to 100 ml with dist.t^O.
Stopping solution [50% (v/v) methanol. 12 % (v/v) acetic acid]. Methanol (50 ml) and
acetic acid (12 ml) were diluted to 100 ml with dist.H2O.
2.6.3.2 Procedure
Polyacrylamide gels, fixed overnight in fixing solution, were washed in 50% (v/v) ethanol
(3 x 20 min), pre-treated in thiosulfate solution for 1 min and rinsed in dist.H2O (3 x 20
sec). Following impregnation for 20 min in the silver nitrate solution, gels were rinsed in
dist.H2O (2 x 20 sec) and immersed in developing solution until bands were visible. The
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gels were rinsed in dist.H2O ( 2 x 2 min), immersed in stopping solution for 10 min and
finally washed for at least 20 min in 50% (v/v) methanol.
2.7 Gelatin-Substrate Polyacrylamide Gel Electrophoresis
Zymogram analysis of proteinases was performed on non-denaturing polyacrylamide gels
in which gelatin had been copolymerised with the acrylamide (Heussen and Dowdle,
1980). After electrophoresis, the gels were incubated in assay buffer containing
appropriate cofactors to ensure specific enzyme activity. The presence of proteinase
activity is indicated by clear bands against a stained gelatin background. In cases where
SDS is used, the proteinases are renatured after electrophoresis but prior to incubation in
the assay buffer. This is done by removal of SDS by incubation of the gel in 2.5% (v/v)
Triton X-100 (Heussen and Dowdle, 1980) prior to incubation in the assay buffer.
2.7.1 Reagents
1% (m/v) gelatin in running gel buffer. Gelatin (0.1 g) was dissolved in running gel buffer
(10 ml Solution B, Section 2.6.1) with gentle heating.
Overlay solution for substrate gels [0.05% (m/v) gelatin]. Gelatin (0.005 g) was dissolved
in running gel buffer (2 ml, Section 2.6.1) with gentle heating and diluted to 10 ml with
dist. H2O.
2.5% (v/v) Triton X-100. Triton X-100 (5 ml) was diluted to 200 ml with dist. H2O.
0.1% (m/v) amido black. Amido black (0.1 g) was dissolved in methanol:acetic acid:dist.
H2O in the proportions 30:10:60 (100 ml), and filtered through Whatman No. 1 filter paper
before use.
2.7.2 Procedure
The procedure for gelatin-containing polyacrylamide gel electrophoresis was essentially
the same as that described in Section 2.6.2 except that 0.1% (m/v) gelatin was
copolymerized with the polyacrylamide (Heussen and Dowdle 1980). This was carried out
by adding 1% (m/v) gelatin (1.5 ml) to running gel buffer (2.75 ml), Section 2.6.1. The
gradient gels were cast as described in Section 2.6.2.
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After electrophoresis, the gels containing SDS were incubated in two changes of 2.5%
(v/v) Triton X-100 for 30 min (mini-gel) or 60 min (standard gels). The gel was then
incubated in assay buffer for 4 h at 37°C. The gel was stained in 0.1% (m/v) amido black
solution for 1 h, and destained in several changes of methanol:acetic acid:dist. H2O
(30:10:60). Proteolytic activity was observed as clear bands of gelatin digestion.
2.8 Two-Dimensional Polyacrylamide Gel Electrophoresis
Two-dimensional gel electrophoresis (2D-PAGE) separates proteins by their iso-electric
points (pi) and electrophoretic mobilities (O'Farrell, 1975). In the first dimension, a
sample is applied to an iso-electric focusing (EEF) acrylamide gel. Within this, the
constituent proteins migrate through a pH gradient until they reach their respective pi. A
protein's pi is the pH value where it has no net charge. Proteins in a sample thus become
focused at their individual pi.
The second dimension further separates the proteins on the basis of their molecular sizes
by using SDS-PAGE (Section 2.6). In the present study, 2D-PAGE was used to analyse
the protein components of MCP-Tb and MCP-rbc.
2.8.1 First Dimension: EEF
2.8.1.1 Reagents
10% (v/v) Triton X-100. Triton X-100 (1 ml) was mixed with 9 ml of dd.H2O.
Gel overlay (8 M Urea). Ultrapure urea (2.4 g) was dissolved in a total of 5 ml
Aliquots (1 ml) were stored at -20°C.
Sample overlay T9.5 M urea. 0.5% (v/v) pH 3.5-10 ampholvtes. 2% (v/v) pH 5-7
ampholytes]. Ultrapure urea (3.75 g), Pre-blended pH 3.5-10 ampholyte (Pharmacia) (125
u.1) were dissolved in 2.5 ml of dd.HbO and made up to 5 ml with dd.HbO.
IEF sample buffer [9.5 M urea. 100 mM dithiothreitol. 4% (v/v) Triton X-100. 0.4% (v/v)
pH 3.5-10 ampholvte. 1.6% (v/v) pH 5-7 ampholyte]. Ultrapure urea (0.57 g),
dithiothreitol (15 mg), 10% (v/v) Triton X-100 (0.4 ml), Pre-blended pH 3.5-10 ampholyte
(Pharmacia) (50 u.1) were dissolved in a total of 1 ml of dd.
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IEF stock acrvlamide [42.3% (7) acrvlamide. 5.4% (C) N.N' methylene bisacrylamidel.
Acrylamide (2.838 g) and N,N' methylene bisacrylamide (0.162 g) were dissolved in a
total of 7.1 ml dd.H2O. Stock could be stored for one month at -4°C.
EEF gel solution [8 M urea. 4.7% (T) acrylamide. 0.6% (C) N.N' methylene bisacrylamide.
1.7% (v/v) Triton X-100. 4% pH 5-7 ampholvte. 0.3% pH 3.5-10 ampholvte]. Ultrapure
urea (3.45 g), EEF stock acrylamide (0.8 ml), 10% Triton X-100 (1.2 ml), Pre-blended pH
3.5-10 ampholyte (Pharmacia) (300 u,l) were added and mixed in a total volume of 7.2 ml
dd.H2O. Aliquots (2.4 ml) were kept frozen at -80°C.
Equilibrating buffer l"50 mM Tris-HCl. 2% (m/v) SDS. 50 mM dithiothreitol. 10% (V/v)
glvcerol. pH6.8], Tris (0.061 g), 10% SDS (2 ml), DTT (0.076 g), glycerol (1 ml) were
dissolved in 5 ml of dd.H2O, adjusted to pH 6.8 with HC1, and made up to 10 ml with
dd.H2O.
2.8.1.2 Procedure
The first dimensional separation (IEF) was performed essentially according to O'Farrell
(1975) in an IsoDalt 2-D electrophoresis apparatus (Hoeffer, San Fransisco, CA, USA).
Polyacrylamide gels (4.7%T) were cast in glass tubes (16 cm x 1.5 mm in diametej). The
tubes were blocked at one end with two layers of Parafilm®. Aliquots of IEF gel solution
were thawed, brought to 25°C and degassed for 15 min. Fresh 10% ammonium persulfate
(Section 2.6) (1.5 ul) and TEMED (1.05 (il) were added to the IEF gel solution (2.4 ml),
swirled to mix, and slowly injected into the bottom of the tube to dislodge any air bubbles.
After polymerisation (for at least 2 h), the tops of the gels were thoroughly rinsed with
dd.H2O. The Parafilm® was removed from the bottom of each tube, the tubes placed back
in the casting stand, and gel overlay buffer applied to a height of 1 cm above the gel
surface.
Solid urea was added to the sample, dissolved by flicking the tube until the sample was
saturated. EEF sample buffer (10 u.1) was added to the sample (50 }il) in a microfuge tube,
mixed and ce'ntrifuged (15 000 x g, 30 sec) to remove undissolved materials. The tube gels
were put into position in the assembled electrophoresis apparatus. The surfaces of the
tubes'were filled with catholyte (20 mM NaOH) solution and the lower buffer chamber
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with anolyte (1M ortho-phosphoric acid). The core was carefully placed in the tank
preventing air bubbles from accumulating at the bottom of the gels. Following prefocusing
(15 min at 200 V, 30 min at 400 V, and 30 min at 600 V), samples (10-15 pig) were loaded
at the catholyte end of the gel and overlaid with sample overlay solution using a syringe
and needle. For good electrical contact, care was taken not to trap air bubbles in the tube
during loading. The gel was run at 600 V for 13 h followed by 1000 V for 1 h. After
electrophoresis, both the top and bottom of each gel was rinsed with dd.H2O to remove
residual base and acid on the gel that would interfere with measurement of the pH gradient.
The tube gels were extruded using water pressure onto glass storage tubes containing
equilibrating buffer (3 ml). The gels were either kept frozen at -80°C or embedded on the
slab gel as quickly as possible to prevent diffusion of proteins from the gel.
2.8.2 Second Dimension: SDS-PAGE
The second dimensional separation was performed using Tricine-SDS-PAGE (Shagger and
Von Jagow, 1987) to separate the subunits. The tube gels were equilibrated in gel buffer
prior to second dimension electrophoresis.
2.8.2.1 Reagents
Agarose overlay [0.2% (m/v) agarose], Agarose (0.1 g) was dissolved in 50 ml of
equilibrating buffer (Section 2.8.1.1).
Anode buffer (0.2 M Tris-HCl. pH 8.9). Tris (96.88 g) was dissolved in approximately
3800 ml of dist. H2O, adjusted to pH 8.9 with HC1 and made up to 4 litres with dist. H2O.
Cathode buffer f 0.1 M Tris. 0.1 M Tricine. 0.1% (m/v) SDS. pH 8.251. Tris (12.2 g),
Tricine (17.9 g) and 10% (m/v) SDS (10 ml) were dissolved and made up tol litre with
dist. H2O.
Gel buffer T3.0 M Tris. 0.3% fw/v) SDS. pH 8.45]. Tris (72.7 g) and SDS (0.6 g) were
dissolved in 150 ml of dist.H2O, adjusted to pH 8.45 with HC1 and made up to 200 ml with
dist. H2O.
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Monomer solution [49.5% (w/v) Acrylamide.. N.N' methylene bisacrylamide]. Acrylamide
(48 g) and N,N' methylene bisacrylamide (3 g) were dissolved in a total of 100 ml of dist.H20.
2.8.2.2 Procedure
A running gel was prepared by mixing monomer solution (32 ml), gel buffer (40 ml) and dist.
H2O (40 ml) and polymerisation initiated by addition of 10% (m/v) ammonium persulfate (0.4
ml) and TEMED (40 ul) (Section 2.6.1). The running gel mixture was poured between glass
plates on assembled Biorad Protean II. Once the pair of slab gels (16 cm x 16 cm) had
polymerised, a stacking gel, with a 2D-comb (1.5 cm) in place, was poured to the top of front
glass plate. The stacking gel consisted of monomer solution (0.5 ml), gel buffer (1.5 ml),
dd.H2O (4 ml), 10% (m/v) ammonium persulfate (30 ul) and TEMED (12 ul). After
polymerisation, the wells in the stacking gel were rinsed with dd.H2O followed by gel buffer. A
freshly thawed IEF tube gel was placed on a 16 cm longitudinally folded piece of Parafilm®.
Excess equilibrating buffer was removed, and the gel was directed from the Parafilm® to the
bevel at the top of the inner glass plate, starting at one side and proceeding across the gel. Care
was taken that the tube gel was in contact with the slab gel over its entire length. All air
bubbles were removed between the tube gel and the slab gel. An agarose overlay was added to
ensure good contact between the gels and to prevent the tube gel from slipping off the slab gel.
Low molecular mass markers were loaded in an adjacent well in the stacking gel.
The lower electrophoresis chamber was filled with anode buffer and the top chamber with
cathode buffer. Electrophoresis was conducted at 80 V until the bromophenol blue marker dye
entered the separating gel and at 100 V for the remainder of the electrophoretic run. At the
end of the electrophoresis, one 2D-gel was silver stained (Blum et al., 1987; Section 2.7) and
the other proteins electrotransferred to polyvinylidene difluoride (PVDF) membranes (Section
2.9) for N-terminal sequencing of the protein component of interest.
2.9 Blotting of proteins onto PVDF membranes
Protein components of MCP-Tb separated by 2D-PAGE were electroblotted onto a PVDF
membrane, essentially as described by Matsudaira (1987). The membranes are mechanically
strong solid phase supports that bind proteins hydrophobically and have been used in
immunoblotting applications as a substitute for nitrocellulose filters (see Section 2.11).
46
Because PVDF membranes are inert to most solvents (e.g. acetonitrile, trifluoroacetic acid,
ethyl acetate, trimethylamine, and hexamine), they are ideal for use in automated gas-phase
sequenators as a solid-phase support for sequence analysis.
2.9.1 Reagents
Electrotransfer buffer [10 mM 3-cyclohexylamino-l-propanesulfonic acid (CAPS). 10% (v/v)
methanol. 0.1 mM thioglvcollic acid. pH 11.0"). CAPS (5.533 g), methanol (250 ml) and
thioglycollic acid (p = 1.33 g/ml; 17.5 JJ.1) were dissolved in 2 litres of dd.H2O, adjusted to pH
11.0 with NaOH and made up to 2.5 litres with dd.H2O.
Stain solution [0.1% Coomassie Brilliant Blue R-250 in 50% (v/v) methanol]. Coomassie
Brilliant Blue R-250 (0.1 g) was dissolved in methanol (50 ml) and the volume adjusted to 100
ml with dd.H2O.
Destain solution [50% (v/v) methanol. 10% (v/v) acetic acid], Methanol (50 ml) and acetic
acid (10 ml) were diluted to 100 ml with dd.H2O.
2.9.2 Procedure
Following 2D-PAGE, the gels were soaked in CAPS buffer for 5 min to reduce the amounts of
Tris and Tricine, PVDF membranes were pre-treated in 100% (v/v) methanol (15 s), dd.BbO (5
min) and stored in electrotransfer buffer. The gel was sandwiched between a sheet of PVDF
membrane and several sheets of filter paper and proteins to be electrotransferred (as per
Section 2.11.2). Following transfer (200 mA, 2 h), the PVDF membrane was washed in
deionised H2O (2 min), immersed in stain solution (5 min), followed by destain solution ( 2 x 5
min). The membrane was finally rinsed in dd.H2O ( 2 x 5 min), air dried and transferred to a
zip-seal plastic bag for storage at -20°C until N-terminal sequencing was conducted.
2.10 Antibody production and isolation
Polyclonal antibodies used in immunocytochemistry (Section 5.5.2) and western blotting
(Section 4.7) were raised in chickens by inoculation of 50 ug of protein (e.g. proteasome or
VSG purified from T. brucei) intramuscularly into the breast muscle. The protein antigens
were mixed with an equal volume of Freund's complete adjuvant before the first injection of
laying hens. At weeks 2, 4 and 6, chickens received booster immunisations with the same
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amount of protein emulsified in Freund's incomplete adjuvant. A control non-immune sample
was obtained from the eggs laid by the same chickens prior to immunisation. Eggs were
collected daily for the duration of the experiment and stored at 4°C until examined for the
presence of IgY antibodies.
Chicken antibodies are passed on to the egg yolk to confer passive immunity to the developing
chick. Consequently, egg yolks of immunized chickens provide a convenient source of
antibodies. Immunoglobulins (IgY) are then easily isolated from the chicken egg yolk by PEG
precipitation (Poison et al., 1985). This circumvents the trauma that laboratory animals such as
rabbits are subjected to during periodic bleeding to obtain anti-sera. Whereas chicken antibody
(IgY) is obtained from egg yolk, rabbit IgG antibody is isolated from mammalian serum. Both
IgY and IgG were purified to apparent homogeneity using the polyethylene glycol (PEG; Mr
6000) precipitation method. PEG (Mr 6000) is a mild precipitating agent that operates on a
steric exclusion mechanism whereby proteins are concentrated in the extrapolymer space, until
they exceed their solubility limits. The methods used in isolating IgG and IgY are essentially as
described by Poison et al. (1964) and Poison et al. (1985) respectively.
Antibody against chicken IgY was raised in rabbits. Purified non-specific chicken IgY (100 jag)
was emulsified in complete adjuvant and injected intradermally into a rabbit. Then two doses of
50 ug antigen in incomplete Freund's adjuvant were given 3 weeks and 5 weeks after the initial
injection. Blood samples were obtained from the animal through the marginal ear vein 10 days
after the third injection. The blood samples were allowed to carefully drip by the sides of the
tube to enable the serum to separate out.
2.10.1 Reagents
100 mM Na-phosphate buffer. 0.02% (m/v) NaNy pH 7.6. NaH2PO4.2H2O (15.6 g) and NaN3
(0.2 g) were dissolved in 950 ml of dist. H2O, titrated to pH 7.6 using NaOH, and made up to 1
litre.
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2.10.2 Procedure for isolation of IgY from chicken egg yolks
Chicken egg-yolks were separated from the egg white and carefully washed under running
water to remove traces of egg-white proteins. The yolk sac was punctured and the yolk
volume determined in a measuring cylinder. Two volumes of 100 mM Na-phosphate buffer,
pH 7.6, was added and mixed thoroughly. Solid PEG (Mr 6 0000, 3.5% (m/v) was dissolved in
this mixture by gentle stirring. The resulting precipitated vitellin fraction was removed by
centrifugation (4 420 x g, 30 min, 25°C), and the supernatant fluid filtered through absorbent
cotton wool to remove the lipid fraction. The PEG concentration was increased to 12% [i.e.
8.5% PEG (m/v) added]. After the PEG had dissolved, the sample was centrifuged (12 000 x
g, 10 min, room temp). The supernatant was removed and the pellet re-dissolved in 100 mM
Na-phosphate buffer, pH 7.6, in a volume equal to the volume obtained after the initial
filtration. PEG was again added to make the final concentration of 12% (m/v) PEG. The PEG
was dissolved and the precipitated protein collected by centrifugation (12 000 x g, 10 min,
25°C). The supernatant fluid was discarded and the final antibody pellet dissolved in 1/6 of the
original egg yolk volume, using 100 mM Na-phosphate buffer, pH 7.6, and stored at 4°C.
2.10.3. Procedure for isolation of IgG from rabbit serum
One volume of rabbit serum was mixed with two volumes of borate buffered saline. Solid PEG
(Mr 6 000) was added to the diluted serum to 14% (m/v), dissolved with constant stirring and
the mixture was centrifuged (12 000 x g, 10 min, 25°C). The pellet was re-dissolved in the
original serum volume, using 100 mM Na-phosphate buffer, pH 7.6. Again PEG was added to
make a 14% (m/v) PEG solution. After the PEG was dissolved, the solution was re-
centrifuged (12 000 x g, 10 min, room temp). Finally, the pellet was re-dissolved in 100 mM
Na-phosphate buffer, pH 7.6, containing 60% (v/v) glycerol. The final volume was adjusted to
be equal to half the original serum volume. The samples were stored at -20°C.
2.10.4 Determination of IgY and IgG concentrations
The A2so of IgY and IgG solutions in 100 mM Na-phosphate buffer were determined and the
concentrations of IgY and IgG calculated using the equation K2%o= Eel, where;
A2go is the absorbance at 280 nm,
c is the concentration of the absorbing species
/ is the light path length and,
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E is the molar extinction coefficient
[extinction coefficient of IgY, E 280 (1 mg/ml) = 1.25 (Coetzer,1985)] and that of IgG, E280 (1
mg/ml) = 1.43 (Hudson and Hay, 1980). It was usually necessary to dilute the immunoglobulin
samples 1:40 before reading the A280 values.
2.11 Western blotting
This technique was used to identify and characterise proteins separated by electrophoresis. The
technique was also used to evaluate the specificity of antibodies raised against the purified
proteins. The procedure was adapted from Towbin et al. (1979). Methanol was included in
the transfer buffer to increase binding of the protein-SDS complexes to the nitrocellulose
membrane. Anionic detergents such as SDS have a tendency to denature antigenically reactive
sites (epitopes) on fractionated molecules. This limitation may be severe when screening panels
of monoclonal antibodies since such antibodies are directed against single epitopes within an
antigenic molecule. However, denaturation was not considered to be a major problem in the
present investigation because polyvalent monospecific antibodies were utilised. The detection
system consisted of an enzyme labelled (e.g. horse radish peroxidase) secondary antibody
directed against a primary antibody. The enzyme catalyses a reaction leading to the formation
of a precipitating coloured product on the nitrocellulose membrane.
2.11.1 Reagents
Blotting buffer (25 mM Tris. 192 mM glvcine. 20% (v/v) methanol. pH 8.3). Tris (9.08 g) and
glycine (43.2 g) were dissolved in 2 litres of dist. H2O, and methanol (600 ml) was added. The
volume was made up to 3 litres with dist.HaO. SDS [3 ml of 10% (m/v) solution, Section 2.6.1]
was added prior to use.
Tris buffered saline (TBS) T20 mM Tris. 200 mM NaCl. pH 7.41. Tris (2.42) and NaCl (11.69)
were dissolved in 950 ml of dist. H2O the pH adjusted to 7.4 with HC1, and made up to 1 litre.
Antibody diluent (0.5% BSA-TBS). BSA (0.5 g) was dissolved in (TBS 100 ml).
Blocking solution (5% non-fat milk powder). Non-fat milk powder (5 g) was dissolved in
TBS.
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Ponceau S stain for protein bands on nitrocellulose. Ponceau S [0.1% (m/v)] was prepared
in 1% (v/v) glacial acetic acid.
4-chloro-l-naphthol substrate solution [0.06% (m/v) 4-chloro-l-naphthol. 0.01% (v/v)
H2O2]. 4-chloro-l-naphthol (0.03 g) was dissolved in methanol (10 ml). Two ml of this
solution was diluted to 10 ml with TBS, with addition of 30% hydrogen peroxide (4 |il).
BCIP/NBT substrate solution. One 5-bromo-4-chloro-3-indolyl phosphate/nitro blue
tetrazolium tablet was dissolved in 10 ml of dist. FfeO.
Enzyme-linked secondary antibodies. A commercial rabbit anti-chicken IgG linked to
alkaline phosphatase purchased from Sigma, was used for western blots. This antibody
cross-reacted with chicken IgY on blots. Initially, before commercial enzyme-labelled
anti-chicken antibodies were readily available, rabbit anti-chicken IgY was conjugated to
horse radish peroxidase (HRPO). The conjugation of HRPO to immunoglobulins was
carried out according to Hudson and Hay (1980). HRPO (4 mg) was dissolved in 1 ml of
dist.H2O and 200 u.1 of freshly prepared 100 mM sodium periodate solution was added.
The mixture was stirred for 20 min at room temperature. It turned a greenish-brown
colour. The mixture was dialysed against 1 mM Na-acetate buffer, pH 4.4, overnight at
4°C. The pH was raised to approximately 9-9.5 by addition of 200 mM Na2CO3 buffer,
pH 9.5 (20 jal), and 1 ml of an 8 mg/ml IgG fraction immediately added. This solution was
left at room temperature for 2 h. Freshly prepared 4 mg/ml Na-borohydride solution (100
l_il) was added and the solution left at 4°C for 2 h to reduce any free enzyme. The mixture
was dialysed against Na-borate buffer, overnight at 4°C, before an equal volume of 60%
glycerol in Na-borate buffer was added and the conjugate stored at 4°C. The dilution of
conjugate to be used was established in a checkerboard ELISA. A suitable working
dilution (1 in 350) of primary antibody was obtained from a steep part of the antibody
titration curve, sufficiently high above background values.
2.11.2 Procedure
Both native-''and SDS-PAGE were usually performed on duplicate gels. One gel was
stained to show the total protein pattern while the other was used for blotting. The
electrophoretic protein transfer procedure (electroblotting) was adapted from Burnette
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quantitative recovery of proteins from SDS-containing polyacrylamide gels. Nitrocellulose
paper, Hybond C (Amersham), was used. Electrophoretic transfer was carried out for 16 h at
30 V. The apparatus was connected to a refrigerated water circulator kept at 8°C. The buffer
was stirred constantly by a magnetic stirrer to ensure even distribution of the cooling buffer.
After 16 h, the sandwich was removed and the filter paper peeled off the gel. The gel was
carefully removed and stained with Coomassie Blue R 250 (Section 2.6) to assess the
efficiency of electroblotting.
The nitrocellulose sheet removed from the filter paper was air dried for about 1.5 h. The
nitrocellulose sheet was transiently stained in Ponceau S for 30-60 sec, rinsed in dist.H2O, the
positions of the MW markers marked with a pencil, and the sheet cut into strips as required
before destaining the strips by addition of a drop of 500 mM NaOH to the dist.H2O. Unbound
sites on the nitrocellulose strips were blocked for 1 h with 5% (m/v) low fat milk powder in
TBS at 25°C, washed in TBS ( 3 x 5 min) and incubated for 2 h with primary antibody in 0.5%
BSA-TBS. The strips were washed in TBS ( 3 x 5 min), incubated in HRPO-linked secondary
antibody, diluted in antibody diluent, for 1 h at 25°C, and again washed in TBS ( 3 x 5 min).
The strips were immersed in substrate solution and allowed to react in the dark until bands
were clearly evident against a lightly stained background. Finally, the strips were removed
from the substrate solution, washed in dist.H2O and dried between filter paper. This last step
ensured good preservation of the bands before photography.
2.12 Enzyme-linked Immunosorbent Assay
A modified enzyme-linked immunosorbent assay (Coetzer et al, 1991) was used to test the
reactivity of the antibody raised against the purified protein. Routine screening assays were
done to evaluate the progress of polyclonal antibody production during the immunization
period. This technique measures quantitative properties of antibodies and so complements
Western blotting, which gives qualitative information about antibody specificity.
2.12.1 Reagents
Phosphate buffered saline (PBS). pH 7.2. NaCl (8 g), K G (0.2 g), Na2HPO4.2H2O (1.15 g)
and KH2PC>4 (0.2) were dissolved and made up to 1 litre with dist. H2O.
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Antibody diluent. See Section 2.11.1
0.5% (m/v) Bovine serum albumin-PBS (BSA-PBS). BSA (0.5 g) was dissolved in 100 ml
ofPBS.
0.1% (v/v) PBS-Tween. Tween 20 (1 ml) was made up to 1 litre in PBS.
0.15M Citrate-phosphate buffer. pH 5.0. A 0.15 M solution of citric acid (22.9 g/1) was
titrated with a 0.15 M solution ofNa2HPO4.2H2O (35.6 g/1) to pH 5.0.
Substrate solution TO.05% (m/v) ABTS and 0.0015% (v/v) H2O2 in citrate phosphate
buffer. pH 5.0], ABTS (7.5 mg) and H2O2 (7.2 u.1) were dissolved in citrate phosphate
buffer, pH 5.0 (15 ml) for one ELISA plate.
Stopping reagent [Citrate-phosphate-0.1% (m/v) NaN2]. NaN3 (0.1 g) was dissolved and
made up to 100 ml in citrate-phosphate buffer.
2.12.2 Procedure
The purified enzyme or VSG (0.1 jig in 100 u.1 of PBS) was incubated in 96-well Nunc-
Immuno MaxiSorp™ microtitre plates overnight at 4°C. The plates were washed in PBS-
Tween [0.1% (v/v) Tween 20 in PBS]. After washing, 200 ul of 0.5% BSA-PBS was
added to each well and incubated for 1 h at 37°C to prevent the non-specific binding of
antibody to the unoccupied spaces in wells in subsequent reactions. The plates were
washed in PBS-Tween and drained. Serial two-fold dilutions of primary antibody (starting
from 1 mg/ml) were prepared in the plate in 0.5% BSA-PBS and incubated (100 u.1, 2 h at
37°C). The plates were then washed three times with PBS-Tween, and incubated for 1 h at
37°C with 100 u.1 of rabbit anti-chicken IgY conjugated to horseradish peroxidase diluted
in 0.5% BSA-PBS. After washing, the peroxidase activity was measured with 100 u.1 of
substrate solution in citrate-phosphate buffer, added to each well. The colour was allowed
to develop (10-15 min) in the dark. The enzyme reaction was stopped by addition of 50 ul
of stopping reagent. Absorbance of each well was read at 405 nm on a Titertek ELISA
plate reader and compared against the background of control samples.
Chapter 3
Purification and characterisation of 20S proteasome from
Trypanosoma brucei
3.1 Introduction
The success of trypanosomes in their mammalian hosts is attributed to their remarkable
ability to evade their host's specific immune response by altering their VSG coat. Lateral
movement of VSG/anti-VSG complexes was detected in earlier studies on the surfaces of
trypanosomes (Russo et al., 1993). This movement was directed from the surfaces of the
parasites into their lysosomes via their flagellar pockets. By using mixtures of protease
inhibitors, which blocked protein breakdown, proteases were implicated in the
internalisation and processing of the VSG/antibody complexes. Endocytosis is a crucial
event in the physiology of trypanosomes and recent experimental data have identified the
ubiquitin-proteasome system as a regulator of endocytosis (Strous et al., 1996; Strous and
Gover, 1999). Even more interesting is the involvement of a lactacystin-inhibitable
protease complex in the quality control of glycophosphosphatidylinositol (GPI) anchor
addition to proteins (Oda et al., 1996; Wilbourne et al, 1998). In trypanosomes, GPI
anchors VSG on the surface of the plasma membrane of the cell (Englund, 1993).
Previous studies by Russo et al. (1993) showed that chymostatin, an inhibitor of
chymotrypsin-like proteases, blocked endocytosis of VSG/anti-VSG complexes. Hence,
we decided to determine whether T. b. brucei possessed chymotrypsin-like activity and to
purify and characterise this activity.
Most studies on enzymes require pure preparations of the enzyme. Pure enzyme may be
obtained by isolating the enzyme either from cell homogenates or from expression systems
following cloning of the gene segment coding for the protein. The latter approach is based
upon the use of conserved gene sequences and requires detailed knowledge of the primary
sequence of the protein. Since this information was not available, chymotrypsin-like
activity was isolated directly from T. brucei lysates. A new isolation method was
developed to achieve this.
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Interestingly, characterisation of the partially purified protease revealed properties
suggesting that it was a high molecular mass, multicatalytic proteinase [also called the
proteasome (Coux et al, 1996, Tanaka et al, 1998)]. For convenience, the multicatalytic
proteinase isolated from T. brucei and from bovine red blood cells will be referred to as
MCP-Tb and MCP-rbc respectively. MCP-rbc was isolated for comparative studies
because it is the host equivalent of the parasite MCP-Tb. While this study was underway,
proteasomes were isolated from T. brucei by another laboratory (Hua et al, 1996,
Mutomba et al, 1997, To and Wang, 1997), but the two studies differ in many aspects.
These differences and their importance will be addressed in the relevant sections.
3.2 Reagents
Fresh bovine blood. Citrated fresh bovine blood was obtained from Cato Ridge Abattoir.
Lvsis buffer (10 mM Tris-HCl. 100 uM Na2EDTA. 1 mM DTT. 50 uM E-64. 2 mM ATP.
pH 7.0). Tris (0.1211 g), Na2EDTA (0.0037 g), DTT (0.0154 g), E-64 (0.2 mg) ATP
(0 1102 g) were dissolved in about 80 ml of dist. H2O titrated to pH 7.0 with HC1 and
made up to 100 ml with dist .H2O.
Standard buffer G HO mM Tris-HCl. 25 mM KC1. 10 mM NaCl. 1.1 mM MgCl2. 100 uM
Na7EDTA. 1 mM DTT. 20% glvcerol (v/vV pH 7.0 )1. Tris (1.211 g), KC1 (1.864 g), NaCl
(0.584 g), MgCl2 (0.223 g), Na2EDTA (0.037 g), DTT (0.154 g), glycerol (200 ml) were
dissolved in about 950 ml of dist. H2O titrated to pH 7.0 with HC1 and made up to 1000 ml
with dist. H2O.
Standard buffer H (20 mM Tris-HCl. 20 mM NaCl. 1 mM EDTA. 1 mM B-
mercaptoethanol. pH 7.6V Tris (9.68 g), NaCl (6.58 g), Na2EDTA (1.489g), p-
mercaptoethanol (280 u.1), were dissolved in about 3500 ml of dist. H2O titrated to pH 7.6
with HC1 and made up to 4 litres.
Equilibrating buffer A (Standard buffer G containing 100 mM NaCH. NaCl (5.84 g) was
added to 950 ml of standard buffer, titrated to pH 7.0 with HC1 and made up to 1000 ml
with dist.H20.
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Elution buffer A (Standard buffer G containing 500 mM NaCl). NaCl (29.22 g ) was
added to 950 ml of standard buffer, titrated to pH 7.0 with HC1 and made up to 1000 ml
with dist.H2O.
Equilibrating buffer B [10 mM potassium phosphate. 1 mM DTT. 20% glycerol (v/v). pH
6.81
KH2PO4 (1.361 g), DTT (0.154 g) and glycerol (200 ml) were dissolved in about 950 ml of
dist. H2O, titrated to pH 6.8 with KOH and made up to 1000 ml with dist. H2O.
Elution buffer B [300 mM potassium phosphate. 1 mM DTT. 20% glvcerol (v/v). pH 6.8].
KH2PO4 (8.1654 g), DTT (0.0308 g) and glycerol (40 ml) were dissolved in dist. H2O,
titrated with KOH to pH 6.8 and made up to 200 ml with dist. H2O.
3.3 Procedures
3.3.1 Purification of MCP-Tb
All enzyme purification procedures were carried out at 4°C. T. b. brucei were propagated
and isolated as outlined in Section 2.3.2. Cells (approximately 1010 trypanosomes) were
suspended in lysis buffer (20 ml) and ruptured in a French pressure cell (Aminco Silver
Springs) at approximately 2 500 Psi. E-64 and EDTA were included in the lysis buffer to
minimize possible proteolytic degradation of MCP-Tb during the purification process by
cysteine and metalloproteases. The cell lysate was centrifuged (100 000 x g, 1 h, 4°C) in a
fixed-angle 75 Ti rotor and the supernatant collected. The pellet was washed twice by re-
suspension in lysis buffer (20 ml), followed by centrifugation (100 000 x g, 1 h, 4°C). The
original supernatant and wash supernatants were combined. Glycerol was added to the
pooled supernatant [20% (v/v) final cone] and the mixture loaded onto a Q-Sepharose
anion exchange column (2.5 x 10 cm), equilibrated with 5 bed volumes of standard buffer
G (30 ml. h"1). Unbound proteins were eluted with equilibrating buffer A. Bound proteins
were eluted with a linear gradient of NaCl from 100-500 mM (400 ml) in buffer A.
Fractions active against Z-Gly-Gly-Leu-AMC were pooled and concentrated (5-10 fold) by
dialysing (using Mr 12 000 cut-off dialysis membrane) against dry polyethylene glycol
(PEG), 20 000.
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The concentrated, active fraction from the Q-Sepharose column (2 ml) was applied to a
Sephacryl S-300 column (2.5 x 87 cm) equilibrated with buffer A. A higher concentration
of NaCl (100 mM) was necessary to avoid non-specific interaction between the protein and
the resin. In this step, low molecular mass contaminants were removed from the proteinase
complex. The enzyme eluted within the fractionation range of the beads as a single peak
of Z-Gly-Gly-Leu-AMC hydrolysing activity (Section 3.4.1). This allowed the relative
molecular mass of the purified protein to be estimated by comparison with the elution
positions of molecular mass markers. These were thyroglobulin (670 kDa), bovine gamma
globulin (158 kDa), chicken ovalbumin (44 kDa), equine myoglobin (17 kDa), and vitamin
B-12 (1.35 kDa). The void volume of the column (Vo) was determined using Dextran Blue
(>2 000 kDa).
The active fractions obtained from the Sephacryl S-300 column were pooled and dialysed
(16 h, 4°C) against three changes of equilibrating buffer B (3 x 1 litre). The dialysed
sample was loaded onto an HA-Ultrogel column (1.5 x 12 cm) equilibrated (20 ml.h"1) with
equilibrating buffer B. HA-Ultrogel is a microcrystalline hydroxyapatite (40% by mass)
embedded in cross-linked 4% beaded agarose. This form of hydroxylapatite for adsorption
chromatography avoids many of the problems posed by hydroxylapatite itself. It needed
no pre-cycling for removal of fines and had satisfactory flow rates. The hydroxylapatite
column was washed with equilibrating buffer B until the absorbance reached baseline
before adsorbed material was eluted with 200 ml of a linear gradient, 10-300 mM
phosphate, in elution buffer B. The fractions containing hydrolysing activity were pooled
and the glycerol concentration diluted to 5% (v/v) (1-5 mg protein) by addition of assay
buffer (Section 3.4.1.1). The sample was layered onto a linear 10-40% (v/v) glycerol
gradient in standard buffer G. After centrifugation (100 000 x g, 22 h, 4°C) in a SW 40
rotor, the enzyme was concentrated by dialysis against dry polyethylene glycol 20 kDa
using 12 kDa cut-off limit dialysis membrane. The glycerol concentration was brought to
20% (v/v) and the purified enzyme stored at -20°C. The activity of the enzyme was stable
at this temperature for several months. However, when a previously stored sample was
used in non-denaturing gel electrophoresis, a smear instead of a sharp protein band was
obtained implyjng that the complex itself may not remain intact after long storage.
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3.3.2 Purification of MCP-rbc
The multicatalytic proteinase from bovine red blood cells (bovine MCP-rbc) was purified
using a procedure adapted from several sources (Dahlmann et al., 1985; Kanayama et al.,
1992; Chu-Ping et al, 1994). Bovine blood (1 000 ml) was collected in 2% (m/v) citrate
and cells sedimented by centrifugation (2 000 x g for 1 h). The supernatant and the buffy
coat were removed by aspiration. The red cells were resuspended in four volumes PBS
and re-centrifuged (2 000 x g; 1 h). The red cells were lysed by stirring (10 min) three
volumes of standard buffer H with one volume of the packed red blood cells. The total
lysate was centrifuged (13 000 x g: 1 h) and the supernatant collected. The pellet was
resuspended in three volumes of standard buffer H, recentrifuged and this supernatant
added to the first. One portion, "Fraction I" of this crude lysate was dialysed against
buffer G for subsequent isolation of MCP-rbc from the erythrocytes. The second portion,
"Fraction II" (for isolation of PA700) was subjected to batch ion-exchange
chromatography on DEAE cellulose (See Section 6.2.2). This enabled the simultaneous
purification of MCP-rbc and PA700 from the same starting material for a parallel
experiment (Section 6.2).
Fraction I, previously dialysed against standard buffer G and stored at -20°C, was thawed
and fractionated by the addition of solid (NFL^SC^ to 45% (m/v) saturation. Precipitated
proteins were collected by centrifugation (15 000 x g, 20 min, 25°C) and discarded. The
supernatant was saturated to 65% (m/v) with respect to (NH^SC^. The mixture [45-65%
(m/v) (NH4)2SO4 saturation] was centrifuged (15 000 x g, 20 min, 25°C). The supernatant
was discarded and the pellet dissolved in about 40 ml of standard buffer G, and dialysed
against three changes of buffer B (3 x 2 litres, 16 h, 4°C).
The dialysed enzyme solution was chromatographed on Q-Sepharose as described for
MCP-Tb in Section 3.3.1. The fractions containing Z-Gly-Gly-Leu-AMC hydrolysing
activity were pooled, dialysed against dry PEG, 20 kDa and further purified on Sephacryl
S-300 and HA-Ultrogel as described for MCP-Tb in Section 3.3.1. The Z-Gly-Gly-Leu-
AMC active pool from HA-Ultrogen was diluted to 5% (v/v) glycerol using assay buffer
(Section 3.4.1.1) and concentrated using dry 20 kDa PEG to approx. 1 ml. Approximately
1-2 mg protein (500 u,l) was layered onto a linear 10-40% (v/v) glycerol gradient in
standard buffer G. The gradient was centrifuged (100 000 x g, 22 h, 4°C) in a SW 40
rotor. Fractions (1 ml) were collected by draining the tube from the top with the aid of a
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peristaltic pump. The fractions were assayed for activity against Z-Gly-Gly-Leu-AMC and
active fractions pooled. The active pool was concentrated by dialysis against dry 20 kDa
PEG. The glycerol concentration was brought to 20% and the sample purity evaluated by
native gradient (5-10%) PAGE (Section 2.6.2).
3.4 Enzyme Assay
3.4.1 Assay with 7-amido-4-methyIcoumarin substrates
A variety of commercially available synthetic peptides were used to determine peptidase
activities of MCP. Peptides with the 7-amido-4-methylcoumarin (AMC) leaving group
provided the most sensitive substrates. These substrates have been used at concentrations
below their Km values of 0.1-1 mM reported for mammalian proteases (Rivett, 1989). Z-
Gly-Gly-Leu-AMC was routinely used to measure the chymotrypsin-like activity, whereas
either H-Pro-Phe-Arg-AMC or Z-Gly-Gly-Arg-AMC was used to assay for trypsin-like
activity of the proteinase.
3.4.1.1 Reagents
Assay buffer (60 mM Tris-HCl. 20 mM KC1. 10 MgCk 1 mM DTT. 1 mM ATP. pH 8.0).
Tris (0.726 g), KC1 (0.149 g), MgCl2 (0.203 g), DTT (0.031 g) and ATP (0.055 g) were
dissolved in 80 ml of dist. H2O, titrated to pH 8.0 with HC1, and made up to 100 ml with
dist. H2O.
Substrate stock solutions. Stock solutions were made to a concentration of 2 mM in
dimethyl sulfoxide (DMSO) and stored at -20°C. Stock solutions were usually diluted in
assay buffer to 0.1 mM just before use.
3.4.1.2 Procedure
This assay system was essentially as described by Dahlmann et al. (1995). Briefly, the
reaction mixture (in a total volume of 100 u.1) consisted of assay buffer (50 pi), peptide-
AMC (25 pi; 0.2 mM) and enzyme (0.1-0.2 pg protein). Reactions were initiated by
addition of either substrate or enzyme and hydrolytic rates were measured at 37°C by
continuously monitoring increases in fluorescence (excitation 360 nm; emission 460 nm)
in a spectrofluorometer (7620 Microplate Fluorometer, Cambridge Technology, Inc.).
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Control assays contained no enzyme. All assays were inspected for reaction linearity.
Enzyme concentrations were adjusted to allow for measurement of initial velocities only.
The changes in fluorescence intensity were converted to micromoles of AMC by
determining, under the same conditions, the fluorescence of a serially diluted standard
solution of AMC.
3.4.2 Assay with Z-Leu-Leu-Glu-P-naphthylamide substrate
The peptide Z-Leu-Leu-Glu-P-naphthylamide (PNA) is routinely used to assay peptidyl
glutamylpeptide hydrolase (PGPH) activity (Orlowski, 1990; Djaballah and Rivett, 1992).
Hydrolysis of this substrate releases 0NA, which can be measured directly in a
fluorometer, or colorimetrically by coupling to a diazonium salt. The product 3NA is
thought to be carcinogenic and is not available commercially. A small amount was
prepared by the total enzymatic digestion of Z-Leu-Leu-Glu-pNA to construct a standard
curve.
3.4.2.1 Reagents
Assay buffer (40 mM Hepes. pH 8.0). Hepes (0.953) was dissolved in 80 ml of dist. H2O,
titrated with NaOH to pH 8.0 and made up to 100 ml with dist. H2O.
Substrate stock solution (10 mM Z-Leu-Leu-Glu-BNA). Z-Leu-Leu-Glu-BNA (0.006 g)
was dissolved in DMSO (1 ml). This substrate was freshly prepared when required.
Borate buffer (100 mM Na-borate. pH 7.4). Boric acid (0.618 g) was dissolved in 80 ml of
dist. H2O, adjusted to pH 7.4 with NaOH and made up to 100 ml with dist. H2O.
3.4.2.2 Procedure
Peptidyl glutamylpeptide hydrolase activity was measured essentially according to Mykles
and Haire (1991). The reaction mixture (200 (j.1) contained 1 mM Z-Leu-Leu-Glu-BNA
(40 ul), 40 mM Hepes, pH 8.0 (100 |il) and approx. 0.2 u.g enzyme and was incubated for
1 h at 37°C. The reaction was stopped by addition of 0.3 ml 1% (v/v) SDS and 1 ml borate
buffer (pH 7.4). The amount of substrate hydrolysed was measured in a Hitachi F-2000
Fluorescence Spectrophotometer (excitation 336; emission 410 nm). Control samples
contained no enzyme.
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To prepare a standard curve 0.6 mM PNA was produced by the complete digestion of Z-
Leu-Leu-Glu-PNA (200 ul; 0.6 mM) by Staphylococcus aureus V8 proteinase (1 ug) in 50
mM ammonium bicarbonate buffer, pH 8.0 (Rivett et al., 1994). A standard curve was
prepared using 40 mM Hepes, pH 8.0, PNA, 1% SDS and borate buffer as described
above.
3.4.3 Degradation of P-casein substrate
The degradation of protein substrates is commonly assayed by measuring radiolabelled,
acid-soluble products in a liquid scintillation counter. Alternatively, the degradation
products of unlabelled protein may be assessed by use of SDS-PAGE. Degradation of P-
casein by MCP-Tb and MCP-rbc were assessed on SDS-PAGE.
3.4.3.1 Reagents
Assay buffer. As per Section 3.4.1.1.
P-casein stock solution. Dephosphorylated p-casein (10 mg) was dissolved in assay buffer
(1 ml). The substrate solution was centrifuged (12 000 x g, 1 min, 25°C) to remove
undissolved material. The pellet was discarded and the protein concentration in the
supernatant was estimated by the Bradford (1976) dye binding method (Section 2.4).
Aliquotes (100 ul) were stored at -20°C.
3.4.3.2 Procedure
Caseinolytic activity of MCP-Tb and bovine MCP-rbc was determined by a gel-
electrophoretic method (Yu etal, 1991). Purified enzyme (0.2 mg/ml, 10 ul) was added to
P-casein substrate (51.3 ug, 90 ul) and assay buffer (75 ul), in 1.5-ml microfuge tubes and
incubated at 37°C. Aliquots of reaction mixture (25 ul) were removed after 0, 45 and 90
min and an equal volume of reducing treatment buffer (Section 2.6.1) added. After boiling
for 5 min to inactivate the enzyme, the samples were analysed by SDS-PAGE (Section
2.6.2). Bands corresponding to the protein substrate and its degradation products were
visualised by silver staining (Blum et al, 1987, Section 2.6.3).
3.4.4 Peptidase Inhibition
Chymostatin, leupeptin, TLCK, and TPCK were each dissolved separately in DMSO at a
stock concentration of 10 mM, and diluted out in 60 mM Tris-HCl pH 8.0. Z-Leu-Leu-
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Leu-H precipitated out of solution soon upon addition of an aqueous buffer and the
enzyme was thus incubated with this inhibitor before addition of assay buffer, a-
chymotrypsin-trypsin inhibitor was dissolved in assay buffer (Section 3.4.1.1) to a
concentration of 20 mg/ml. Benzamidine and 4-(2-Aminoethyl)-benzenesulfonyl fluoride
(AEBSF) were dissolved in assay buffer at a stock concentration of 100 mM and 20 mM,
respectively. Purified proteasome (0.2 ug; 5 ul) was incubated separately with each of the
inhibitors at the specified final concentration for 30 min at 25°C, and assayed for peptidase
activity (Section 3.4.1). Controls, performed in parallel, contained no inhibitors and,
where appropriate, these incorporated the organic solvents used to prepare stock solutions
of inhibitors.
3.4.5. Determination of pH stability
Enzyme stability is pH-dependent and the optimum stability of an enzyme may differ from
the pH at which it is optimally active. Three main approaches are often used to study pH
stability of an enzyme. The enzyme may be pre-incubated at various pH values and
assayed at those values. This method assesses a combination of stability and activity at a
particular pH. Alternatively, after pre-incubation at various pH values, the enzyme is
assayed at its optimal pH. Lastly, hydrolysis of the substrate can be monitored
continuously at various pH values with excess substrate and the decrease in velocity over
time used to calculate the half-life of the enzyme at each pH. In this study the second
method was used to assess influence of pH on stability of the proteasome. This method
was chosen because it gives a better reflection of the effect of pH on stability without
interference of pH on activity. The assay buffer was substituted with constant-ionic-
strength Acetate/Mes/Tris buffer (Ellis and Morrison, 1982). Constant-ionic strength
AMT buffer eliminates any effects attributable to buffer salts or differing ionic strength.
3.4.5.1 Reagents
AMT buffers [100 mM acetate. 100 mM MES. 20 mM Tris containing 4 mM Na2EDTA"|.
Glacial acetic acid (1.72 ml), MES (5.86 g), Tris (7.27 g) and Na2EDTA.2H2O (0.45 g)
were dissolved in dist. H2O (240 ml). This solution was divided into 12 aliquots (20 ml
each) each of which was titrated with either HC1 or NaOH to the appropriate pH. The
volume of each aliquot was made up with dist. H2O to 25 ml.
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3.4.5.2 Procedure
The pH profile of each activity of the proteasome was determined in triplicate over a pH
range of 3.0 to 12.0 using constant-ionic strength AMT buffer. Enzyme (5 ja.1) and AMT
buffer (50 (il) at the required pH were incubated for 30 min at 25°C. The reaction was
started by addition of 25 ul of 0.2 mM peptide-AMC substrate and the activity followed as
described in Section 3.4.1. PGPH activity was measured using Z-Leu-Leu-Glu-PNA (0.2
mM) as described in Section 3.4.2. The addition of enzyme and substrate solutions did not
significantly change the pH of the AMT buffer in the final reaction mixture.
The pH stability of the enzyme was determined by incubating the enzyme in AMT buffer
of pH 3.0 to 12.0 for 1 h at 37°C. This was followed by addition of pH-8.0 assay buffer
(Section 3.4.1) and Z-Gly-Gly-Leu-AMC or Z-Gly-Gly-Arg-AMC.
3.5 Results
3.5.1 Multicatalytic proteinase purification
The steps used for isolating multicatalytic proteinase (MCP) from Trypanosoma brucei are
summarised in Table 3.1. The MCP-Tb was purified over 61-fold with an overall recovery
of 7%. The first extract (high-speed centrifugation supernatant) contained approximately
40% of the total activity in the lysate but the specific activity decreased by over 40%
compared to the starting material. The decrease in percentage recovery and specific
activity possibly resulted from activity remaining in the pellet during centrifugation but
could also be attributed to the removal of contaminating enzyme activity such as
trypanopain and oligopeptidase that hydrolyse the peptide-AMC substrates (Mbawa et al.,
1992; Morty et al, 1998). For this reason, the inclusion of the crude trypanosomal lysate
in the purification table makes the enrichment factors and the yield appear small. Thus, a
purification table beginning with high-speed soluble (HSS) material might be more
accurate and would give an enrichment of 109 and an overall recovery of 17%. However,
an important point would have been concealed that nearly 50% of the total Z-Gly-Gly-Leu-
AMC activity remains in the pellet. Attempts to extract this activity from the pellet by
solubilisation with detergents were unsuccessful since enzyme activity was lost. Anion
exchange chromatography of the soluble supernatant fraction from high speed
centrifugation on Q-Sepharose at pH 7.0 (Fig. 3.1) was a critical step in this purification
procedure for other contaminating Z-Gly-Gly-Leu-AMC hydrolysing activities were
eliminated in this step.
Although the cysteine protease inhibitor E-64 (Barret et al, 1986), (50 uM) and the
metalloprotease inhibitor EDTA (100 \M) were routinely included in the lysis buffer, it
was necessary to fractionate the proteins on Q-Sepharose within two hours after cell lysis
to minimise possible degradation of MCP-Tb by endogenous proteases. The lysis buffer
also contained 2 mM ATP instead of 20% glycerol to maintain MCP-Tb integrity
(Kanayama et al, 1992) and allow for faster sedimentation of contaminating proteins in













Figure 3.1. Anion exchange chromatography of trypanosomal MCP-Tb on Q-Sepharose.
Q-Sepharose (2.5 x 10 cm, 30 ml. h"1) was equilibrated in standard buffer G [10 mM Tris-HCl, pH 7.0
containing 0.1 mMNa2EDTA, 1 mM DTT, 25 mM KC1, 1.1 mMMgCl2 and 20% glycerol]. After elution of
unbound protein with standard buffer G containing 100 mM NaCl, bound protein was eluted with a linear
gradient ( - - ) of 100 to 500 mM NaCl in standard buffer G over 5 column volumes and fractions (9 ml)
collected ( ) A ^ ; (—) enzyme activity against Z-Gly-Gly-Leu-AMC.
The pi vaues of the subunits of MCP isolated from rabbit reticulocytes range between 5.2
and 5.4 (Hough et al, 1987). The charge on the MCP-Tb complex is the summation of
individual net charges of the subunits. Assuming a high degree of similarity in the amino
acid composition between rabbit reticulocyte MCP and MCP-Tb, MCP-Tb should be
negatively charged at pH 7.0. The MCP-Tb complex apparently has a net negative charge
at pH 7.0. This would explain why it binds to Q-Sepharose. Contaminating proteinases
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such as trypanopain probably elutes in the unbound fraction because trypanopain-Tc has a
pi of 7.4 (Mbawa et al, 1992) and should be weakly positively charged or neutral at pH
7.0. The bound fraction was eluted from the column at about 350-380 mM NaCl The
elution pattern of the proteins and the proteinase was essentially similar to that found in
MCP-rbc purification. The total recovery of MCP-Tb was about 20%. It should be noted
that the fractions showing peak activity against Z-Gly-Gly-Leu-AMC degraded several
other peptide substrates including Z-Phe-Arg-AMC, Z-Gly-Gly-Arg-AMC, Suc-Leu-Leu-
Val-Tyr-AMC and Z-Leu-Leu-Glu-pNA. These are the activities associated with cysteine,
trypsin-like and chymotrypsin-like proteinase, and peptidyl glutamylpeptide hydrolase
(PGPH) activities (Mbawa et al, 1992; Rivett, 1993; Orlowski et al, 1993). The activity
eluted from the Q-Sepharose column was subjected to molecular exclusion
chromatography on Sephacryl S-300 (Fig. 3.2).
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Figure 3.2. Molecular exclusion chromatography of trypanosomal MCP-Tb on Sephacryl S-300
Column, 2.5 x 87 cm (427 ml bed volume); standard buffer G [10 mM Tris-HCl, pH 7.0 containing 0.1 mM
Na2EDTA, 1 mM DTT, 25 mM KC1, 1.1 mM MgCl2and 20% glycerol], flow rate 36 ml. h"
1 (7.3 cm. h1); and
fractions, 9 ml. Void volume was 167 ml. (....) A280; (—) enzyme activity against Z-Gly-Gly-Leu-AMC.
The column was calibrated under similar conditions with protein standards; thyroglobulin, Mr 670 kDa,
bovine gamma globulin, Mr 158 kDa, chicken ovalbumin, M, 44 kDa, equine myoglobin, M, 17 kDa and
vitamin Bi2, Mr 1.35 kDa.
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The gel-filtration column effectively eliminated low molecular mass contaminants. This
step also served as a buffer change step for the subsequent purification step. The enzyme
eluted close to the void volume as a single symmetrical peak of activity. The elution
volume (Ve) of the enzyme was 189 ml whereas Vo was 167 ml. Molecular mass analysis
using molecular mass standards on the same column indicated a high relative molecular
mass of 670 kDa for the Z-Gly-Gly-Leu-AMC activity. Pooled fractions from the




















Figure 3.3. Hydroxyapatite column chromatography of trypanosomal MCP-Tb
HA-Ultrogel (1.5 x 12 cm, 20 ml. h"1) was equilibrated in equilibration buffer B [10 mM potassium
phosphate, 1 mM DTT, 20% (v/v) glycerol]. After elution of unbound proteins with equilibration buffer B,
bound protein was eluted with a linear gradient (—) of 10-300 mM in buffer B over 10 bed volumes and
fractions (4 ml) collected. ( ) A2g0, (—) enzyme activity against Z-Gly-Gly-Leu-AMC.
Potassium phosphate was chosen as elution buffer because of the poor solubility of sodium
phosphate salts at low temperatures. The active fractions were eluted from HA-Ultrogel at
150 mM potassium phosphate. A sharp peak of activity coincided with a small protein
peak. The total recovery from the HA-Ultrogel column was 10% and resulted in a 31-fold
purification.
The final purification was achieved by glycerol density gradient (10-40%) sedimentation.
The specific activity of the purified MCP-Tb was 7.5 nmol.min'Vmg"1 protein against Z-
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Gly-Gly-Leu-AMC substrate of MCP-Tb, with a 61-fold purification and 7% recovery of
activity. Both the yield and specific activity were greater than those of bovine MCP-rbc
(Table 3.1). Bovine MCP-rbc was purified 171-fold in a five-step procedure with a yield
of 3%. The recovery of Z-Gly-Gly-Leu-AMC hydrolysing activity was low after the
(NH4)2SO4 fractionation step. This low yield, however, appears not to be due to loss in the
MCP-rbc activity but is probably due to the presence in the crude extract, of other
endogenous proteinases with activity towards the Z-Gly-Gly-Leu-AMC substrate.
Table 3.1. Summary of the purification of the MCP-Tb from T. brucei and MCP-rbc from bovine red
blood cells.
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HSS = High speed supernatant
The purification factor (171-fold) and yield (3%) of MCP-rbc obtained in this study are
consistent with the purification factor (173-fold) and yield (5.5%) of rat skeletal muscle-
MCP purified using Z-Val-Gly-Arg-AMC to monitor purification (Dahlmann et al., 1985).
However, the results differ from the enrichment (34.3-fold) and protein recovery (1.0%) of
rat skeletal muscle-MCP using Suc-Ala-Ala-Phe-AMC to monitor activity (Dahlmann et
al, 1985). MCP-rbc showed a higher purification factor than human MCP from liver (115-
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fold) using Z-Gly-Gly-Arg-AMC (Mason, 1990), but comparatively lower than the
purification factor (380.4) and yield (7.0%) obtained using Suc-Leu-Leu-Val-Tyr-AMC to
monitor MCP purification from rabbit reticulocytes (Hough et al, 1987). The variation in
activity and protein recovery may result from different purification protocols or difference
in cell types constituting the starting material. MCP has been estimated to constitute up to
1% of the mammalian cell protein content (Tanaka et al, 1986), but concentration varies
considerably among cell types. The MCP concentration is greater in organs [e.g. bovine
pituitary (Pereira et al, 1992; Eleuteri et al., 1997)] where average rates of protein
breakdown are greater than in other tissues [e.g. skeletal muscle (Dahlmann et al, 1995)].
A comparison of the specific activities obtained suggests that MCP is more abundant in T.
brucei (at least 2.4-fold) than it is in bovine erythrocytes and this is consistent with the
high levels of activity and rapid cell division rates of these organisms.
3.5.1.1 Subunit analysis
Enzyme homogeneity was assessed by native PAGE as outlined in Section 2.6.2. The
enzyme migrated as a single band of about 590 kDa on a non-denaturing (5-10%) gradient
gel (Fig. 3.4).
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Figure 3.4. Evaluation of MCP-Tb and MCP-rbc purification by gradient PAGE and SDS-PAGE.
Panel A. non-denaturing (5-10% gradient) PAGE of MCP-Tb (lane 1), MCP-rbc (lane 2) and Mr
markers (lane 3), thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), LDH (140 kDa) and BSA
(67 kDa). Panel B, reducing SDS-PAGE (12.5%) analysis of MCP-rbc (lane 1), MCP-Tb (lane 2) and Mr
markers (lane 3), phosphorylase b (94 kDa). bovine serum albumin 68 kDa, ovalbumin (43 kDa), carbonic
anhydrase (30 kDa), soybean trypsin inhibitor (20.1 kDa) and oc-lactalbumin (14.4 kDa) performed as
described in Section 2.6.2 and the gels were silver stained.
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The molecular mass obtained from gel electrophoresis was less than that for similar
enzyme complexes reported in archaebacterium and yeast cells (Hilt and Wolf, 1992;
Seemuller et al, 1995). When analysed on reducing and non-reducing SDS-PAGE, the
enzyme showed a polypeptide band pattern at 27, 26, 22 and 21 kDa. The protein bands
obtained under reducing and non-reducing conditions appeared similar indicating that the
subunits of the trypanosomal MCP-Tb are held together by hydrophobic interactions and
do not appear to involve disulfide bonds.
3.5.1.2 Zymogram analysis
Gelatin zymogram analysis of purified MCP-Tb and MCP-rbc show that proteolytic
activities are present only in intact native forms of the enzymes. The sites of proteinase
activity are visible as clear bands against a stained gelatin background on the upper part of
the gel (Fig.3.5). The MCP-Tb and MCP-rbc dissociate upon electrophoresis on SDS-
PAGE to give protein subunits in the 18-30 kDa range. The proteinase activity is lost upon
dissociation of the subunits.







Figure 3.5. Gelatin-substrate SDS-PAGE analysis of MCP-Tb and MCP-rbc
Purified MCP-Tb and MCP-rbc were electrophoresed on 10% SDS-PAGE co-polymerised with 0.1% (m/v)
gelatin. Lane a, MCP-Tb plus inhibitor (Z-Leu-Leu-Leu-H), lam b, MCP-Tb alone, lane c, MCP-rbc plus
inhibitor and lane d, MCP-rbc alone. The gel was incubated with assay buffer (Section 3.4.1) and stained
with amido black as outlined in Section 2.7.2
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Bands of activity were not seen in the presence of the proteasome specific inhibitor Z-Leu-
Leu-Leu-H (5 (J.M) (Jensen et al., 1995). Since there were no sites of proteolytic activity
in lanes where the inhibitor was included, the proteinase activity of MCP-Tb, therefore,
may not be independent from the peptide-hydrolysing sites of MCP-Tb. It is important to
note that MCP-Tb clearly behaves like a proteinase, not merely a peptidase. In this respect
it is more similar to T. brucei proteinases such as trypanopain-Tb than to the trypsin-like
enzyme called OP-Tb which only hydrolyses short peptides and not proteins (Troeberg et
al, \996;Mortyet al., 1998).
3.5.1.3 Degradation of proteins
MCP-Tb (2 ug) completely degraded dephosphorlylated P-casein (51.3 ug) within a 90-
min incubation period (Fig. 3.6A). The estimated specific activity of MCP-Tb was 17.1
mg dephospho-casein.mg MCP-Tb"1.h'1. The trypanosomal MCP-Tb activity against
dephosphorylated P-casein is slightly greater than that reported for bovine MCP. MCP
from bovine pituitary cells degrades dephosphorylated p-casein with a specific activity of
10-12 mg dephospho-casein.mg MCP.'1 h'1 (Pereira et al, 1992a). A six-fold greater
concentration of MCP-rbc (12 (j.g; Fig. 3.6B) than MCP-Tb (2 u.g) was required in the
present study to completely degrade dephosphorylated P-casein (51.3 u,g) within 90
minutes. The higher concentration of MCP-rbc is evidenced by visualisation of the
enzyme bands in the 90-min digestion lane.
The specific activity of purified MCP-rbc was 2.85 mg dephospho-casein.mg MCP-rbc"1.h"1
which is in agreement with caseinolytic specific activity of latent bovine pituitary MCP of
2-3 mg dephosphorylated casein degraded.mg MCP.^h"1 (Pereira et al, 1992). The
enhanced specific activity of the parasite MCP-Tb towards proteins such as casein may
have a physiological significance in terms of degradation of host proteins to provide
nutriment for the parasite or for rapid turnover of proteins in this highly active parasite.
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Figure 3.6. Activity of purified MCP-Tb and MCP-rbc against p-casein
Purified MCP-Tb (A) and MCP-rbc (B) were incubated with p-casein for different time periods at 37°C
(Section 3.4.3.2). Proteolysis was terminated by boiling the reaction mixtures for 5 min, and degradation
products were analysed by SDS-PAGE. Samples were: Mr markers as in Fig. 3.4 (lanes 1 and 10). reaction
mixtures at 0 min (lanes 2 and 9), 45 min (lanes 3 and 8), 90 min (lanes 4 and 7) and 120 min (lanes 5 and 6).
The degradation products were visualised on SDS-PAGE after silver staining.
3.5.2 Substrate Specificity
Evaluation of subsite specificity of the trypanosomal MCP-Tb cleavage of peptide
substrates is shown in Table 3.2. The MCP-Tb manifests a broad specificity. It cleaves
chymotrypsin-like bonds with bulky hydrophobic (Leu) or aromatic (Phe, Tyr) residues in
position Pi as well as polar residues with either basic (Arg) or acidic (Glu) residues.
However, a potential substrate with a sulfur-containing residue (Met) in Piwas not readily
hydrolysed, thus indicating that this site does have some discrimination. An oligopeptidase
with trypsin-like activity described in T. brucei hydrolyses Z-Arg-Arg-AMC better than Z-
Pro-Phe-Arg-AMC (Morty et al, 1998). Conversely, MCP-Tb was found to prefer Z-Pro-
Phe-Arg-AMC.
Comparisons of MCP-rbc and MCP-Tb activities show that specific peptidase activities of
MCP-Tb were 1 to 5-fold higher than those of MCP-rbc for the different substrates tested
(Table 3.2). The 'ratios' represent the magnitude by which specific activity of the MCP-
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Tb exceeds that of MCP-rbc. The MCP-Tb showed an overal trend of a higher specific
activity than that of the bovine enzyme. However, comparative data on specific activity of
the MCP from bovine and trypanosome sources need to be treated with some caution. The
purification protocols for the two enzymes differ. It is possible that the additional
ammonium sulfate precipitation step involved in the purification of the erythrocyte MCP-
rbc had effect on its specific activity.
Table 3.2. Hydrolysis of synthetic substrates by MCP purified from T. brucei and from bovine
erythrocytes
Activity was assayed in the presence of a peptide-AMC (50 \xM) or peptide-pNA (200 \M) substrate and




































































Proteasomes have been shown to be sensitive to high salt concentration (Mason, 1990).
Furthermore, salt precipitation is not beneficial for purification of an intact higher
molecular mass 26S proteasome (Kanayama et al, 1992; Dahlmann et al, 1995). Be that
as it may, the data shows the trypanosomal MCP-Tb hydrolyses Suc-Leu-Tyr-AMC and
Suc-Leu-Leu-Val-Tyr-AMC considerably more rapidly than the bovine MCP-rbc. In
contrast, Z-Gly-Gly-Leu-AMC was slightly more rapidly hydrolysed by the bovine MCP-
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rbc than by the trypanosomal MCP-Tb. The specific activities of different proteasome
preparations against different synthetic peptide substrates are compared in Table 3.3 with
those obtained in this study for purified MCP-Tb and MCP-rbc.
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Considerable variation can be observed in specific activity against similar substrates,
depending on the cell type, isolation procedure or enzyme assay system used. While quite
similar values were obtained in this study for MCP-Tb against Suc-Leu-Leu-Val-Tyr-AMC
(10.9 nmol.min"1 .mg'1) and that of Hua et al. (1996) of 6.3 nmol.min'1.mg'1, To and Wang
(1997) reported a significantly higher value (69.2 nmol.min"1.mg"1).
In some cases major differences have been reported between different MCP preparations.
For example, MCP isolated from T. acidophilum has no activity against Sue-Leu-Tyr-
AMC (Tamura et al, 1996), whereas the same substrate was found to be hydrolysed by
both MCP-Tb and MCP-rbc in the present study. Also, Z-Gly-Gly-Arg-AMC-hydrolysing
activity is present in MCP-Tb and MCP-rbc but absent in the archaebacterium proteasome
(Tamura et al, 1996). However, it is not possible to compare the present results on MCP-
Tb activity against Z-Gly-Gly-Arg-AMC with those of similar enzymes isolated from
bloodstream Tbrucei by other laboratories [e.g. 27.9 nmol.min"1.mg"1 for Hua et al. (1996),
orl58 nmol.min"1.mg"1. for To and Wang (1997)] because their purification data is not
available.
MCP-Tb is also shown to have PGPH activity as evidenced by Z-Leu-Leu-Glu-PNA
hydrolysis. The specific activity of MCP-Tb or MCP-rbc against Z-Leu-Leu-Glu-PNA is
consistent with that reported for MCP from bovine erythrocyte (Chu-Ping et al, 1994) and
lobster muscle (Mykles and Haire, 1991). However, the present PGPH results differ from
the reported specific activity of MCP from rat skeletal muscle (Dahlmann et al, 1995) or
bovine pituitary (Olowski et al, 1993; Eleuteri et al, 1997). Overall, specific activities
obtained in the present study compare well with those of earlier studies.
3.5.3 Susceptibility to Inhibitors
The sensitivity of the proteasome activities to inhibition by various typical serine protease
inhibitors is shown in Table 3.4. Antipain, E-64 and EDTA were found to have no effect
on the activity of either MCP-Tb or MCP-rbc (results not shown). The peptide aldehyde,
Z-Leu-Leu-Leu-H, was the most potent inhibitor of both proteasomes tested, resulting in
complete loss of activity against Z-Gly-Gly-Leu-AMC and Z-Gly-Gly-Arg-AMC. There
was no significant difference in sensitivity between the trypanosomal and bovine
proteasome to Z-Leu-Leu-Leu-H. Inhibition of the enzyme was dose dependent at
inhibitor concentrations of 0 to 10 uM (Fig. 3.7). The IC50 values for MCP-Tb and MCP-




Figure 3.7. Concentration dependent inhibition of MCP-rbc and MCP-Tb by Z-Leu-Leu-Leu-H
inhibitor
Purified bovine MCP-rbc (A), and MCP-Tb (B) were incubated with increasing concentrations of Z-Leu-
Leu-Leu-H, for 30 min at 37°C followed by determination of the Z-Gly-Gly-Leu-AMC (O) and Z-Gly-Gly-
Arg-AMC-hydrolysing activities (D). Values are expressed as % activity relative to control activities in
samples containing no inhibitor.
There was also no significant difference between the IC50 values for the inhibition of the
trypsin-like and chymotrypsin-like activities of MCP-rbc and MCP-Tb by Z-Leu-Leu-Leu-
H. Although both Z-Gly-Gly-Arg-AMC and Z-Gly-Gly-Leu-AMC-hydrolysing activities
of MCP-Tb were sensitive to Z-Leu-Leu-Leu-H inhibition, this peptide aldehyde could not
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be used as an active site titrant for MCP-Tb in crude lysate from T. brucei. This is because
the peptide aldehyde is known to inhibit other proteases especially calpains (Jensen et al,
1995; Tsubuki et al, 1996) and possibly OP-Tb (Morty et al, 1998). The prohibitive cost
of the proteasome specific inhibitor, lactacystin (Feteany et al, 1995) obviated its use in
the present study. Z-Leu-Leu-Leu-H was, however, useful for inhibition studies on the
purified proteasome.
Chymostatin inhibited Z-Gly-Gly-Leu-AMC activity of MCP-Tb and MCP-rbc by 70%
whereas their Z-Gly-Gly-Arg-AMC activity was inhibited by 30% (Table 3.4). Leupeptin
inhibited trypanosomal MCP-Tb and bovine MCP-rbc activity against Z-Gly-Gly-Arg-
AMC to a similar extent (82% and 75%, respectively). The trypsin-like activity of the
parasite proteasome appears to be slightly more sensitive to leupeptin inhibition than that
of the bovine proteasome.
Table 3.4. Effect of various serine protease inhibitors on the activity of MCP-Tb and MCP-rbc
Purified MCP preparations were incubated for 30 min at 25°C with inhibitors in assay buffer as described in
Section 3.4.4. The enzyme activity was determined at 37°C against Z-Gly-GIy-Leu-AMC or Z-Gly-Gly-Arg-































































The patterns of inhibition of MCP-Tb and MCP-rbc by the various inhibitors are consistent
with their different activities. However, the degree of inhibition does depend on the
specific activity of the purified enzyme and the concentration of the inhibitor used. For
example, it has been shown that 2 mM chymostatin is required to inhibit Suc-Leu-leu-Val-
Tyr-AMC hydrolysing activity completely in the 20S proteasome from T. acidophilum,
whereas only 0.25 mM inhibits rabbit reticulocyte-MCP activity. Leupeptin (1 mM)
inhibited the Suc-Leu-Val-Tyr-AMC activity by 40% (Ditzel et al., 1997) whereas
0.25mM leupeptin achieved a 12% inhibition of the same substrate (Hough et al., 1987).
AEBSF, which is known to inhibit a wide range of serine proteinases, had minimal effect
on the activities of the proteasomes. There was a 16 and 13% inhibition of chymotrypsin-
like activity for T. brucei and bovine-derived proteasome, respectively. The trypsin-like
activity was apparently more sensitive to AEBSF with 32% and 27% inhibition of activity
for trypanosomal and bovine proteasome respectively. In bovine pituitary MCP, AEBSF
(1 mM) show minimal inhibition of 5% of chymotrypsin-like activity (Orlowski et al.,
1993).
TLCK and TPCK also had minimal effects on the trypsin-like and chymotrypsin-like
activities of the proteasomes. Chymotrypsin-like activity was even partially stimulated by
TLCK, which is consistent with the previous observations on T. brucei and rabbit
reticulocyte proteasomes (Hough et al., 1987; Hua et al., 1996). Benzamidine and a-
chymotrypsin-trypsin inhibitor had no significant effect on the proteasome activities even
at high concentrations. In archaebacterium 20S proteasome, benzamidine (10 mM) was
even shown to stimulate chymotrypsin-like activity (Ditzel et al., 1997).
3.5.4 Effect of pH on MCP-Tb activities
The effect of pH on the activities towards Z-Gly-Gly-Leu-AMC, Z-Gly-Gly-Arg-AMC
and Z-Leu-Leu-Glu-pNA is shown in Fig. 3.8. The enzyme was stable over a broad range
of pH-values between 6 and 10. No residual activity remained at below pH 4. Half-
maximal activity remained at pH 5.0. The chymotrypsin-like and PGPH activities had
similar pH profiles with optimum activity for hydrolysis of Z-Gly-Gly-Leu-AMC and Z-
Leu-Leu-Glu-PNA being 7.5 while the activity towards Z-Gly-Gly-Arg-AMC was











Figure. 3.8. The effect of pH on the three activities of MCP-Tb
The pH stability (A) was detennined by incubating the enzyme for 30 min at a range of pH values from 3 to
12. The residual enzyme activity against Z-Gly-Gly-Leu-AMC (•) and Z-Gly-Gly-Arg-AMC (•) was
assayed at pH 8.0 as described in Section 3.4.5.2. The pH-activity profile (B) against Z-Gly-Gly-Arg-AMC
(D), Z-Gly-Gly-Leu-AMC (O) and Z-Leu-Leu-Glu-pNA (a) were perfonned over the pH range 3-12 as
described in Section 3.4.5.2, except that assay buffer was replaced by Acetate/Mes/Tris buffers. Values are
expressed as a percentage of maximal activity recorded for each substrate.
3.6 Discussion
Proteases of parasitic protozoa have been implicated in a wide range of host-parasite
interactions including the invasion of host cells, processing of host proteins for nutrition,
evasion of host immune responses, and transformation of parasites from one
developmental stage to another (North, 1991; Lonsdale-Eccles et al, 1993; McKerrow et
al, 1993). Cysteine proteases are found in T. brucei (Lonsdale-Eccles and Mpimbaza,
1986, Troeberg et al, 1996), T. congolense (Mbawa et al, 1991b), T. cnizi (Murta et al.,
1990), and Leishmania spp. (Coombs et al, 1991), where they are mainly responsible for
protein degradation within lysosomes. A cytosolic serine protease has been identified in 7!
brucei (Kornblatt et al., 1992, Morty et al., 1998) and membrane-bound metalloproteases
are present in T. brucei (El-Sayed and Donelson, 1997), Leishmania spp (Etges and
Bouvier, 1993) and T. cruzi (Bontempi et al., 1984). Although a multicatalytic protease
(proteasome) has been detected in T. cruzi (Gonzalez et al, 1996) and T. brucei (Hua et
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al, 1996; To and Wang, 1997; Mutomba et al, 1997, Lomo et al, 1997), biochemical
characterisation and contribution of the parasite MCP to pathogenicity remains unclear.
In this chapter the author reported an effective purification procedure for MCP from
bloodstream T. brucei and presented a biochemical comparison between the parasite
protease (MCP-Tb) and the bovine host proteasome (MCP-rbc) activities. Different
protocols involving column chromatography have been used to purify the proteasome from
different tissues (Chu-Ping et al, 1992; Dahlmann et al, 1995; Hua et al, 1996; Orlowski
et al, 1997). Ammonium sulfate precipitation as a first step in a purification protocol is
common to those protocols where starting material is not limiting. However, where
starting material is limited, as in the case of cultured cells, this step has usually been
avoided. At the start of this study, no procedure had been described for the isolation of
proteasomes from African trypanosomes. Subsequently, however, the isolation of
proteasomes from T. brucei (Hua et al, 1996) has been described. This protocol differs
from that described in the present study. For instance, Hua et al. (1996) employed a
combination of anion exchange chromatography and a series of glycerol gradient
sedimentation steps in an attempt to isolate the proteasome. However, reports (Chu-Ping
et al, 1994; DeMartino et al, 1994) indicate that a 700 kDa proteasome activator (and
probably other high molecular mass proteins) co-purified with the catalytic 20S complex
on an anion exchange column under the stated conditions (Hua et al, 1996). It is unlikely
that proteins of similar molecular masses such as the 20S proteasome and its 700 kDa
activator may be separated by stepwise density gradient procedures but the presence of
such associated (contaminating) proteins may not be revealed on non-denaturing
polyacrylamide gels. It is not yet known whether the 700 kDa activator protein is present
in trypanosomes. Nevertheless, the lack of demonstration of the activator protein may not
be considered as proof for the absence of such a protein. Other possible contaminants are
high molecular mass proteases, tricorn protease (Tamura et al, 1996), or a giant protease
(Geier et al, 1999) recently described in eukaryotic cells but yet to be identified in
parasitic protozoa. The data on purification of MCP from T. brucei (Hua et al, 1996) was
not provided and as such it is not possible to compare their yield with that obtained with
the present protocol.
Although several reports show that the relative molecular mass of the 20S proteasome
from archaebacterium and eukaryotic cells is 700 kDa (Coux et al, 1996; Tanaka 1998)
the relative molecular mass of MCP-Tb was estimated in the present study to be 590 kDa
by gradient PAGE. The MCP-Tb was found (on a reducing SDS-PAGE) to have
components of at least four different molecular masses, 27, 26, 22 and 21 kDa. If equal
amounts of the four components are assumed, approximately six of each would be needed
to make up the total complex. This argument implies that MCP-Tb, like the
Thermoplasma and yeast 20S proteasomes, is composed of a stack of four rings of subunits
(Lowe et al, 1995; Groll et al, 1997). However, the MCP-Tb differs from Thermoplasma
and yeast proteasomes in having six, instead of seven, subunits forming each ring of the
complex (Lowe et al., 1995; Seemuller et al, 1995; Groll et al, 1997) indicating that the
parasite MCP-Tb might have lost four of its MCP-Tb subunits in the course of evolution.
However, a reduction in the number of proteasomal subunits has not been reported in other
systems although the immunomodulatory cytokine, y-interferon (y-IFN) does induce
replacement of three pairs of homologous proteasomal subunits (X, Y and Z, by LMP7,
LMP2 and MECL1, respectively) in eukaryotic cells (Nandi et al, 1996). This causes an
alteration of the proteolytic specificity to favour antigen presentation (Golgberg et al,
1997). This ability to switch indicates that some of the subunits of a proteasome may be
relatively easily exchanged and so may be loosely bound together. This situation may also
apply to MCP-Tb because different estimates of the Mr were obtained in the present study
depending upon the estimation technique. In gel electrophoresis (a fairly harsh procedure)
a relatively smaller value (Mr 590 000) was obtained than when the gentle procedure of gel
filtration through Sephacryl S-300 (Mr 670 000) was used. Furthermore, the size of 590
kDa was estimated on a PAGE gel which separates proteins on the basis of their charge to
mass ratios, resulting in inaccurate Mr determinations. If the same assumptions are made
about the subunit masses as was done above, MCP-Tb may also be composed of seven,
rather than six, subunit domains with a calculated Mr of 672 000. Taken together, the
results suggest that MCP-Tb may also have readily exchangeable domains and this, in turn,
may explain why different preparations of the T. brucei proteasome have different
enzymatic properties.
In the present study it was shown that MCP-Tb has a chymotrypsin-like activity that
hydrolyses substrates faster than the trypsin-like activity and a low PGPH activity. Thus, it
is similar to the enzyme from eukaryotic organisms and unlike that from the
archeabacterium Thermoplasma 20S proteasome (Tamura et al, 1996). This observation
corroborates earlier reports (Hua et al, 1996; To and Wang, 1997) on a proteasome
isolated from T. brucei. Characterisation of subsite specificity indicates that MCP-Tb
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catalyses cleavage of a wide range of substrates with different amino acid residues in Pi
position (Leu, Phe, Tyr, Arg, Glu, Table 3.2). These may be distinguished as aromatic
(Phe, Tyr), large (bulky) hydrophobic residues (Leu, Val) and small neutral residues (Gly,
Ala). If Met occupies the Pi-binding position, the cleavage efficiency diminishes.
The results also demonstrate the importance of secondary binding site interactions. Thus, a
tripeptide (e.g. H-Pro-Phe-Arg-AMC) was hydrolysed much more readily than a dipeptide
(e.g. Z-Phe-Arg-AMC). In addition, whereas it may be assumed that Leu in position Pi
(e.g. Z-Gly-Gly-Leu-AMC) favours hydrolysis, the influence which is simultaneously
exerted by residues in positions P2, P3 and P4 that may contribute to substrate binding
should also be taken into account. The faster hydrolysis of Suc-Leu-Leu-Val-Tyr-AMC
than Suc-Leu-Try-AMC by MCP-Tb suggests that some residues play complementary
roles in specificity. This is in agreement with the observation that the nature of amino acid
residue in the P3 position directs substrates to distinct catalytic sites of the mammalian
proteasome (Cardozo et al, 1994). Indeed, it has been proposed that the residue in the Pi
position does not contribute to the selection of a cleavage site by the proteasome, but rather
that the residues in the P3 and P4 positions determine cleavage specificities of the
proteasome (Cardozo et al, 1994; Tsubuki et al, 1996). Furthermore, it appears that the
residue in the P2 position is solvent-exposed, unconstrained by the active site cleft, and
therefore also unlikely to contribute to the cleavage specificity (Groll et al, 1997).
Although fluorogenic peptides have been useful for the characterisation of the different
proteolytic activities, it is noteworthy that they have little relevance for the cleavage
specificities in non-synthetic peptides or proteins. An analysis of degradation products of
oxidized insulin B chain by purified human 20S proteasomes has shown that most peptide
bonds can be cleaved by the proteasome and many of the preferred sites cannot be
described in terms of the specificities described by experiments with fluorogenic peptides
(Ehring et al, 1996). The same is true for the cleavage pattern observed in ovalbumin
(Dick et al, 1994), gonadotropin-releasing hormone (Leibovitz et al, 1995), bradykinin
(Zolfaghari et al, 1987) and neurotensin (Cardozo et al, 1992). However, just like MCP-
rbc, on the basis of multiple preferred substrates and reactions with different class-specific
protease inhibitors, MCP-Tb still qualifies to be described as having the classical multiple
peptidase activities, designated chymotrypsin-like, trypsin-like and PGPH activities
(Cardozo, 1993). Indeed we demonstrated for the first time in the present study that
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caseinolytic activity of MCP-Tb differs from that of MCP-rbc in terms of specific activity
for the hydrolysis of dephosphorylated P-casein.
Studies on trypanosomatids show that class-specific inhibitors can kill parasites in vitro
(Rosenthal et al, 1991; Mutomba et al, 1997). For this reason, the inhibitory effects of
various serine protease inhibitors on the activities of MCP-Tb and MCP-rbc were
examined (Table 3.4). Peptide aldehyde Z-Leu-Leu-Leu-H exhibited considerable
inhibitory effects on the proteasome consistent with earlier reports on the proteasome from
bovine brain and lungs (Jensen et al, 1995; Tsubuki et al, 1996). Similar inhibition of
MCP-Tb and MCP-rbc may demonstrate a close relationship between the structures of the
distantly related enzymes. This close relationship suggests that the catalytic mechanism of
the MCP-Tb activity may be strictly conserved (Lupas and Baumeister, 1998). On the
other hand, the observed lack of specificity of Z-Leu-Leu-Leu-H to MCP-Tb implies that a
drug design based on this peptide inhibitor may not achieve the required selective toxicity
in therapy.
Neither the trypsin- nor chymotrypsin-like activities of MCP-Tb or MCP-rbc were
inhibited by the classical chymotrypsin-like and trypsin-like inhibitors, TLCK or TPCK,
thus indicating that these proteasomes do not have the required residues near the active site
for the reagents to alkylate, notably His or Ser. On the other hand, inhibition of MCP-Tb
by leupeptin and chymostatin indicates that a tetrahedral intermediate is involved in the
catalysis reaction. Inhibition of the trypsin-like activity was most effective with leupeptin,
while chymostatin was less effective. Conversely, chymostatin inhibited the chymotryptic-
like activity more effectively than the trypsin-like activity, which was scarcely inhibited by
chymostatin. This suggests that the two activities of MCP-Tb are distinct, as is the case in
MCP-rbc (Stein etal, 1996).
Unfortunately, the multiple activities of the proteasome present a problem in kinetic
analysis of individual activities, because of an overlap in substrate specificity (Stein et al,
1996. Notably, the apparently better substrate for chymotrypsin-like activity may
simultaneously be hydrolysed by the trypsin-like activity of the same proteasome. The
possibility of the selective inhibition of chymotrypsin-like or trypsin-like activities of
MCP-Tb by the alternate use of chymostatin and leupeptin is therefore of interest for the
characterisation of MCP-Tb. The slight inhibition by chymostatin of the trypsin-like
S3
activity may be ascribed to steric hindrance of the binding of the Z-Gly-Gly-Arg-AMC
substrate. The peptide aldehyde inhibitors are structural analogues of the peptide
substrates and compete for the substrate binding sites.
The pH activity and stability studies suggest that the trypanosomal proteasome is localised
in an alkaline, hence non-lysosomal, compartment as reported in other eukaryotic cells
(Tanaka et al, 1989; Rivett et al, 1992; Peters et al, 1994). The trypanosomal
proteasome exhibited a pH optimum that is too high for the proteasome to function
efficiently in the mostly acidic environment of the lysosomes. Indeed, the purified enzyme
lost its activity completely at a pH less than 4.0. This was contrary to the stability at pH
2.5 for a similar large multicatalytic protease from mammalian cells (Tsuji and Kurachi,
1989). The pH optimum of 11 for the trypanosomal proteasome activity against Z-Gly-
Gly-Arg-AMC also differs from that reported by Mason (1990), who showed that human
multicatalytic protease hydrolyses the same substrate with a pH optimum of 10.0. There
is, however, a consensus on the pH optimum of about 7.5 for the chymotrypsin-like
activity in the human multicatalytic protease (Mason, 1990), rat enzyme (Dahlmann et al,
1985) and hamster kidney cells (Tsuji and Kurachi, 1989). Distinct pH-activity profiles
imply different activities of the same enzyme rather than the same activity hydrolysing
different substrates in a non-specific manner.
Zymogram analysis of MCP-Tb activity (Fig 3.5), as well as in vitro degradation of
proteins (Fig. 3.6), indicate that the MCP-Tb hydrolyses whole proteins. Thus, MCP-Tb
can readily be distinguished from another trypsin-like, cytosolic hydrolase called OP-Tb
(oligopeptidase from T. brucei; Morty et al, 1998) that hydrolyses only short peptides and
not proteins (Troeberg et al., 1996). Since proteasomes degrade protein substrates into
peptides of focused length (mostly between 4 and 10 residues), a property shared between
prokaryotic and eukaryotic proteasomes (Wenzel et al., 1994; Ehring et al, 1996), it seems
likely that OP-Tb, possibly in conjunction with other cytosolic peptidases, may complete
the degradation initiated by MCP-Tb by degrading the peptides generated by the
proteasome complex. Thus, MCP-Tb and OP-Tb may play complementary roles in
extralysosomal protein and polypeptide degradation within T. brucei.
The new purification protocol for the isolation of MCP-Tb from T. brucei developed in this
study (Lomo et al., 1997) should be applicable to the isolation of similar enzymes from
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other protozoan organisms. Further, the results presented in this chapter show that MCP-
Tb has substrate specificity and inhibitor profile characteristics that identifies MCP-Tb as a
proteasome. Curiously, MCP-Tb was found to have a relative molecular mass that was
less than that of the MCP-rbc. To date, there has been no report on Mr differences between
20S proteasomes isolated from different cell-types. Consequently, structural and
immunochemical studies on MCP-Tb and MCP-rbc are discussed in Chapter 4.
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Chapter 4
Structural and immunochemical studies of MCP-Tb
4.1 Introduction
The structures of 20S proteasomes from Thermoplasma and eukaryotes are virtually
indistinguishable on electron micrographs (Dahlmann et al, 1989, Baumeister et al, 1997).
Projections down the cylinder axis (end-on views) show a ring-shaped structure, whereas
projections perpendicular to the cylinder axis (side-on views) appear rectangular with a
characteristic pattern of four striations, suggesting a stack of four rings (Lowe et al, 1995).
An immunoelectron microscopic investigation has shown that the a-subunits form the outer
rings while the P-subunits forms the inner rings (Grziwa et al., 1991). Mass measurement by
means of STEM (Scanning Transmission Electron Microscopy) has helped to determine the
stoichiometry (0170707017) and metal decoration studies revealed the sevenfold symmetry of the
complex (Piihler et al, 1992). The significant implication of the symmetry is that a maximum
of fourteen different subunits (seven a-type and seven P-type) can be accommodated in a
single proteasome.
Although the quaternary structure of the eukaryotic complex is very similar to that of the
Thermoplasma proteasome, there are variations reported in the literature with respect to the
dimensions of the complex (Arrigo et al., 1988, Piihler at al, 1992, Baumeister at al, 1997).
Furthermore, the present study shows that MCP-Tb has a lower relative molecular mass
compared to the bovine MCP-rbc. Consequently, MCP-Tb was subjected to structural
investigation by electron microscopy of negatively stained particles. Further investigation
involved determination of N-terminal amino acid sequences of a protein component of MCP-
Tb. The protein sequence information was used to identify MCP-Tb as a proteasome
complex, and to determine phylogenetic relationship of the MCP-Tb subunit and its
homologues which are part of proteasomes from other organisms.
Antibodies were raised against MCP-Tb, VSG and PA700 for use in immunochemical and
immunolocalisation studies and inhibition of proteasome activity. Polyclonal, monoclonal and
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anti-peptide antibodies constitute the major types of antibody that can be produced.
Knowledge of pitfalls associated with each type of antibody may assist in the choice of the
type of antibody and interpretation of otherwise unexpected results. For this reason, types and
characteristics of the various antibody groups will be discussed briefly with regard to the
experimental requirements of this study.
Polyclonal antibodies are raised by immunization of experimental animals with purified
antigens. Preparations of these antibodies from serum contain a population of antibodies that
react with a number of epitopes within the inoculated target protein. Monoclonal antibodies
on the other hand are the homogeneous products of a single B-cell clone targeting specificity
for a particular epitope (Kohler and Milstein, 1975). Monoclonal antibodies are generated by
fusing a single primed B-cell with an immortal tumour cell to produce an immortal B-cell
hybridoma. Anti-peptide antibodies are raised against sequences within the primary sequences
of a precursor or mature proteins. Careful selection of the peptide often results in anti-peptide
antibodies that recognise the whole parent protein.
The polyclonal nature of an antibody preparation may be an advantage as tissue or cell
fixation for immunolocalisation often results in progressive destruction or cross-linking of one
or more target epitopes. For this study, immunization with purified proteins was considered
suitable since the polyclonal antibody recognizes a number of targeted epitopes, and
theoretically such an antibody preparation should have a higher chance of producing
successful labeling by recognizing at least one surviving epitope in a fixed antigen. This is
particularly important if the target antigen is sensitive to the tissue fixation and processing
regime which precedes tissue sectioning and immunolabeling.
However, the inherent heterogeneity of polyclonal antibodies may also pose several problems
precluding, for example, the exclusive recognition of a single specific epitope (e.g. the active
site of an enzyme). In addition, 'background' or 'contaminating' antibodies may arise from
highly immunogenic trace contaminants in the antigen preparation, eliciting a stronger or
rivaling antibody response to that elicited by the major antigen present in the inoculated
preparation. The latter problem may be assessed in part by determining the specificity of
labeling, by probing a western blot of a crude homogenate of tissue (i.e. from which the
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antigen used to raise the antibody, was isolated). In the present study, the antibodies targeted
only the protein against which it was raised. Such results minimised the likelihood that the
antibody preparation targeted common epitopes in other proteins. Hence, the polyclonal
antibodies raised were used for labeling without the need to affinity purify the antibody
fractions. Affinity purification has a potential disadvantage, as it tends to select for the lower
affinity antibodies as the more avidly bound antibodies may be too tightly bound to the
immobilized target antigen to be easily eluted in a non-denatured form.
Monoclonal antibodies usually give a strong reaction, provided that the epitope is not cross-
linked or destroyed by fixation. Monoclonal antibodies have the potential to recognize
common epitopes in other proteins and are expensive, but because they target a single epitope,
they are usually high titre and give a strong signal. For reasons of costs, and considering that
monoclonal antibodies target a single epitope that may not survive fixation, monoclonal
antibodies were not used in the present study.
Anti-peptide antibodies constitute a unique reagent for which, as yet, there is no substitute
(Briand et al., 1985). The peptide antibody approach provides one of the few ways in which
protein and antigen processing may be studied. Such antibodies may be used to circumvent
the cross-reactivity between proteins such as cathepsins L and H that have conserved
sequences in some regions (Ritonja et al., 1988). The amino acid sequence of MCP-Tb was
not available and studies involving the use of anti-peptide antibodies were therefore not
possible in the present study.
The antibodies used in the immunochemical and immunolocalisation studies reported in this
thesis were produced against proteins purified during the course of the study. The purified
proteins included VSG (Section 4.4), 20S proteasome (MCP-Tb) from T. brucei (Section
3.3.1), and PA700 from bovine red blood cells (Section 6.2). Antibodies raised against the
MCP-Tb were used for immunolocalisation of the enzyme in T. brucei sections (Chapter 5),
and to test for antigenic similarities between the parasite MCP-Tb and the 20S proteasome
(MCP-rbc) from bovine red blood cells (Section 3.3.2). The ability of these antibodies to
inhibit proteasome activity was also investigated (Chapter 4). Anti-VSG antibodies were used
in immunolocalisation studies (Chapter 5), while anti-PA700 antibodies were used to study the
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interaction between MCP-Tb and the bovine PA700 activator, reported in Chapter 6. For
reasons of ease of presentation and flow of results, the characterisation of anti-VSG and anti-
PA700 antibodies is shown here in Chapter 4 with that of the other antibodies.
4.2 Electron microscopy
To examine the morphology of MCP, a drop of purified MCP-Tb or MCP-rbc (0.1 mg
protein/ml) was placed on a Formvar coated nickel grid. The sample was dried by absorbing
the excess solution with filter paper placed by the sides of the grids. The grids were stained in
the dark at 25°C for 10 min with 1% (m/v) aqueous uranyl acetate, and then for 10 min with
alkaline lead citrate. The protein samples were examined under a transmission electron
microscope Philips CM 120 Biotwin at magnifications 74 000 and 105 000.
4.3 Protein sequencing
Two-dimensional electrophoresis of MCP-Tb or MCP-rbc (15 ug) was performed as described
in Section 2.9.1. The separated protein components were electrophoretically transferred to a
PVDF membrane and stained with Coomassie Blue (see Section 2.10.1). The membrane
region containing the selected protein spot was cut out with a clean razor. Protein (20 pmol)
was sequenced on an automated Perkin Elmer Applied Biosystems Procise 491 (Molecular
Biology Unit, University of Natal). Phenylthiohydantoin (PTH) amino acids were identified
online with a 785A Applied Biosystems PTH analyser by reversed-phase HPLC. A "FASTA
Search" of the Swiss-Prot database was conducted for sequence similarities. The N-terminal
amino acid sequences of various a- and P-subunits of eukaryotic proteasomes were aligned
with "DIALIGN"(Morgenstem et al., 1996).
4.4 Purification of VSG
Variant surface glycoproteins were purified from T. bntcei using a technique based on
extraction of acid treated proteins into chloroform/methanol, followed by selective repartition
into an aqueous salt solution (Jackson et al. 1985).
4.4.1 Reagents
Tes buffer. pH 7.5 [20mM Tes. 140 mM NaCl. 5mM MeSC^. 0.1 mM EGTA. 0.1 mM PMSF.
10 mM glucose and 75 mM benzyl alcohol! Tes (4.584 g), NaCl (8.182 g), MgSO4.7H2O
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(1.233 g), (EGTA 0.038 g), glucose (1.802 g) and benzyl alcohol (7.98 ml) were dissolved in
800 ml of dist. H2O, adjusted to pH 7.5 with NaOH and made up to 1 litre.
4.4.2 Procedure
A suspension of bloodstream form of T. brucei (approx. 1 x 109 cells) in 10 ml of PSG buffer,
pH 7.5 at 0°C was added with stirring to an equal volume of Tes buffer, pH 7.5 so that the
final concentration of cells was 5xlO8 cells/ml. The mixture was incubated at 37°C for 5 min
then an equal volume of Tes buffer without benzyl alcohol at 0°C added and centrifuged (12
000 x g; 5 sec). The supernatant was carefully removed and concentrated 10-fold by dialysing
against PEG 20 kDa at 4°C. The protein in the concentrate was further purified with 0.2
volumes of 50% trichloroacetic acid and centrifuged (3 000 x g, 10 sec). The precipitated
protein was resuspended in distilled deionized water (4 ml). The suspension was extracted
with 20 volumes of chloroform/methanol (2:1, v/v) with vigorous shaking for 5 min and then
stored overnight at 5°C. This storage procedure increases the final yield of purified VSG.
The extract was separated into two phases by centrifugation (12 000 x g; lh) after the addition
of 0.2 volume of 0.9% (w/v) NaCl solution. The upper aqueous phase contained pure VSG
and was removed by aspiration and dialyzed against a large volume of distilled deionized
water, at 4°C for a total of 36 h. The purity of VSGs was assessed by SDS-PAGE (Laemmli
1970) as outlined in Section 2.6.
4.5 Production of antibodies against VSG, MCP-Tb and PA700 in chickens
Polyclonal antibodies were raised in chickens against purified VSG (Section 4.4), MCP-Tb
(Section 3.3.1) and bovine proteasome activator PA700 (Section 6.2) as outlined in Section
2.10.
4.6 ELISA and western blotting analysis of proteins
An ELISA was performed on each antibody as outlined in Section 2.12. Immunoblot analyses
were carried out as outlined in Section 2.11. The specificity of the antibodies was tested on
blots of purified antigen alongside a crude trypanosome lysate. The crude lysates (high speed
supernatant) were prepared by lysis of T. brucei cells, followed by centrifugation of the
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homogenate (100 000 x g, 4°C; 1 h) as outlined in Section 3.3.1. An aliquot (5 ul) of the
supernatant was subjected to either native PAGE (3 to 10% acrylamide gradient) or SDS-
PAGE (10%). The gel-separated proteins were transferred to nitrocellulose membranes as
described in Section 2.11.2. The different chicken IgY preparations, at concentrations
determined from the ELISA above, were used to probe the western blots.
4.7 Inhibition of MCP activity by antibodies
Assays for inhibition of MCP activity by antibodies were carried out as described for
cathepsin L (Coetzer et ai, 1991). MCP-Tb or MCP-rbc (0.1 ug) were incubated at 37°C for
15 min with chicken anti-MCP IgY, or pre-immune chicken IgY, at different antibody
concentrations. After incubation, the enzymic reactions were started by the addition of the
substrate Z-Gly-Gly-Leu-AMC (25 uM). The released fluorophore was measured
fluorometrically in a continuous assay as outlined in Section 3.4.1. Inhibition of the enzyme




Examination of negatively stained MCP-Tb and MCP-rbc particles under the electron
microscope revealed both similarities and differences (Fig. 4.1 A and Fig. 4.IB). Like MCP-
rbc, MCP-Tb assumes a barrel-shape with a rectangular side view (14.5 ± 0.3 nm long and 10
± 0.5 nm wide) with a pseudo 7-fold symmetry. The end-on view is donut-ring like with an
estimated outer diameter of 10 ± 0.3 nm and a dark stained inner diameter of 2.9 ± 0.4 nm.
There was no significant difference in the monomeric dimensions of MCP-Tb and MCP-rbc
donut-like structures. MCP-Tb differs from MCP-rbc in that MCP-Tb forms a peculiar "end-
on" association of particles to create long ribbon-like chains [up to 200 nm long (Fig. 4.1 A)].
The chains of MCP-Tb units do not break upon dilution of the sample (4.1C) implying strong
interactions between the associated units. There was no obvious association between MCP-
rbc units even at high concentration of the enzyme (Fig. 4. IB) or when the enzyme was
diluted (Fig. 4. ID)
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Figure 4.1 Electron micrographs of purified MCP-Tb and MCP-rbc
The purified MCP-Tb (a) and MCP-rbc (b) were negatively stained with 1% uranyl acetate, and examined
under a transmission electron microscope at a magnification of 105 000. The arrows show MCP-Tb units




In view of the observed differences in relative molecular mass between native MCP-Tb
and MCP-rbc (Fig. 3.4), 2D-PAGE was carried out to evaluate possible differences
between their subunit composition (Fig. 4.2).
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Figure 4.2 Characteristic 2D-PAGE patterns of subunits of MCP-rbc and MCP-Tb
Purified MCP-rbc (A) and MCP-Tb (B) were subjected to 2D-PAGE and silver stained. Some polypeptide
components of MCP-Tb (C) do not stained with Coomassie Blue. Mr markers (C) are as shown in the legend
to Figure 3.4B. The arrow indicates the polypeptide component blotted for N-terminal microsequencing.
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The MCP-rbc appears to have a more complicated pattern of spots on the two-dimensional gel
(Fig. 4.2A). There were at least 28 different polypeptide components on the 2D-PAGE of
MCP-rbc which were more numerous than those obtained for MCP-Tb (Fig. 4.2B). The
relative molecular masses of the MCP-rbc subunits ranged from 21 to 34 and they had a wider
range of pi-values than those of MCP-Tb of between 4 to 10.
The two-dimensional gel revealed 12 spots of protein components of MCP-Tb when silver-
stained. An arrow shows the spot of protein component sequenced (Fig. 4.2B and C). Some
protein components did not stain with Coomassie Blue (4.2C). The relative molecular masses
of the protein components range from 17 to 27 kDa and have a wide range of pi values
between 4 and 7. Protein components are concentrated towards the basic end of the pH
gradient. The pattern of polypeptide components was highly reproducible, although the spots
differ in intensity when silver-stained or Coomassie Blue-stained. The 2D-PAGE also
facilitated the separation of subunits of MCP-Tb for subsequent N-terminal microsequencing.
4.8.3 N-terminal sequence
The subunit selected for N-terminal sequencing is indicated in Fig. 4.2 (arrow). Selection was
based on the observation by Rivett (1993) that this subunit is not N-terminally blocked and
could therefore be subjected to N-terminal sequencing directly. The 12 N-terminal amino acid
residues of MCP-Tb identified were LXAIXQYAKIXV. Cysteine residues are not normally
detected by the PTH-derivative analyser hence appear on the chromatogram as blank 'X'.
Residues 2, 5 and 11 in the sequence may be cysteine residues.
A FASTA search for sequence similarity in the SWISS-PROT database found no matches.
However, the N-terminal sequence had some (albeit minimal) similarities within P-type
sequences of proteasomes from different species. Sequences of the N-terminal regions of
different proteasomal P-type subunits share some conserved regions but have variable lengths
at the N-terminus (Fig. 4.3). The third (Ala) and the fourth (He) residues from the N-terminus
are conserved in Human Hs-C5, Human Hs-10 and Saccharomyces cerevisiae Doa3 subunits











































Figure 4.3 Comparison of N-terminal sequences of a P-type subunit of MCP-Tb with other possibly related
proteins.
Different P-type subunits of MCP were aligned with the N-terminal sequence of MCP-Tb designated Tb-x. The
second column shows the species Escherichia coli (Ec), Mycobacterium leprae (Ml), Trypanosoma brucei (Tb),
Thermoplasma acidophilum (Ta), Saccharomyces cerevisiae (Sc), and Homo sapiens (Hs). Protein sequences
indicated are subunits of preoteasomes from the organisms shown. The numbering corresponds to the amino acid
residues in the protein. Dashes indicate gaps introduced for better alignment. Single-letter abbreviations for
amino acid residues have been used and similar residues arc shaded gray. 'X' may be cysteine residues.
4.8.4 Antibody profile
The progress of antibody response to the respective immunogens, was followed by ELISA
analyses (Section 2.12) of IgY extracted from egg yolks collected at different time intervals
(Fig. 4.4). The increase in antibody titre, which is expressed here as the concentration of
antibody at which A^os-values are significantly higher than those of equivalent pre-immune
controls, is shown for the course of the inoculation period. The two chickens inoculated with
the same antigen showed a similar progress of antibody production with minor variations in
antibody titre. The profile of primary antibody response has been shown for one chicken for
each antigen.
The chickens responded well during the course of the immunization program. There was a
quicker antibody response against VSG (Fig. 4.4A) than against MCP-Tb (Fig. 4.4B) but the
titre of the latter was higher (large increase between weeks 6 and 9, and decrease from weeks
9 to 12). Immunization of chickens with bovine PA700 showed a slower antibody response
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Figure 4.4. Progress of immunization of chickens with T. brucei VSG, MCP-Tb and PA700 as
determined by ELISA
Parasite proteins (1 (ig/ml) were adsorbed to tlie wells of microtitre plates for 16 h at 4°C and incubated with
antibodies directed against VSG (A), MCP-Tb (B) and PA700 (C). Antibodies were collected pre-
immunization (•) and after 3 (V), 6 (•), 9 (0), and 12 weeks (A). Binding was visualised by incubation
with rabbit anti-chicken HRPO-linked secondary antibodies as described in Section 2.12. Each point is tlie
mean absorbance at 405 nm of duplicate samples.
The antibody production peaked for MCP-Tb in week 12 with a titre of 15 ng.ml"1 and for
VSG with a titre of 12 ug.ml'1 in week 9 although the antibody had not titrated to
completion. The peak antibody production against PA700 was 60 pig.ml"1 at week 6 that
had a similar antibody titre to week 9 (4.4C). There was a decrease in antibody production
against PA700 in week 12 of the inoculation programme.
4.8.5 SDS-PAGE and Immunoblot analyses of VSG
Trypanosomes usually overcome the immune capabilities of a host animal by undergoing
antigenic variation, a phenomenon that involves sequential replacement of variant surface
glycoproteins (VSG). VSGs were purified from T. brucei and the purity of VSG assessed
by SDS-PAGE. They showed a single band of relative molecular mass of 65 kDa (Fig
4.5A).










Figure 4.5. Electrophoretic and immunoblot analyses of purified VSG.
Panel A, reducing SDS-PAGE of Mr markers (lane 1), as in Legend to Fig. 3.4 and VSG (lane 2). The gel
was silver stained (Section 2.6.3). Panel B, purified VSG (lane 1) and crude trypanosome lysate (lane 2)
were electroblotted from reducing SDS-PAGE onto nitrocellulose and probed by chicken anti-VSG
antibodies. The bound antibodies were detected as described in Section 2.11.2.
Anti-VSG antibodies raised in chickens recognized both purified VSG (Fig. 4.5B, lane 1)
and VSG in a crude trypanosome lysate (not shown) separated on SDS-PAGE. This
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indicated that the anti-VSG antibodies were specific since they did not cross-react with any
protein in the crude lysate. These antibodies were used in immunolocalisation studies
reported in Chapter 5.
4.8.6 Western blot of MCP-Tb
Fig 4.6A shows western blotting experiments of the targeting of purified MCP-Tb (lane 1)
and MCP-rbc (lane 2) electrophoresed on a non-denaturing PAGE by chicken anti-MCP-
Tb IgY. Fig. 4.6B shows a blot of polypeptide components of MCP-Tb and MCP-rbc
separated by SDS-PAGE. The antibodies recognized only 27 kDa subunits of MCP-Tb















Figure 4.6. Western blot analyses of MCP-Tb and MCP-rbc with chicken anti-MCP-Tb IgY
Purified MCP-Tb (lane 1) and MCP-rbc (lane 2) were electroblotted from non-denaturing PAGE (Panel A)
and reducing SDS-PAGE (Panel B) onto nitrocellulose and probed with chicken anti-MCP-Tb IgY. The
bound antibodies were detected in both Panels A and B as described under Section 2.11.2. The positions of
Mr markers are indicated.
4.8.7 Inhibition of MCP-Tb activity by chicken anti-MCP IgY
The effect of anti-MCP-Tb antibodies on the proteolytic activities of purified MCP-Tb and
MCP-rbc was tested (Fig 4.7). Although the antibodies had inhibitory effect on the MCP-
Tb activity, complete inhibition of the enzyme activity was not observed. Anti-MCP-Tb
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antibodies did not inhibit the activity of MCP-rbc. Pre-immune antibodies had no effect on
MCP-Tb or MCP-rbc activities.
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Figure 4.7. Comparative effects of chicken anti-MCP-Tb on MCP-Tb and MCP-rbc hydrolysis of Z-Gly-
Gly-Leu-AMC.
MCP-Tb (D and D) or MCP-rbc ( • and • ) was incubated with various amounts of anti-MCP-Tb IgY (Dand D)
or preimmune IgY ( • and D).
4.9 Discussion
Structural Analysis
MCP-Tb is similar to eukaryotic MCP with respect to size and shape. PAGE analysis of
MCP-Tb shows that it has a similar molecular mass (albeit slightly smaller) and complex
composition as MCP-rbc. Electron microscopy of negatively stained MCP-Tb preparations
suggests a cylindrical structure as in MCP-rbc, rat muscle and liver proteasomes (Baumeister
et al, 1988, Djaballah et ah, 1993). Particles viewed end-on appears to be ring-shaped and
side-on a rectangular shape with four striations, suggesting a characteristic stack of four rings.
MCP-Tb, like the MCP-rbc, has a six-fold symmetry. Thus, morphological similarities
between MCP-rbc and MCP-Tb suggest that MCP-Tb is equivalent to the 20S proteasome and
unlike the high molecular mass tricorn protease (Tamura et ah, 1996) or the recently described
giant protease (Geier et al., 1999).
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A unique feature observed for MCP-Tb is the end-on association of the MCP-Tb units to
form long ribbon-like chains. The implication of this end-on interaction between the
MCP-Tb units is not certain at present, neither has it been reported in other proteasome
preparations. However, it is likely that MCP in trypanosomatids may exists in "intestine-
like organelles" rather than singly as the characteristic "meat-grinder" appearance of other
proteasome. This end-on association of the MCP-Tb units may have a significant
functional meaning. For instance, the direct passage of protein substrates from one MCP-
Tb unit to another may result in more efficient processing of the substrate compared to
MCP-Tb units acting singly. A scenario can thus be envisaged where the MCP activator
PA700, caps the end of MCP-Tb only after every ten or more units rather than individual
MCP units. This low frequency of PA700 may explain the failure to hitherto isolate an
intact PA700 from the trypanosomes.
Analysis of the subunit composition of MCP-Tb revealed 12 spots. This differs from the
observations of Hua et al. (1996) that reported 8 different components of a similar T.
brucei enzyme resolved on a 2D-PAGE. In contrast to MCP-Tb, MCP-rbc showed at least
28 different protein components. These differences may be partly explained by the fact
that different polypeptides are not always present in equal amounts and that the number
appears to vary depending upon the species (Rivett, 1993). For example, yeast
proteasomes have 14 different types of subunits (Heinmeyer et al., 1991), plant
proteasomes 12 to 15 (Schliephacke et al., 1991) and other proteasomes have been
reported to have 25 distinct polypeptides (Rivett and Sweeney, 1991, Zwickl et al, 1992,
Chen and Hochstrasser, 1995). This contrasts with the simple pair of subunits (a, 27 kDa
and P, 25 kDa; Dahlmann et al., 1989) that makes up the archaeon T. acidophilum,
proteasome. A natural question is whether the population of eukaryotic proteasomes is
composed of a mixture of biochemically related particles with varied subunit composition
or whether the various subunits not related to each other combine in a single complex. It is
likely that the differences in polypeptide composition may be due to differences in
proteasome complexity. It is also possible that some subunit heterogeneity is not always
detected by 2D-PAGE, the standard method of analysis, or that the supposed
subpopulations of proteasomes may actually contain additional factors that are not part of
the 20S particle proper. Further, the differences in the number of polypeptides appearing
on the 2D-gel may arise from proteolysis of some subunits of proteasome during
purification, storage or activation of the enzyme (Rivett and Sweeney, 1991, Weitman and
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Etlinger, 1992). Phosphorylation (Haass and Kloetzel, 1991) or glycosylation
(Schliephacke et al., 1991) may alter the properties of particular subunits.
For the purpose of comparison of the primary sequence of MCP-Tb subunit with the
protein sequences in the database, a protein component of MCP-Tb (Tb-x) was selected
and its N-terminal sequence determined. The spot selected for N-terminal sequencing
from the 2D-PAGE of MCP-Tb was presumed to be a P-type subunit. The p-type subunits
have been shown to migrate to the bottom end of the two-dimensional gel (Zwickl et al.,
1992, Chen and Hochstrasser, 1995) and are generally not N-terminally blocked (Rivett,
1993). It has also been shown that the P-type subunits possess the proteolytic activity in
the proteasome (Seemuller et al., 1995). As predicted, Tb-x was found not to be N-
terminally blocked.
In general, sequence similarities and sequence alignments are theoretical sequence
analyses that are biologically important. Similarity of a pair of amino acid sequences may
provide insight into evolutionary relationships, allow the function and sometimes the
structure of the protein to be mapped in relation to well-characterised proteins. Multiple
alignment can be used to identify the best conserved sequences or structural motifs. For
instance, yeast Doa3 protein has extensive sequence similarity to 20S proteasome p-type
subunits and has been implicated in the chymotrypsin-like activity of the yeast proteasome
(Chen and Hochstrasser, 1995). Detection of these homology domains in uncharacterized
protein sequences may give valuable clues to the biological role of the protein. However,
sometimes homology regions do occur in several otherwise unrelated proteins (Asano et
al., 1997; Lupas et al., 1997). Nevertheless, such homology regions frequently confer a
specific functionality to the proteins. In the present experiment alignments were done and
resulted in the listed sequence comparisons (Fig. 4.3). Clearly, the alignment homologies
are weak, but since the proteins all have only weak homologies with respect to each other,
and since all have proteasome associations, it is not surprising that the protein from MCP-
Tb is not overly like any of the others.
A longer continuous sequence of the MCP-Tb subunit would provide a better picture of the
sequence similarity when aligned with sequences of other proteasome subunits. Further, it
is possible that the lack of similarity at the amino-terminus of the mature P-type subunits is
a consequence of post-translational modifications of the subunits. For instance,
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mammalian proteasome subunit Lmp7 has been shown to be proteolytically processed from a
~30 kDa precursor to a mature form of ~23 kDa found in 20S particles (Glynne et al., 1993).
Similarly, the yeast Doa3 subunit is cleaved post-translationally to produce the mature form
detected in purified proteasomes (Chen and Hochstrasser, 1995). In both cases the precursor
subunits are amino-terminally processed but the exact position of processing is uncertain. As
noted in the alignment results, the sequences have variable lengths attributed to the
prosequences cleaved off in mature proteins. The prosegments of the proteasome subunit
precursors have been suggested to play a role in preventing premature enzyme activation and
may also be important for sub-cellular localization (Friih et al., 1992, Glynne et al., 1993).
Related proteins retain the same basic three-dimensional fold and functionally important
residues, long after evolutionary divergence may have led to a randomization of the amino
acid sequence at non essential positions (Akiyama et al., 1994, Lowe et al., 1995). Thus,
absence of domains homologous to the N-terminal sequence of MCP-Tb (Tb-x) subunit may
imply that the sequence is part of a less conserved, non-essential region in the enzyme rather
than the sequence of a novel molecule. N-terminal sequencing of further subunits as well as
those of internal peptides obtained by limited hydrolysis of subunits will clarify sequence
similarities between MCP-Tb and proteasomes from other species.
Immunochemical studies
For the purposes of different experiments in this study, antibodies were raised against MCP-
Tb and VSG isolated from T. brucei as well as the proteasome activator PA700 isolated from
bovine host erythrocytes. MCP-Tb was found to be highly immunogenic in chickens. By
week six post-inoculation, a high titre of antibodies was produced. Interestingly, VSG that has
a molecular mass of 65 kDa (Cross, 1975) elicited a higher titre of antibodies compared to
MCP-Tb that has a native Mr of 590 kDa. This suggests that the immunogenicity of the
antigens depends more on the nature of the inoculated substance than on the molecular size of
the immunogen. The VSG has a glycolipid component (Englund, 1993) that probably makes
it more immunogenic. On the other hand, MCP-Tb consists of an assembly of protein
subunits with no evidence of a non-protein component. The bovine proteasome activator
PA700 was less immunogenic compared to the T. brucei derived immunogens.
102
Chicken anti-MCP-Tb antibodies reacted avidly with purified MCP-Tb, as well as the
enzyme in a crude lysate separated by non-denaturing PAGE (Fig. 4.6), but did not react
with MCP-rbc on a blot. Although the parasite MCP-Tb and bovine host MCP-rbc have
functional and morphological similarities (Sections 3.5.2 and 4.8.1), the lack of
immunological cross-reactivity suggests that the two enzyme complexes have undergone
evolutionary divergence to become antigenically distinct. Interestingly, anti-MCP-Tb
antibodies did not recognize all subunits of MCP-Tb separated by SDS-PAGE. This was
thought to be a reflection of the differential immunogenicity of the different subunits of
MCP-Tb. This may be the result of the relative exposure of respective MCP-Tb subunits
to the immune system of the chickens. The hidden epitopes are probably those of the P-
type subunits in the hydrophobic channels of MCP-Tb. In agreement with our observation,
polyclonal antibodies raised against the MCP isolated from other sources (Tanaka et al,
1986, McGuire et al, 1988) do not recognize all the polypeptide components separated by
SDS-PAGE. The antibody binding to individual subunits of MCP is relatively specific.
Antibodies raised against (3-type subunits recognize the P-type subunits on the native MCP
and do not cross react with a-type subunits (Rivett and Sweeney, 1991). This has enabled
elucidation of topography and the arrangement of a- and P-type subunits of MCP
(Dahlmanne/a/., 1999).
Studies have shown that anti-enzyme antibodies may activate, inhibit or have no effect on
the enzyme activity depending on the enzyme under study, the region targeted by the
antibody and the substrate used to assess the antibody effect (Dingle et al, 1971, Edwards
et al, 1990, Coetzer et al, 1992; Troeberg et al, 1997). The anti-MCP-Tb antibodies
produced in the present study had an inhibitory effect on the MCP-Tb but had no effect on
MCP-rbc activity. This differential targeting of parasite and host MCPs bodes well for
developing a vaccine using MCP-Tb. The pre-immune antibodies had no effect on MCP-
Tb activity. The inhibitory effect on MCP-Tb activity is likely to be due to specific
binding of polyclonal antibodies to the MCP-Tb. However, it is not clear whether the
inhibition is due to occlusion of the substrate binding or active site (an unlikely scenario in
view of the buried position within the core of the complex), occlusion of the entrance to
the core, or simply a distortion of the complex. The antibody bound to the regulatory or
catalytic subunit of MCP-Tb may cause conformational changes leading to alteration in the
substrate binding or active site of the enzyme (Djaballah et al, 1993).
103
A contrasting observation was made by Rivett and Sweeney (1991) who observed no effect of
anti-MCP antibodies on proteolytic activities of MCP against small synthetic peptide
substrates and even on protein degradation. It is notable that they used rabbit IgG raised
against rat liver MCP. Thus, the discrepancy in the two observations could be ascribed to
different sources of MCP, differences in species in which the antibodies were raised, or
differences in complexities of the trypanosomal and rat liver MCPs (Arnon and Shapira, 1967,
Coetzer et al, 1992, Rivett, 1993).
The physiological significance, if any, of the production of enzyme inhibitory antibodies by
the host against the parasite enzyme is still unknown. In some studies, proteases such as
trypanopain-Tc from T. congolense and cruzipain from T. cruzi have been recognized as major
antigens in cattle and human infections respectively (Authie et al, 1992; de Souza et al,
1990). A positive correlation has been shown between the production of antibodies against
Trypanopain-Tc and trypanotolerance in cattle (Authie et al, 1993) suggesting that such
antibodies may help protect the infected host. The mode by which the antibodies to the
parasite protease may protect the host is still unclear. However, the antibodies may kill the
parasite through complement activation or interfere with the physiology of the parasite
through inhibition of the parasite enzyme.
The present study has shown that the parasite MCP-Tb and the host MCP-rbc have no
discernible structural differences under the electron microscope yet they are immunologically
distinct. Furthermore, anti-MCP-Tb antibodies inhibit MCP-Tb activity but do not affect the
MCP-rbc activity. The latter was not unexpected since anti-MCP-Tb antibodies were found
not to cross react with MCP-rbc in a western blot. The use of specific antibodies, and anti-
peptide antibodies in particular, is a common tool for the study of an enzyme's function in
vivo. Anti-peptide antibodies targeted to a specific primary sequence of an enzyme can often
give invaluable information as to the contribution of an enzyme to a particular physiological
function. The N-terminal sequence of a subunit of MCP-Tb obtained in this study may be
used in the design of a peptide sequence for further investigation of MCP-Tb functions in vivo.
While immunological differences between MCP-Tb and MCP-rbc bode well for vaccine
development, there are limitations with regard to the location of the target molecule in the
parasite. A potential vaccine target should be either a secreted molecule or a molecule
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exposed on the surface of the parasite. To this end, a study was conducted using the high titre
specific antibodies prepared against MCP-b and VSG to localise MCP-Tb and VSG in T.
brucei sections as discussed in Chapter 5.
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Chapter 5
Localisation of MCP-Tb in Trypanosoma brucei
5.1 Introduction
The multicatalytic proteinase (MCP) is a non-lysosomal protease complex (for reviews;
Coux et al, 1996, Tanaka et al, 1998). In eukaryotic cells, MCP has been localised in the
cytoplasmic matrix, in association with the endoplasmic reticulum, and in the nucleus
(Akhayat et al, 1987; Tanaka et al, 1989; Peters et al, 1994; Palmer et al, 1996). The
heterogeneous localization of MCP is consistent with its proposed multiple functions in
intracellular protein turnover and RNA processing (Pouch et al, 1995). However, no
report is available with regard to the relative distribution of MCP in trypanosomatids. The
purpose of the investigation reported in this chapter was to determine the subcellular
localisation of the MCP complex in bloodstream forms of T. brucei. The localisation of
MCP in these parasites was evaluated by two different techniques. Firstly, parasites were
disrupted by a French Pressure Cell and the homogenate obtained subjected to differential
centrifugation. The subcellular fractions thus obtained were assayed for MCP-Tb activity.
The subcellular fractions were also screened for the presence of putative organelle marker
enzymes. The second approach to localising MCP in T. brucei involved
immunocytochemistry at the electron microscopy level using polyclonal antibodies raised
against the purified MCP-Tb.
Immunocytochemistry is an accurate method for subcellular localisation and
characterisation of different molecules. This technique has been used successfully to
localise intracellular proteins including MCP in rat tissue (Kamakura et al, 1988; Palmer
et al, 1996), Drosophila (Haass et al, 1989), sea urchin (Akhayat et al, 1987) and newt
(Peters et al, 1994). The success of cytochemical experiments depends on the specificity
of the antibodies, the resin used for embedding, and the potency of immunogold probes.
The specificity of the polyclonal antibodies raised against MCP-Tb and VSG to their
respective antigens was illustrated in Sections 4.13 and 4.11 respectively. The resins used
in the present experiments are low temperature (Lowicryl ) embedding media chosen with
regard to their ability to enable retention of antigenicity and preservation of the
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infrastructure of the specimen (Roth et al, 1981; Hobot, 1989). It is believed that
maintenance of low temperature during processing of specimens is a valuable aid to not
only the preservation of ultrastructure, but also to the retention of soluble components in
their in vivo positions and conformations (Roth et al, 1981; Weibull and Christiansson,
1986). Different resins that can be used for tissue embedding at low temperatures have
been developed. One such embedding media is the Lowicryl resin.
Lowicryl resins are acrylate-methacrylate mixtures that form a vinyl type of carbon
backbone during polymerisation (Carlemalm et al., 1985). Properties that make Lowicryl
resins suitable for use at low temperatures include miscibility with different organic
solvents, low viscosity, and ability to be polymerised by ultraviolet light. Lowicryl K4M
is polar and Lowicryl HM20 is non-polar and these can be used at -35°C and -50°C
respectively, while Lowicryl KIIM and Lowicryl HM23 are the respective polar and non-
polar ultra-low temperature equivalents (Acetarin et al., 1986). Lowicryl K4M can be kept
in a partially hydrated state during dehydration and infiltration, since the resin can be
polymerised with up to 5% (m/m) water in the resin block. Low temperature embedding
may be achieved by the progressive lowering of temperature (PLT) technique
(Kellenberger, 1985). This technique involves stepwise reduction in temperature as the
concentration of the dehydrating agent is increased.
Once the specimen sections are cut from the embedding media, enzyme or gold labeling
techniques may be employed to facilitate the visualization of intracellular components.
Gold labeling systems take a number of forms. An immunogold label entails the coupling
of colloidal gold to an antibody. This antibody-gold conjugate may be used directly where
the gold particle is bound to a primary antibody, which will bind to the antigen of interest,
or the conjugate may be used as a secondary antibody which then binds to a primary
antibody bound to the targeted antigen. The latter technique has been used in this study for
it has the advantage of an amplifying effect, as many secondary antibodies, and thus many




SHADE Buffer T250 mM Sucrose. 50 mM Hepes. 2 mM ATP. 5 mM Na2EDTA. pH 7.4).
Sucrose (8.56 g), Hepes (1.19 g), ATP (0.11 g), Na2EDTA (0.19 g) were dissolved in 90
ml of dist.H2O, adjusted to pH 7.4 with NaOH and the volume made up to 100 ml with
dist.H2O.
5.2.2 Procedure
Cells were fractionated by differential centrifugation as previously described (Grab et a!.,
1987). Trypanosomes (approx. 1 x 109 cells) were washed in SHADE buffer at 4°C. The
parasites were disrupted by a French Pressure cell under chamber pressure of 2500 psi.
The homogenate was centrifuged (705 x g, 10 min, 4°C). The resulting pellet designated
the crude nuclear fraction (NU) contained unbroken cells, nuclei and cell debris. The
resulting supernatant was centrifuged (2 800 x g, 10 min, 4°C) to produce a large granule
(LG) fraction. This was followed by a small granule (SG) fraction produced from
centrifugation (15 000 x g, 10 min, 4°C) of the post-LG supernatant. The last
centrifugation step (123 000 x g, 90 min, 4°C) in a 75 Ti rotor produced the crude
microsomal (MI) pellet fraction and the cytosolic (CY) supernatant. All pellets, with
exception of MI, were washed with the same buffer and the washings incorporated into the
next centrifugation step.
5.3 Determination of enzyme activities
5.3.1 Acid Phosphatase
5.3.1.1 Reagents
Assay buffer HOP mM Na acetate buffer. pH 5.01 Glacial acetic acid (572 ul) was added
to 80 ml of dist.H2O, adjusted to pH 5.0 with NaOH and made up to 100 ml with dist.H2O.
Para-nitrophenvl phosphate C50 mM Na2 pNPP). Na2/?NPP (65.8 mg) was dissolved in 5
ml assay buffer.
Stopping solution HO mM NaOH). NaOH (40 mg) was dissolved in 100 ml of dist.H2O.
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5.3.1.2 Procedure
Acid phosphatase (EC 3.1.3.2) activity was assayed usingp-nitrophenol phosphate (pNPP)
as a substrate essentially as described previously (Tosomba et al, 1996). The reaction
mixture consisted of assay buffer (25 ul), pNPP (5 ul) and 20 ul enzyme solution made up
in a 96-well microtitre plate. The reaction was stopped by the addition of 10 mM NaOH
(200 u.1). The amount of /?-nitrophenol liberated was measured spectrophotometrically at
405 nm using a BIO-TEK EL 312 microtitre plate reader. One unit of enzyme was defined
as the amount liberating 1 umole of/?-nitrophenol per minute under the above conditions.
An extinction coefficient of 1.465 mole"1.ml.cm"1 was used to determine the number of
units of the/Miitrophenol (Tosomba et al, 1996).
5.3.2 Cysteine protease
5.3.2.1 Reagents
Assay buffer flOO mM Mes. 2 mM Na?EDTA. 6 mM DTT. pH 6.0). Mes (1.952 g),
Na2EDTA (74.4 mg) and DTT (6.7 mg) were dissolved in 80 ml dist.H2O, adjusted to pH
6.0 with NaOH and made up to 100 ml.
Substrate stock solution (1 mM Z-Phe-Arg-AMCY Z-Phe-Arg-AMC (1.3 mg) was
dissolved in DMSO (2 ml). Aliquots (100 ul) were kept at -20°C. The substrate was
diluted with assay buffer to a working concentration of 0.1 mM before use.
5.3.2.2 Procedure
Cysteine protease activity was measured with substrate Z-Phe-Arg-AMC as described
(Mbawa et al., 1992). Briefly, the incubation mixture consisted of assay buffer (50 ul), Z-
Phe-Arg-AMC (25 ul) and enzyme protein solution (10 ul) in a total volume of 100 ul.
The reaction proceeded for 15 min at 37°C. The release of fluorophore was monitored as




Assay buffer (500 mM Tris-acetate. 100 mM MaSO*. pH 7.41 Tris (6.055 g) and
MgSO.7H2O (2.464 g) were dissolved in 80 ml of dist.H2O, adjusted to pH 7.4 with acetic
acid and made up to 100 ml with dist.H2O.
ATP solution (200 mM Na^ATPV Na2ATP.3H2O (0.121 g) was dissolved in 1 ml of assay
buffer.
Phosphoenolpyruvate solution (50 mM Na^PEP). Trisodium phosphoenolpyruvate (58.5
mg) was dissolved in 5 ml of assay buffer.
Oligomycin solution (lmg/ml oligomycin). Oligomycin (5 mg) was dissolved in 5 ml of
assay buffer.
50% (v/v) TCA. TCA (10 g) was dissolved in 20 ml of dist.H2O.
Ascorbic-molvbdate solution \2% (m/v) CgHgOg. 0.42% m/v (NHAMoTO^HgO., 0.5 M
H2SO4]. Ammonium molybdate (0.42 g) and cone. H2SO4 (2.86 ml) were dissolved in 80
ml dist. H2O, transferred to a 100 ml volumetric flask and the volume adjusted to 100 ml
with dist. H2O. This solution was stable at room temperature. The required ascorbic-
molybdate solution was made 2% ascorbic acid (reducing agent) just before use (Ames,
1966).
5.3.3.2 Procedures
Total ATPase (EC 3.6.1.3) activity was measured by ATP hydrolysis employing an ATP-
generating (phosphoenolpyruvate-pyruvate kinase) assay system (Pullman and Penefsky,
1963). Briefly, the assay mixture consisted of assay buffer (100 |j.l), ATP (5 ul), MgSO4
(10 ul), phosphoenolpyruvate (100 ul), pyruvate kinase (40 ul) and 20 ul enzyme protein
solution, with or without oligomycin (10 ul). Incubations were carried out at 37°C with
gentle shaking (50 oscillations/min) for 30 min. The reaction was stopped by addition of
50% (v/v) TCA (100 ul). Blanks were prepared in separate microfuge tubes by stopping
the reaction at time zero with 50% (v/v) TCA (100 ul). After centrifugation (15 000 x g;
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25°C, 5 min) of the precipitated proteins, an aliquot of the supernatant solution (200 ul)
was removed for determination of inorganic phosphate liberated.
The inorganic phosphate was determined by the method of Ames (1966). The clear
supernatant (200 ul) was mixed with ascorbic-molybdate solution (800 ul) and incubated
for 20 min at 45°C. The inorganic phosphate was measured by monitoring absorbance at
820 nm using a Pharmacia LKB Ultrospec HI Spectrophotometer. A molar extinction
coefficient of 6.05 umole'Vml.cm"1 was used to determine the number of u,moles of the
inorganic phosphates released. The 'mitochondriaF ATPase activity was estimated as the
difference between total ATPase activity and the activity resistant to 10 ug oligomycin per
ml (Opperdoes etal. 1977b).
5.3.4 Glycerol-3-phosphate dehydrogenase
5.3.4.1 Reagents
Assay buffer (158 mM triethanolamine. pH 7.8). Triethanolamine (1.48 g) was dissolved
in 30 ml of dist. H2O, adjusted to pH 7.8 with HC1 and made up to 50 ml with dist.H2O.
10% Triton X-100. See Section 2.8.1.1
50% (v/v) TCA. See Section 5.3.3.1
Dihydroxyacetone phosphate solution (10 mM DHAP). Dihydroxyacetone phosphate
(85 mg) was dissolved in 5 ml of assay buffer.
NADH solution (10 mM NADH). NADH (5 mg) was dissolved in 630 ul of dist.H2O.
5.3.4.2 Procedure
Glycerol-3-phosphate dehydrogenase (EC 1.1.1.8) activity was assayed
spectrophotometrically by following the oxidation of NADH as described (Rovis and
Baekkeskov, 1980). The reaction mixture (0.9 ml) consisted of assay buffer (450 u,l),
NADH (18 ul), dihydroxyacetone phosphate (198 ul), 10 (v/v) Triton X-100 (9 ul) and
enzyme protein solution (20 uj). The reaction mixture was incubated for 15 min at 25°C.
The reaction was stopped by addition of 50% TCA (100 (il). The mixture was centrifuged
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(15 000 x g, 25°C, 2 min) in a microfuge to remove any precipitate. The amount of NADH
oxidized was estimated at 340 nm using a Pharmacia LKB Ultrospec III
Spectrophotometer. A molar extinction coefficient of 1.109 mmor'.ml.cm'1 was used to
determine the number of umoles of NADH oxidized.
5.3.5 Malate dehydrogenase
5.3.5.1 Reagents
Assay buffer T200 mM Tris. 2 mM Na?EDTA. pH 7.5). Tris (2.42 g) and Na2EDTA (74.4
mg) were dissolved in 80 ml dist.H2O, adjusted to pH 7.5 with HC1 and made up to 100 ml
with dist.H2O.
L-malate solution (5 mM DL-Nai-malate). Malic acid (4.5 mg) was dissolved in 5 ml of
dist.H2O.
Oxidized NAD solution (1 mM NAD"1"). NAD+ (1 mg) was dissolved in 1.5 ml of
dist.H2O.
5.3.5.2 Procedure
Malate dehydrogenase (EC. 1.1.1.37) activity was measured spectrophotometrically by
following the reduction of NAD+ as described (Opperdoes et al, 1977b). The reaction
mixture (0.9 ml) consisted of NAD+(90 u.1), L-malate (90 u.1), Assay buffer (450 u.1) and 10
u.1 of enzyme protein solution. The reaction mixture was incubated for 15 min at 25°C and
the reaction was stopped by addition of 50% (m/v) TCA. (100 u.1). The mixture was
centrifuged (15 000 x g, 25°C, 2 min). The amount of NADH formed was estimated at 340
nm using a Pharmacia LKB Ultospec III Spectrophotometer. A molar extinction
coefficient of 1.109 mmole'Vml.cm"1 was used to determine the number of umoles NAD+
reduced.
5.3.6 MCP-Tb
Multicatalytic protease complex (EC 3.4.99.46) activity was measured using Z-Gly-Gly-
Leu-AMC as/a substrate under conditions described in Section 3.4.1.
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5*4 Immunocytochemistry
5.4.1 Lowicryl K4M-embedding of trypanosomes
During this investigation, use was made of initial embedding in gelatin of the fixed,
isolated trypanosomes. Initial embedding in gelatin capsules, as opposed to exclusive use
of flat embedding in Lowicryl, circumvents a special problem, notably the inhibition of
polymerization by atmospheric oxygen due to the large resin surface in contact with air.
To further overcome this problem, a relatively airtight chamber was used with N2 entry and
exit ports, so as to create an anaerobic environment within the chamber itself. The N2 gas
is denser than air and when released into the chamber, settles at the bottom expelling air
from the chamber.
5.4.1.1 Reagents
Phosphate buffered saline CPBS) (U01M NaH2PCU 0.15 M NaCl. 2.5 mM KC1. pH 7.3Y
NaH2PO4 (1.38 g), NaCl (8.76 g) and KC1 (0.186 g) were dissolved in about 800 ml of
dist.H2O, adjusted to pH 7.3 with NaOH and made up to 1 litre.
Hepes stock C400 mM N-2-hydroxvethyl-piperazine N'-2-ethane sulfonic acid, 500 mM
sucrose. pH 7.31 Hepes (10.92 g) and sucrose (17.12 g) were dissolved in 90 ml of
dist.H2O, adjusted to pH 7.3 with NaOH and made up to 100 ml. The solution was
aliquoted and stored frozen.
10% (v/v) gelatin-PBS. Gelatin (1 g) was dissolved by gentle heating in 10 ml of PBS, pH
7.3
Fixative stock f4% (v/v) paraformaldehyde. 0.1 (v/v) glutaraldehyde in 400 mM Hepes. pH
7J3]. Paraformaldehyde (2.5 ml of 16% stock) and glutaraldehyde (40 JJ.1 of 25% stock)
were added to about 8 ml of 400 mM Hepes, the pH adjusted to 7.3 if necessary and the
solution made up to 10 ml with 400 mM Hepes.
30% (v/v) Ethanol. Ethanol (3 ml, AR) was made up to 10 ml with dist.H2O.
50% (v/v) Ethanol. Ethanol (5 ml, AR) was made up to 10 ml with dist.H2O.
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75% (y/y) Ethanol. Ethanol (7.5 ml, AR) was made up to 10 ml with dist.H2O.
95% (v/v) Ethanol. Ethanol (9.5 ml, AR) was made up to 10 ml with dist.H2O.
Lowicryl K4M resin. Lowicryl K4M resin (Electron Microscopy Sciences, Fort
Washington, PA) was formulated essentially as described by the manufacturers. Cross-
linker A (2.7 g) and monomer B (17.3 g) were pipetted into an amber coloured glass
container on a balance in a fume-hood. Initiator C (0.1 g of solid) was weighed out
separately, added to the mixture and dissolved by bubbling N2 through the resin, which
also serves to expel O2. Care was taken to avoid skin contact or inhaling resin fumes as the
resin is thought to cause dermatitis. Each batch of resin could be stored for at least 3
months in the dark at room temperature.
5.4.1.2 Procedure
Bloodstream forms of T. brucei, isolated from rat blood (Section 2.3.2) and maintained on
ice, were fixed in 2% paraformaldehyde and 0.05% glutaraldehyde in 200 mM Hepes
buffer (pH 7.3) containing 250 mM sucrose (by addition of equal volume of cells in
suspension to stock fixative solution). After fixation for 60 min at room temperature, the
fixed cells were pelleted by centrifugation in a microfuge (15 000 x g, 25°C, 3 sec) and
fixative drawn off to avoid cross-linking of the gelatin before reaching the cells. The cells
were washed (3 x 20 min) with 200 mM Hepes containing 50 mM glycine to quench the
free aldehyde groups. The pellet and 10% gelatin-PBS were separately heated to 37°C.
All excess liquid in the tubes was removed and 50 ul of warm gelatin added. The pellet
was centrifuged again after incubation for 60 min at 37°C. The microfuge tubes were
placed on ice to allow gelatin to set and cut into small sizes (approx. 1 mm3). Cells were
subjected to progressive lowering of temperature (PLT) dehydration: 30% ethanol (0°C,
ice bath at -4°C, 30 min), 50% ethanol (-20°C, 3 parts crushed ice + 1 part NaCl placed at -
10°C, 30 min), 75% ethanol (-35°C, 1.2 parts ice + 2 parts CaC1.6H2O, 30 min), 95%
ethanol (-35°C, 30 min), 100% ethanol (-35°C, 30 min, repeated once). Petri dishes were
agitated at least twice during each 30 min incubation step. Cells were infiltrated with a 1:1
mixture of resin and 100% ethanol (-35°C, 30 min, 3 ml). This was followed by a 2:1
mixture of resin and 100% ethanol (-35°C, 1 h, 3 ml), pure resin (-35°C, 1 h, 3 ml) and
again pure resin (-35°C, overnight, 3 ml). The following day the Petri dishes were placed
in heat sinks, resin replaced and the unit flooded with N2. Resin was allowed to
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polymerize in a N2 atmosphere at -35°C in indirect ultraviolet light (360 nm, 24 h)
followed by direct ultraviolet radiation (48 h). Petri dishes were placed on a sunny
windowsill for at least 4 days until the resin had properly hardened.
5.4.2 Sectioning of Lowicryl K4M blocks
Lowicryl K4M is a hydrophilic resin, therefore care was taken not to wet the block surface
during sectioning. This was accomplished by sectioning with the level of fluid in the
knife-trough slightly below the surface, while still maintaining a wet knife-edge. Nickel
grids were used (although gold grids could also be used) for labeling, as copper tends to
oxidize in the labeling solutions. The stability of sections on the grid during labeling and
in the electron microscope was improved by coating grids with formvar.
5.4.2.1 Reagents
0.25% (m/v) Formvar in chloroform. Formvar (0.25 g) was dissolved in chloroform (100
ml).
5.4.2.2 Procedure
A glass dish of about 20 cm diameter was completely filled with dist.FkO. A clean
microscope slide was dipped into the formvar solution, the excess allowed to drain and the
remaining film dried. The dried film was loosened around the edges of the slide with a
razor blade, and floated onto the surface of the water. Nickel grids were placed, shiny side
up, on the floating film. Using a piece of wire mesh as a support, the film was recovered
by a scooping motion through the water, leaving the film covering the mesh. Individual
formvar-coated grids could then be torn away from the formvar film when required.
Small blocks were cut with a hacksaw from a petri dish containing Lowicryl K4M
embedded T. brucei cells. The block was mounted onto a plastic stub and the block
trimmed on a microtome to a pyramidal face. The ultrathin sections (approx. 90 nm thick)
were cut with a glass knife and collected onto formvar coated nickel grids. Grids were
dried and could be stored indefinitely before labeling.
5.4.3 Immunolabeling of Lowicryl-embedded sections
Immunolabeling experiments described here made use of the protein A-gold labeling
system. Protein A has high affinity for IgGs. Protein A binds to the F c portion of the
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molecule (Forsgren and Sjoquist, 1966), specifically to the CH2 and CH3 domain
(Deisenhofer, 1981) and acts in a pseudo-immune (a non-antigenic type) fashion that does
not interfere with the binding of immunoglobulin to its antigen. Protein A interacts
strongly with most IgG classes of several mammalian species such as human, rabbit,
guinea pig, and dog, and less strongly with IgG classes from goat, sheep and rat (Forsgren
and Sjoquist, 1966) and not at all to chicken (Langone, 1982). Where primary antibodies
from weaker reacting species are used, a 'linker' secondary antibody from a strong reacting
species may be used followed by the protein A-gold probe. Indeed, immunogold probes,
where the secondary antibody is adsorbed onto the gold surface instead of protein A,
would also be a viable alternative. This offers a further advantage of signal amplification,
because more than one immunogold probe may bind to a single tissue-bound primary
antibody (Merighi, 1992). Protein A binds immunoglobulins in a one-to-one ratio (Slot et
al., 1989), an important factor when quantitative immunocytochemical labeling studies are
being undertaken (Griffiths and Hoppeler, 1986).
Labeling of ultrathin sections with protein A-gold, in general follows standard protocols
(Merighi, 1992) with the manipulation of variables such as choice of blocking agent,
length of incubation times, and length and stringency of washing. The protocol used was
essentially as outlined by Roth (1986) except that BSA was used as a blocking agent and
grids were washed in drops rather than by spraying.
5.4.3.1 Reagents
2% (m/v) Gelatin-PBS. Gelatin (200 mg) was dissolved in 10 ml PBS (Section 5.4.11).
1% (m/v) BSA-PBS. BSA (globulin-free, 100 mg) was dissolved in 10 ml PBS.
1% (m/v) Glutaraldehvde in PBS. Glutaraldehyde (40 \xl of 25% stock) was diluted in 960
III PBS.
0.02M Glvcine in PBS. Glycine (0.015 g) was dissolved in 10 ml of PBS.
Antisera. Chicken anti-MCP IgY, chicken anti-VSG IgY, and rabbit anti-chicken IgY
(linker antibody) were diluted in 1% BSA-PBS. The optimal dilution was determined
empirically for each of the antibodies. Chicken anti-VSG IgY and anti-MCP IgY were
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used at 10 ng/ml and 20 ng/ml respectively. Rabbit anti-chicken IgY linker antibody was
used at a 1/200 dilution.
Gold labels. Protein A-gold probes (used at 1/425 and 1/200 dilutions for 5 nm and 10 nm
gold probes respectively) were optimized and provided by Dr. Edith Elliot, Department of
Biochemistry, University of Natal.
5.4.3.2 Procedure
Immunolabeling was performed by incubation of the grids containing the ultrathin sections
prepared as described in Section 5.4.2. Grids were floated, section-side down, on droplets
of reagents placed on Parafilm spread onto a bench. During the reaction, droplets were
covered with a large glass petri dish to protect them from dust and spillage. The grids were
transferred from one reagent droplet to another with a nickel wire loop (0.2 mm diameter,
forming a 1 mm loop). The same loop was used for each reagent as the loop carries a
small volume of liquid over, which introduces a dilution factor.
Immunogold labeling was performed at 25°C using the following incubation steps:
1) Blocking in 1% (w/v) BSA in PBS (20 ul, 5 min), followed by a 2% (w/v) gelatin
droplet (20 u.1, 5 min).
2) Labeling in appropriate dilution of primary antibody (10 u.1, 2 h).
3) Washing in PBS (20 ul, 5x2 min).
4) Labeling in appropriate dilution of secondary (linker) antibody (10 ul 1 h)
5) Washing in PBS (20 jil, 5x2 min).
6) Labeling in protein A-gold (5 nm or 10 nm), diluted in BSA-PBS (10 u.1, 1 h).
7) Washing in PBS (100 ul 5x2 min).
8) Fixing in Glutaraldehyde in PBS (10 u.1, 5 min).
9) Washing in PBS (100 ul, 2x2 min) followed by dist.H2O (100 ul 4x2 min).
10) The grids were gently blotted and allowed to dry.
As a control, all steps were repeated with immune antibody substituted with a non-immune
preparation, at the lowest dilution of immune antibody used.
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5.4.4 Counterstaining of Lowicryl K4M sections
Lowicryl K4M embedded sections are counterstained in a manner similar to those for
traditional electron microscopy resins. Sections may be stained with either aqueous or
alcoholic solutions of uranyl acetate and lead citrate (Hobot, 1989). A combination of lead
acetate (Millonig, 1961) and uranyl acetate provide superior quality of contrast and fine
granular staining (Roth et al, 1990). Trypanosome staining with uranyl acetate and lead
citrate provided sufficient contrast. Since Lowicryl K4M is hydrophilic, the sections were
incubated on drops of stains for short periods of time. Prolonged staining was found to
cause contamination and distortion of the sections.
5.4.4.1 Reagents
2% (m/v) Uranyl acetate. Uranyl acetate (1 g) was dissolved in dist.H2O (50 ml), and the
addition of 95% ethanol (1 ml) to assist solubility. The uranyl acetate solution was stored
in the dark at 4°C.
1M NaOH. NaOH (0.4 g) was dissolved in dist.H2O (10 ml).
Lead citrate. Lead citrate (1.33 g) and trisodium citrate.2H2O (1.76 g) were added to
freshly boiled and cooled dist.FkO and shaken intermittently for 30 min. NaOH (8 ml)
was added to clear the milky solution. The solution was adjusted to 50 ml with freshly
boiled and cooled dist.HbO and stored in the dark at 4°C in an airtight container.
5.4.4.2 Procedure
Dried grids were inverted onto uranyl acetate (4 min, in the dark), washed with dist.HaO by
gentle pipetting (500 ul) and inverted onto lead citrate (30 sec) in a closed glass petri dish
containing NaOH pellets to remove CO2. The grids were again washed with gentle
pipetting (500 u.1), blotted, allowed to dry and viewed in JEOL 100CX Transmission
Electron Microscope at 80 kV.
5.5 Results
5.5.1 Subcell,ular Fractionation
As a first approach to the subcellular localisation of MCP-Tb in bloodstream form of T.
brucei, a homogenate was fractionated by differential centrifugation into a nuclear fraction,
a large-granule fraction, small-granule fraction, microsomal and soluble cytosolic
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fractions. Each of these subcellular fractions was enriched in a particular organelle. The
identity of these organelles was determined by assaying for the activity of marker enzymes
described in the literature (Opperdoes et al, 1977a; Grab et al, 1987; Mbawa et al,
1991b). The specific activity of MCP-Tb was also determined in each of the five fractions.
This allowed the determination of the distribution of MCP-Tb in the various subcellular
fractions (Table 5.1).
The highest relative specific activity of acid phosphatase was found in the MI fraction
(Table 5.2). This is in agreement with the reported acid phosphatase enrichment in the
microsomal fraction of T. brucei and T. congolense (Steiger et al, 1980; Grab et al, 1987;
Tosomba et al, 1996). This enzyme, however, has additional significant activities in the
LG, SG and CY fractions, probably reflecting its heterogeneous localisation in the flagellar
pocket, lysosomes and in the Golgi apparatus of trypanosomes (Langreth and Balber, 1975;
Grab et al, 1987; Tosomba et al, 1996).
Table 5.1 Distribution of MCP-Tb in different subcellular fractions from T. brucei
Fractions F|-F5 in the order of their isolation are; NU, nuclear, LG, large-granule; SG, small-granule; MI,
microsomal; and CY, cytosolic fractions. Distribution is expressed as percentages of the ratios of activity in
the fraction over the sum of activities of the five fractions obtained. Values presented are from a






























































Parasite plasma membrane including the flagellar pocket, sediments in the NU fraction,
whereas lysosomes are enriched in the SG fraction (Lonsdale-Eccles and Grab, 1987;
Mbawa et al, ,1991b). The high relative specific activity of acid phosphatase in the MI
fraction may^hus be attributed to enrichment of Golgi apparatus in the MI fraction. Acid
phosphatase was thus adopted as an unequivocal marker enzyme for the Golgi apparatus in
the MI fraction.
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The commonly used marker enzymes for mitochondrial activity are largely repressed in
bloodstream form of T. brucei (Vickerman, 1965; Opperdoes et al, 1977a). However,
mitochondrial ATPase is active both in bloodstream trypomastigotes and insect forms
(Opperdoes et al, 1977b). The mitochondrial ATPase is stimulated by uncouplers such as
carbonylcyanide /?-trifluoromethoxy-phenylhydrazone or 2,4-dinitrophenylhydrazone
(Lomo et al, 1996). This activity is also stimulated by Mg2+ ions (Opperdoes et al,
1977b). The mitochondrial ATPase is specifically inhibited by oligomycin (Pullman and
Penefsky, 1963). Thus, the oligomycin-sensitive portion of the Mg2+-stimulated ATPase
activity is referred to as the mitochondrial ATPase in the enzyme distribution studies. The
mitochondrial ATPase activity was optimal in the LG fraction, comparable with
enrichment of mitochondria in the LG fractions (Opperdoes et al., 1977a).
Table 5.2. Distribution of marker enzymes from T. brucei in fractions obtained by differential
centrifugation
The experiments were performed as described in Section 5.2.2. Fractions F|-F5 are as outlined in the Legend
to Table 5.1. Distribution of AcP, acid phosphatase; ATPase, mitochondrial ATPase; CysP, cysteine
protease; GPDH, glycerol-3-phosphate dehydrogenase, MCP-Tb, multicatalytic protease from T. brucei; and
MDH, malate dehydrogenase are expressed as the percentage of specific activity in the fraction over the sum
of the specific activities of the five fractions. Total protein in each fraction was determined as described in


















































The distribution profile of cysteine protease activity was as described previously
(Lonsdale-Eccles and Grab, 1987; Mbawa et al., 1991b), showing the highest relative
specific activities in the SG fraction. It has been shown by electron microscopy that
lysosomes are enriched mainly in SG and partly in the LG fractions of trypanosomes (Grab
et al, 1987). The localisation of cysteine proteases in the lysosomes (Lonsdale-Eccles and
120
Grab, 1987; Mbawa et al, 1991b), therefore, shows that cysteine protease activity is an
appropriate marker for lysosomes in trypanosomes.
Glycerol-3 -phosphate dehydrogenase (GPDH), an enzyme marker for glycosomes
(Opperdoes et al, 1977a; Rovis and Baekkeskov, 1980), presented its maximal specific
activity in the SG and MI fractions. This distribution profile is consistent with electron
microscopy confirmation that glycosomes are found in the SG and MI fractions (Grab et
al, 1987). Low GPDH activity in the soluble supernatant fraction confirms that GPDH is
an appropriate marker for intact glycosomes
The distribution profile of MCP-Tb activity shows that a major proportion of specific
activity is in the soluble CY fraction and partly in the NU and MI fractions. The LG and
SG fractions appear to be devoid of MCP-Tb activity. The low activities of MCP-Tb
detected in LG and SG fractions are likely to be from contaminating MCP-Tb.
Malate dehydrogenase (MDH) is typically considered to be a mitochondrial marker
enzyme in mammalian cells. In trypanosomes, however, MDH has been shown to be a
mitochondrial as well as a microbody enzyme (Opperdoes et al, 1977b). In the present
experiment, MDH showed maximal relative specific activities in the particulate NU and
soluble CY fractions. The pattern of activity observed in MDH does not conform to the
established particulate localisation of the enzyme in T. brucei (Opperdoes et al, 1977b).
Thus the enzyme could not be used as an organelle marker for mitochondria or glycosomes
in these studies.
5.5.2 Immunocytochemistry
A polyclonal antibody was raised in chickens against the purified MCP-Tb and its titre
determined by ELISA (Section 4.10). To test for specificity, the antibody was used to
probe a western blot of crude trypanosome lysate and purified MCP-Tb (Section 4.13).
The antibody was used to label sections of bloodstream form T. brucei embedded in
Lowicryl K4M resin. Since protein A does not interact with primary antibodies raised in
chickens (Forsgren and Sjoquist, 1966; Langone, 1982), a secondary 'linker' secondary
antibody, rabbit anti-chicken IgY, was used. Antigen-antibody complexes were visualised
using 5 nm protein A gold probes. The antibody strongly labeled the nucleus (Fig 5.1a)
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and comparatively low labeling was present in the cytoplasm (Fig. 5.1b). Figure 5.1c
shows labeling adjacent to a microbody.
Localisation of VSG in the T. brucei section was performed in a three-step
immunocytochemical procedure, which had been found to be more sensitive than a two-
step procedure. Optimal labeling in the electron microscopic experiments was found when
the purified chicken anti-VSG IgY antibodies were used at the dilutions used in the
western blot analysis (Section 4.11). After applying chicken anti-VSG IgY, followed by
rabbit anti-chicken IgY and protein A gold complex (particle size 10 nm) to the
trypanosome section, labeling by gold particles was seen on the flagellar pocket surface
and on the surface of the parasite (Fig. 5.2a). The labeling on the flagellar pocket was
consistent in most sections observed. Gold labeling was also observed in lysosome-like
organelles in the parasite as well as on the surface of the flagella within the flagellar pocket
(Fig. 5.2b).
There was good preservation of the ultrastructure of the parasite section embedded in
Lowicryl K4M resin (Fig 5.3a). Control incubations with pre-immune IgY instead of the
purified primary antibodies (Fig. 5.3b), followed by secondary antibodies and protein A
gold, provided evidence of the specificity of labeling. As a control for methodology,
glucagon hormone was localised in sections of the pancreas using specific rabbit anti-
glucagon antibodies in parallel experiments to those performed with anti-MCP-Tb and
anti-VSG antibodies. Labeling was restricted to the 3-cells in the pancreas (Fig. 5.3c).
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Figure 5.1. Immunocytochemical localisation of MCP-Tb in bloodstream forms of T. brucei.
The Lowicryl K4M embedded sections were fixed in 2% paraformaldehyde and 0.05% glutaraldehyde, 200
mM Hepes, pH 7.3 and labeled with primary (chicken anti-MCP-Tb IgY) antibody, secondary (rabbit anti-
chicken IgY) antibody and protein A-colloidal gold (5 nm particle size), (a)- Arrows shows gold labeling in
the nucleus, N. (b)-Labeling of cytoplasm, C. (c)-Labeling of cytoplasm (arrow) around a microbody.
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Figure 5.2. Immunocytochemical localisation of VSG in Lowicryl K4M embedded T. brucei.
The sections were fixed in 2% paraformaldehyde and 0.05% glutaraldehyde, 200 mM Hepes, pH 7.3 and
labeled with primary (chicken anti-VSG) antibody, followed by secondary (rabbit anti-chicken IgY) antibody
and protein A gold (10 nm particle size), (a)- Arrows show labeling in the flagellar pocket, FP, and some




Figure 5.3. Transmission electron micrograph of Tbrucei and P-cells of pancreas
(a)- Glutaraldehyde-fixed trypanosomes showing general ultrastructure, Transverse section of the flagella, F,
Pellicular microtubules, M, Nucleus, N. (b)- 71 brucei section incubated with chicken preimmune IgY,
rabbit anti-chicken IgY and protein A-gold. (c)-immunocytochemical localisation of glucagon in p-cells of
pancreas with anti-glucagon antibodies and protein A-gold conjugates used in the experiments to localise




Knowledge of intracellular distribution of MCP is important in elucidating the precise role
of the proteinase in the trypanosome. Immunolocalisation of MCP has previously been
communicated in a variety of cell types including rat liver, brain and muscle (Palmer et ah,
1996, Kamakura et ah, 1988), human liver (Tanaka et ah, 1989), Drosophila (Haass et ah,
1989), sea urchin (Akhayat et al., 1987), and newt (Peters et ah, 1994). In each of these
cases MCP was observed in both the nucleus and cytoplasm. However, there are no
reports with regard to intracellular localisation of MCP in trypanosomes.
When MCP-Tb was assayed in the subcellular fractions obtained after differential
centrifugation of the T. brucei homogenate and the results expressed as relative specific
activity, the enzyme represented a soluble cytosolic and organelle-associated distribution
of activities. About 22% of the MCP-Tb activity fractionated together with the nuclear
fraction containing a large number of cells that resemble those identified by Opperdoes et
ah (1977a) as ghost cells. Although association of MCP-Tb with the plasma membrane
fraction is unlikely, previous reports demonstrated the presence of MCP in the nuclei of
eukaryotic cells (Rivett et ah, 1992; Palmer et ah, 1996). The MCP-Tb activity in the NU
fraction presents a pattern similar to malate dehydrogenase activity. The distribution
profile of malate dehydrogenase in the present study did not reveal the expected
preferential association with mitochondria or glycosomes (Opperdoes et ah, 1977a). The
mitochondria fractionated mainly in the LG fraction, whereas the glycosomes were
reported to be in the SG and partly in the MI fractions (Grab et ah, 1987). The distribution
of malate dehydrogenase was different from previous reports and could not be reliably
used as a marker for an organelle. Although prior evidence for nuclear localisation of
MCP is compelling, no conclusion can be drawn from the available results to exclude
MCP-Tb association with the nuclear membranes.
From the present results and those in previous reports (Opperdoes et ah, 1977a; 1977b),
oligomycin-sensitive ATPase is shown to be undoubtedly mitochondrial. The activity of
*
mitochondrial ATPase shows peak activities in the LG with a little trailing in the NU
fraction, consistent with the electron microscope confirmation of sedimentation of
mitochondria in the LG fraction (Opperdoes et ah, 1977a). Considering that 75% of MCP-
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Tb activity is in the CY fraction and 22% in the NU fraction, and that maximal specific
activity (32%) of mitochondrial ATPase coincides with fractions in which only trace
amounts of MCP-Tb are present, the two enzymes are most likely located in different
organelles.
Interestingly, cysteine protease and glycerol-3-phosphate dehydrogenase activities
presented a similar distribution profile with peak activities in the SG fraction. Cysteine
protease is a reliable marker of lysosomes in T. brucei (Lonsdale-Eccles and Grab, 1987;
Mbawa et al, 1991b), whereas glycerol-3-phosphate dehydrogenase is located within the
glycosomes in T. brucei (Opperdoes et al, 1977a; Rovis and Baekkeskov, 1980). Thus
lysosomes and glycosomes were probably enriched in the SG fraction of this author's
preparation. Since neither cyteine protease nor glycerol-3-phosphate dehydrogenase
activity coincides with the Fl or F5 fractions where MCP-Tb is enriched, it is tempting to
conclude that neither lysosomes nor glycosomes contain MCP-Tb.
Several marker enzymes have been shown to be latent in organelles and their activities
increased several fold by use of detergents such as 0.1% Triton X-100 (Duschak and
Cazzulo, 1991; Nowicki et al, 1992; Weitman and Etlinger, 1992). In the present case,
MCP-Tb was sufficiently active against the Z-Gly-Gly-Leu-AMC substrate, thus obviating
the use of detergent to enhance the proteolytic signals. Part of the reason for high activity
of MCP-Tb could be that it exists freely in the cytoplasm rather than within organelles.
This enables ease of access of the substrate to the catalytic site of MCP-Tb.
Acid phosphatase had optimal activity in the MI fraction of the present preparation. Acid
phosphatase has previous been reported to be localised in the flagellar pocket, lysosomes
and Golgi apparatus in trypanosomes (Langreth and Balber, 1975; Grab et al., 1987;
Tosomba et al., 1996). Incidentally, the MCP-Tb activity is very low in the MI fraction
suggesting that MCP-Tb may not be associated with the flagellar pocket membrane,
lysosomes or the Golgi apparatus. The non-lysosomal localisation of MCP-Tb is further
supported by enrichment of lysosomal protease (CysP) activity in the SG and LG fractions
where there is no significant MCP-Tb activity. The fractionation results indicate that
MCP-Tb has a considerable cytosolic activity (75%) and this compares well with the
previous reports in sea urchin (Akhayat et al, 1987), human liver (Tanaka et al, 1989) and
Drosophila (Haass et al, 1989) proteasomes.
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Immunocytochemical localisation
Embedding of T. brucei cells in Lowicryl K4M resin using the PLT method (Kellenberger,
1985) not only showed good ultrastructural preservation of the cell organelles, but also
preserved the epitopes in the T. brucei section for successful immunolabeling procedures.
Furthermore, the extraction of proteins and membrane lipids from biological materials
embedded at low temperature is reduced (Weibull and Christiansson, 1986), and the
Lowicryls enabled the use of a low concentration of glutaraldehyde concentration for a
short period (Hobot, 1989).
The present investigation of the localisation of the MCP-Tb complex in T. brucei using
polyclonal antibodies raised against purified trypanosomal MCP shows the presence of
MCP in the nuclei and the cytoplasm (Fig 5.1a). These results are consistent with previous
reports showing the presence of MCP in the nuclei of mammalian cells (Knetch et al,
1991; Rivett et al., 1992; Palmer et al, 1996), but differ from earlier reports in which no
staining of nuclei were observed (Akhayat et al, 1987; Haass et al, 1989, Kamakura et al,
1988; Tanaka et al, 1989). The presence of MCP-Tb in the nuclei and cytoplasm is in
agreement with our cell fractionation results showing that MCP-Tb has a high soluble
cytosolic activity (Table 5.1) and that the nuclear fraction also has significantly high MCP-
Tb activity (Table 5.2). There are discrepancies in the literature with regard to the
proportion of MCP in the nucleus and cytoplasm. In some cases the complex has been
located largely in the cytoplasm whereas in other cases it appears to be predominantly in
nuclei. For example, MCP is predominantly nuclear in growing rat fibroblasts (Arrigo et
al, 1988), in human leucocytic and liver cells (Kumatori et al, 1990; Rivett et al, 1992),
and in muscle cells (Stauber et al, 1987), but is apparently absent from the nucleus of
some human liver cells (Tanaka et al, 1989). It appears that proportions of the nuclear
MCP is developmentally regulated such that changes in localisation of MCP is observed
during development of lower eukaryotes including Drosophila (Haass et al, 1989), sea
urchin (Akhayat et al, 1987) and newt (Pal et al, 1988). From the observed strong
labeling of the nuclei as compared to the cytoplasm in T. brucei, it appears that the
proportion of MCP-Tb is higher in the nuclei than the cytoplasm of the bloodstream form
of the parasite. However, this difference in labeling may simply be a reflection of different
levels of epitope exposure.
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The presence of MCP-Tb in the nuclei of T. brucei and the reports of intracellular
occurrence of polyubiquitin and the ubiquitin-activating enzyme in T. brucei (Wong et al.
1992, Lowrie et al, 1993), suggests that MCP-Tb may also have a nucleus-specific
function in the parasite. Proteolysis may be involved in the regulation of proteins of the
nuclear scaffold, which change with the differentiation stage of the cell. The nuclear
proteins are believed to play a fundamental role in growth-related functions in the cell
nucleus, including regulation of gene expression (Levinger and Varshavsky, 1982).
Although localisation of MCP-Tb in the nucleus suggests its function in the degradation of
nuclear proteins, it is not certain whether proteins involved in growth-regulation or gene
expression are endogenous substrates for the enzyme.
As might be expected from current knowledge, exogenous proteins taken up by
endocytosis in trypanosomes are translocated through endocytic vesicles, which eventually
fuse with lysosome-like organelles (Mbawa et al., 1991b). Consequently, the proteins are
degraded by the lysosomal proteases such as the trypanopains (Lonsdale-Eccles and Grab,
1987; Mbawa et al., 1992). However, considering the nuclear or cytoplasmic localisation
of MCP (Rivett et al., 1992; Peters et al., 1994; Palmer et al, 1996), a carrier molecule is
envisaged for transmembrane translocation of exogenous proteins from the endocytic
vesicles to the cytosol. At the moment no such transporter molecule has been reported
putting into question the mechanism by which the exogenous proteins are delivered into
the cytosol for degradation by the MCP-Tb. It has been suggested that trypanosomes
possess a mechanism for excluding exogenous proteins from part of the endocytosis
pathway and that molecular sorting occurs in some of the cisternal organelles associated
with the endosomal system of the parasite (Webster and Grab, 1988; Webster and Fish,
1989). The components of the antigen-processing and presentation machinery in
mammalian cells may be of relevance in an attempt to elucidate the translocation
mechanism of exogenous proteins into the cytosol of the trypanosomes. In mammalian
cells, MCP participates in the degradation of cytosolic antigens into short peptides for
presentation by MHC class I molecules of antigen presenting cells (Dick et al, 1994; Rock
et al, 1994). A transporter molecule (TAP1/TAP2 heterodimer) associated with antigen
processing is responsible for the ATP-dependent transmembrane translations of selected
peptides from the cytosol to the site of MHC class 1 assembly (Kleijmeer et al, 1992). A
similar transporter molecule may facilitate translocation of materials across organelle
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membranes into the cytosol for degradation by MCP-Tb in the parasite (Wilbourn et al,
1998).
VSG is known to cover the surface of the parasite, including the flagellum and the flagellar
pocket (Vickerman, 1969; Cross, 1990). Thus, immunolocalisation of VSG at these sites
served as a control for the methodology. It is notable that localisation of VSG and MCP-
Tb in the same intracellular compartment may not necessarily have a functional meaning.
For instance, VSG is synthesised on the ribosomes and the polypeptide enters the lumen of
the rough endoplasmic reticulum and is transported to the smooth endoplasmic reticulum
and Golgi apparatus where post-translational modification takes place (Grab et al, 1984;
Ferguson et al, 1988; Cross, 1990). MCP has been shown to be responsible for processing
of several ER-proteins (Coux et al., 1996), however, not all ER-proteins may be substrates
for the MCP. In the present case, MCP-Tb was shown to be cytosolic but its association
with ER is not evident. Nevertheless, previous reports indicate that MCP is localised on
the cytoplasmic side of the ER, in addition to the cytoplasm and nucleus (Rivett et al.,
1992; Peters et al, 1994). Since lumenal ER-proteins are thought to translocate across ER
membrane to the cytoplasmic side for proteasomal processing (Wilbourn et al, 1998), this
ER-associated MCP may participate in the degradation of ER-proteins.
Interestingly, recent evidence shows a direct implication of MCP in quality control of
glycophosphatidylinositol (GPI) anchor addition to proteins (Wilbourn et al, 1998). VSG
vary biochemically and thus antigenically, however, one part of the VSG molecule stays
relatively constant (Zamze et al, 1988). This part, called a 'cross-reacting determinant'
(CRD) is a complex glycolipid side-chain structure of the VSG molecule, identified as
GPI, believed to anchor VSG on to the plasma membrane of African trypanosomes
(Englund, 1993). Inhibition of MCP activity by lactacystin blocks the intracellular
processing ofprecursor GPI suggesting involvement of MCP in GPI quality control (Oda et
al, 1996). Improperly processed GPI-anchored proteins are degraded by ER-associated
MCP and involve re-export of lumenal proteins into the cytoplasm for ultimate degradation
by the MCP (Wilbourn et al, 1998). Thus, it is our hypothesis that inhibition of MCP-Tb
activity in trypanosomes may interfere with the synthesis and addition of the GPI-anchor
of the trypanosomal VSG. Chymostatin, an inhibitor of chymotrypsin-like activity in
MCP-Tb, was reported to inhibit clearance of bound anti-VSG antibodies on the surface of
T. brucei (Russo et al, 1993). However, this phenomenon may be ascribed more to the
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endocytotic role of MCP (Staub et ai, 1997; Strous and Govers, 1999) rather than the
interference with post-translational processing of the GPI-anchored protein (Oda et ai,
1996; Wilbourn et ai, 1998) in the parasite.
Lastly, nuclear localisation of MCP-Tb (Fig. 5.1b) suggests a possible role of MCP-Tb in
the control of gene expression. There are several genes coding for VSGs that are
expressed sequentially in a mutually exclusive manner (Borst and Cross, 1982). The
synthesis of VSG is under strict transcriptional control in the parasite (Steinert and Pays,
1985). MCP may exert its transcriptional control over VSG synthesis by degradation of
nuclear proteins involved in gene expression (Levinger and Vershavsky, 1982). Thus, it
appears reasonable to conclude that inhibition of MCP-Tb may interfere with the synthesis
of VSG. The problem as it were is the success of inhibition of the parasite MCP-Tb
without significantly affecting the host cell MCP and the relevant physiological processes
of the host.
In conclusion, the antibodies produced as described in the previous chapters to specifically
target MCP-Tb and VSG in T. brucei sections, proved useful in showing the intracellular
distribution of MCP-Tb in the parasite. The surface associated labeling of VSG was
expected and served to validate the methodology used to localise MCP-Tb in the present
study. The cytosolic and the nuclear localisation of MCP-Tb in the present study is
consistent with literature reports of the localisation of a similar enzyme in other cell-types,
providing circumstantial evidence for its role in cytosolic and nuclear proteolysis. The
next chapter presents a study on how these proteolytic activities of MCP-Tb could be
enhanced by interaction with the host regulatory molecule, PA700.
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Chapter 6
Studies on the effects of bovine PA700 on MCP-Tb
6.1 Introduction
The proteasome is a cylindrically shaped, intracellular complex of proteins. Its proteolytic
activity is modulated by a number of specific regulatory proteins. One such regulator is called
PA700 or 19S regulator. This is a protein complex that has no proteolytic activity by itself.
However, it activates multiple proteolytic activities of the 20S proteasome. The active sites
(threonine residues) of proteasomes are located within the interior of the proteasomes and
access to these sites seems to be regulated by large (19S and US) protein complexes (e.g.
Coux et al, 1996; Tanaka, 1998) that appear to cap the ends of the cylinders. Association of
the proteasome with either of these caps greatly enhances the hydrolysis of fluorogenic
peptides (Chu-Ping at al, 1992; 1994). Complexes of the 20S proteasome with the US
particle (also called PA28) can degrade peptides only. Thus, the 20S/11S complex particles
have no effect on protein degradation and do not use adenosine 5'-triphosphatase (ATP) for
activation (Chu-Ping et al, 1994). In contrast, the complexes of the 20S proteasome with the
19S particle (also called PA700; the term used in this study) called the 26S proteasome can
degrade both peptides and proteins, particularly ubiquitinated proteins, in an ATP dependent
manner (DeMartino et al, 1994; Tanaka, 1998). Interestingly, a recent report indicates that
the 20S proteasome can bind both PA700 and PA28 simultaneously to form an even larger
ternary complex (Hendil et al, 1998), but the significance of this is not clear.
PA700 is a 700 kDa protein complex composed of approximately 16 different subunits (Chu-
Ping at al, 1994). The masses of the usbunitsrange between 25 and 110 kDa. Six of these
subunits belong to the rapidly growing ATPase family of proteins called AAA (ATPase
Associated to a variety of cellular Activities) (Confalonieri and Duguet, 1995; Coux et al,
1996;Lupase/a/., 1997).
Although 26S proteasomes have been isolated from several eukaryotic organisms (Tanaka,
1998), it is not clear whether trypanosomes have a 26S proteasome. Indeed the failure to
isolate an intact 26S complex from these organisms led To and Wang (1997) to conclude that
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trypanosomes may not possess an ATP-ubiquitin-dependent pathway of protein degradation.
However, several observations tend to argue against this conlusion, including: the probable
involvement of ubiquitin-like processes in the degradation of high turnover T. cruzi proteins
(Henriquez et al, 1993); the presence of several polyubiquitin genes in T. brucei (Wong et al.,
1992); and the presence of various components of the ubiquitin-ligase system in different
trypanosomatids including T. brucei (Lowrie et al, 1993). Furthermore, in this Chapter,
evidence is provided showing that bovine PA700 enhances the activity of the T. b. brucei 20S
proteasome in an ATP dependent manner. Hence we may infer that the ATP-dependent
pathway of protein degradation is present in trypanosomes and that the failure thus far to
identify a 26S proteasome (or the PA700-like molecule) in trypanosomes may be due to an
unusual lability of this complex in trypanosomes.
6.2 Purification of bovine PA700
PA700 was purified from bovine red blood cells as described by Chu-Ping et al. (1994). The
PA700 co-purifies with the bovine 20S proteasome and PA28 activator in most stages of
purification. However, separation of PA700 from the 20S proteasome and PA28 may be
achieved by ammonium sulphate precipitation. The bovine PA700 protein complex usually
precipitates from a clear fraction (DEAE-fractionated) at 38% ammonium sulphate saturation
whereas the 20S proteasome remains in solution at this ammonium sulphate concentration.
Proteasomes require glycerol (20% v/v) to maintain enzyme stability (McGuire et al., 1988)
whereas PA700 does not (Chu-Ping et al, 1994), hence the need to use buffer G (Section 3.2)
for purification of the proteasome.
5.2.1 Reagents
Phosphate buffered saline (PBSl See Section 2.12.1
Standard buffer H. See Section 3.2
Equilibrating buffer (Standard buffer H containinglOO mM NaCl*). NaCl (5.844 g) was added
to 950 ml of standard buffer, adjusted to pH 7.6 with HC1 and made up to 1 litre with standard
buffer H.
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Elution buffer (Standard buffer H with additional 500 mM NaCO. NaCl (29.22 g) was
added to 950 ml of standard buffer, adjusted to pH 7.6 with HC1 and made up to 1 litre
with standard buffer H.
Sodium phosphate buffer (20 mM Na-phosphate buffer. pH 7.6). NaH2PO4.2H2O (3.13 g)
was dissolved in 950 ml of dist. H2O, titrated to pH 7.6 using NaOH, and made up to 1
litre.
Sodium phosphate elution buffer (200 mM Na-phosphate. pH 7.6). NaH2PO4.2H2O (31.2
g) was dissolved in 950 ml of dist. H2O, titrated to pH 7.6 using NaOH, and made up to 1
litre.
6.2.2 Procedure
A portion of the crude bovine red blood cell lysate, "Fraction I" (Section 3.3.2) was used
for the isolation of the proteasome activator PA700. DE-52 cellulose was equilibrated with
standard buffer H containing 100 mM NaCl. The DEAE cellulose resin was added to the
red blood cell lysate supernatant (approximately 5 ml of lysate per ml of DE-52) and
mixed for 30 min. The resin was filtered and washed extensively until the eluate was clear.
The resin was mixed with elution buffer (1 ml elution buffer/ml DE-52), stirred gently for
10 min, filtered and washed with additional volumes of elution buffer until most of the
bound proteins were eluted. The clear fraction eluted was termed "Fraction II" (Chu-Ping
etai, 1994).
Ammonium sulfate was added to Fraction II to 38% saturation over 30 min with constant
stirring. Precipitated proteins were collected by centrifugation. The pellet was
resuspended in a large volume of standard buffer H, saturated to 38% ammonium sulfate.
The pellet was washed in buffer H saturated to 38% ammonium sulfate to remove PA28
and the 20S proteasome, both of which are soluble at this salt concentration. The pellet
was dissolved in a small volume of equilibrating buffer and dialyzed for 16 h against a
large volume of the same buffer. After dialysis, insoluble material was removed by
centrifugation (30 000 x g; 30 min) and the soluble fraction subjected to chromatography
on Sephacryl^S-300 using equilibrating buffer.
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Fractions collected were assayed for PA700 activity (Section 6.2.4). Fractions containing the
highest level of activity were pooled and subjected to ion exchange chromatography on
DEAE-Toyopearl (2.5 x 10 cm) equilibrated (30 ml. h"1) with equilibrating buffer. Bound
proteins were eluted with a linear gradient of 100-350 mM (400 ml) NaCl in equilibrating
buffer. Eluted fractions were assayed for PA700 activity. Active fractions were pooled and
dialyzed against 20 mM sodium phosphate buffer, pH 7.6, and applied to HA-Ultrogel (1.5 x
12 cm) equilibrated (20 ml. h"1) in the same buffer. PA700 was eluted by a linear gradient of
20-200 mM phosphate buffer. The active fractions were concentrated by ultrafiltration and
stored at -70°C.
6.2.3 Phosphatase assay
Assays for phosphatase activity of purified PA700 were based on the ATPase assays of
Reenstra and Forte (1990). This assay uses /?-nitrophenyl phosphate as substrate. Upon
hydrolysis, the /?-nitrophenyl phosphate liberates inorganic phosphate and /?-nitrophenol. The
substrate is colourless, but the product p-nitrophenol is yellow in alkaline solution, absorbing
maximally at 405 nm. Hence progress of this reaction may be followed continuously at this
wavelength using a spectrophotometer.
6.2.3.1 Reagents
Assay buffer (20 mM Hepes/Tris buffer. pH 7.2). Hepes (476.6 mg) was dissolved in 80 ml of
dist. H2O, adjusted to pH 7.2 with solid Tris and made up to 100 ml.
Para-nitrophenyl phosphate [50 mM Nag-pNPPl. See Section 5.3.1
Stopping solution (10 mM NaOFT). See Section 5.3.1
6.2.3.2 Procedure
The reaction mixture consisted of purified PA700 (1-2 |ig), assay buffer, pH 7.2 (50 JJ.1), 50
mM/?-nitrophenyl phosphate (10 uJ), 2 mM ouabain (5ul), with or without of 100 mM KC1
(10 (il), in a total volume 100 ul When required, vanadate was dissolved in the assay buffer
at the required concentration. Incubations were carried out for 60 min at 37°C with gentle
shaking (50 oscillations per minute). The reactions were stopped by the addition of 20 mM
NaOH (50 ul). The amount ofp-nitrophenol liberated was determined spectrophotometrically
at 405 nm using a BIO-TEK EL 312 microtitre plate reader.
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Potassium ion-stimulated phosphatase activities were determined from the difference in
optical density in the presence and absence of K+. One unit of enzyme activity was defined as
the amount of enzyme liberating 1 umole /7-nitrophenol per minute under the above
conditions. An extinction coefficient of 1.465 u,mole"l.ml.cm~l was used to determine
concentration of released p-nitrophenol (Tosomba et al., 1996).
6.2.4 Activation Studies
6.2.4.1 Reagents
Assay buffer [90 mM Tris. 10 mM DTT. 0.12 mM ATP. 20 mM MgCk pH 8.0]. Tris
(2.725 g), DTT (0.386 g), ATP (0.0165 g) and MgCl2 (1.017 g) were dissolved in 200 ml of
dist.H2O, adjusted to pH 8.0 with HC1 and made up to 250 ml with dist.H2O.
Substrate stock solution. See Section 3.4.1.1
6.2.4.2 Procedure
Purified MCP-Tb and PA700 were pre-incubated at 37°C for 45 min essentially as described
(Chu-Ping et al., 1994). This pre-incubation mixture consisted of assay buffer (50 u.1),
purified MCP-Tb (0.2 ug) and PA700 (1-2 u.g) in a final volume of 75 ul. After the pre-
incubation, 25 ul of substrate (50 uM peptide-AMC or 0.2 mM peptide-PNA final cone.) in
30 mM Tris/HCl, pH 8.0 containing 1 mM dithiothreitol was added and the release of AMC or
|3NA was measured spectrophotometrically (Section 3.4.1.2). Control assays, conducted in
parallel, consisted of pre-incubation mixtures and subsequent assay mixtures in the presence
and absence of proteasome and activator.
To study the effect of the activator on the kinetic properties of the enzyme, MCP-Tb (0.2 ug)
was pre-incubated with ATP and saturating amounts of activator (2 ug). The activity of the
MCP-Tb was assayed against increasing concentrations of each peptide-AMC substrate (from
0-500 uM) or Z-Leu-Leu-Glu-PNA (0-2 mM). Control experiments contained no PA700
activator. The maximal reaction velocity (Vmax) and substrate concentration required for half-
maximal velocity (apparent Km) were estimated by hyperbolic regression using the software
package Hyper (obtained from Dr. J. S Easterby, University of Liverpool, U.K.).
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6.2.5 Assay for PA700-Proteasome Association
Under physiological conditions, the proteasome exists as a 20S complex or, when in
combination with the PA700 activator, as a 26S proteasome (Coux et al., 1996). The 26S may
be isolated intact from mammalian cells using gentle protein purification techniques
(Dahlmann et al., 1995). However, dissociated 20S proteasome and its PA700 activator may
also be isolated separately and may then be associated in vitro (Chu-Ping et al., 1994). This
section describes an assay to measure the association of trypanosomal MCP-Tb and PA700
isolated from bovine red blood cells.
6.2.5.1 Reagents
Phosphate buffered saline (PBS). pH 7.4. See Section 2.12.1
BSA-PBS [0.5% (w/v) BSA-PBSl See Section 2.12.1
PBS-Tween fO.1% (\N) Tween 20/PBS1. See Section 2.12.1
10 mM Tris/HCl. pH 7.5. Tris (1.21 g) was dissolved in 950 ml of dist. H2O, titrated to pH
7.5 with HC1 and made up to 1 litre.
Tris/HCl-Tween [0.1% Tween 20 (v/vVTris-HCl. pH 7.51. Tween 20 (1 ml) was made up to 1
litre with stirring in 10 mM Tris-HCl, pH 7.5.
Elution buffer ( 20 mM Tris-HCl. 0.5 mM NaCl. pH 7.51 Tris (2.42 g) and NaCl (0.029 g)
were dissolved in 950 ml of dist. H2O, titrated to pH 7.5 with HC1 and volume made up to 1
litre with dist. H2O.
Antibodies. Anti-PA700 IgY and anti-proteasome IgY were raised in chickens and isolated as
described in Section 2.10.3. Antibodies were raised in rabbits against chicken IgY and
isolated as described in Section 2.10.4.
6.2.5.2 Procedure
A direct binding assay, adapted from Realini et al. (1997) was used to determine whether
bovine PA700 binds the MCP-Tb isolated from T. b. brucei. The wells in a microtiter plate
were coated (16 h; 4°C) with 150 ul of rabbit anti-chicken IgY at 20 ug/ml in PBS.
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Unoccupied sites in the wells were blocked with 200 \x\ of 0.5% (m/v) BSA-PBS by
incubation for 1 h at 37°C. The microtitre plate was washed three times between each
incubation step with PBS-Tween. This was followed by incubation with chicken anti-
trypanosomal MCP-Tb IgY or control pre-immune IgY at concentrations of 20 u,g/ml in 0.5%
BSA-PBS (200 ul) for 2 h at 37°C. Trypanosomal MCP-Tb (200 ul, 30 ug/ml in BSA-PBS)
was incubated in each well for 16 h at 4°C followed by incubation with various dilutions of
PA700 in 10 mM Tris/HCl, pH 7.5 for 20 min, at room temperature and 120 min at 4°C. The
plates were quickly rinsed twice with an excess of cold (4°C) 10 mM Tris/HCl, pH 7.5, PBS-
Tween and once with 10 mM Tris/HCl, pH 7.5. The bound PA700 was eluted with 150 (il of
0.5 M NaCl in 20 mM Tris/HCl, pH 7.5, and dot-blotted onto nitrocellulose for probing with
chicken anti-PA700 IgY. Bound antibodies were detected as described (Pike et al, 1992)
using alkaline phosphatase-conjugated rabbit anti-chicken IgG that cross-reacts with chicken
IgY and BCIP/NBT substrate.
6.3 Results
6.3.1 Subunit analysis
Both the bovine-derived proteasome activator PA700 and the trypanosome-derived MCP-Tb
were purified to apparent homogeneity as evidenced by single bands on native PAGE gels
(Fig. 6.1 A; lanes 2 and 3 respectively). The molecular masses of PA700 and the MCP-Tb
were each estimated by molecular exclusion chromatography to be about 700 kDa. Since
PAGE separates proteins on the basis of their charge-to-mass ratio, the molecular mass
indicated in Fig 6.1 A is merely a rough estimation and consequently lower than that indicated
by molecular exclusion chromatography. When the bovine PA700 was subjected to reducing
SDS-PAGE, multiple protein bands ranging from 20-100 kDa were observed (Fig. 6.IB; lane
1). This protein profile is similar to that reported before (DeMartino et al, 1994). Under
similar conditions, the trypanosomal MCP-Tb showed protein bands ranging from 18-27 kDa
(Fig. 6. IB; lane 2). This profile is characteristic of eukaryotic proteasomes (Tanaka, 1998)
and differs from that of prokaryotes (Lowe et al, 1995). There was no difference in the
subunit profiles of PA700 and the MCP-Tb under reducing and non-reducing SDS-PAGE
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Figure 6.1. Electrophoretic analyses of purified PA700 and MCP-Tb
Panel A, non-denaturing PAGE of M r markers (lane 1) as in legend to Fig. 3.4, PA700 (lane 2) and MCP-Tb
(lane 3). Panel B, reducing SDS-PAGE (12.5%) analysis of PA700 (lane 1); proteasome (lane 2); M r
markers (lane 3) as in legend to Fig. 3.4.
6.3.2 Specificity of anti-MCP-Tb and anti-bovine PA700 antibodies
To assess recognition of the trypanosomal 20S proteasome and bovine PA700, by their
respective antibodies, immunoblots of the native proteins (Fig. 6.2, panel A) and their
respective subunits (Fig. 6.2, panel B) were prepared. Chicken anti-PA700 recognised
intact bovine PA700 (Fig. 6.2A; lane 1) and two of its larger subunits of 97 and 104 kDa
(Fig. 6.2B; lane 1) but did not recognise the other subunits. There was no cross-reactivity
between anti-PA700 antibodies and any of the protein bands of trypanosome lysates
separated on native PAGE (results not shown). Chicken anti- trypanosomal proteasome
antibodies recognised the trypanosomal 20S proteasome on blots of native PAGE gels
(Fig. 6.2A; lane 2) and only some of its subunits (in the region of 27 kDa) on blots of SDS-
PAGE gels (Fig. 6.2B; lane 2). The anti-20S proteasome antibody did not cross-react with
















Figure 6.2. Immunoblot analysis of PA700 and the MCP-Tb
Purified PA700 (lane 1) and MCP-Tb (lane 2) were electroblotted from non-denaturing PAGE (Panel A) and
reducing SDS-PAGE (Panel B) onto nitrocellulose and probed by chicken anti-PA700 IgY (Panel A, lane 1
and Panel B, lane 1) and chicken anti-proteasome IgY (Panel A, lane 2 and Panel B, lane 2) antibodies. The
bound antibodies were detected as described under Section 6.2.5. The positions of the Mr markers are
indicated.
6.3.3 Phosphatase activity of PA700








Figure 6.3. Effect of K+ ion concentration on />-nitrophenyl phosphatase (pNPPase) activity of PA700.
Reaction mixture (100 ul) contained 20 mM HepesAns buffer, PH 7.2 and either 2 ug (0) or 0.2 ^g of
PA700 (V), with the indicated KC1 concentrations. Reactions were initiated by the addition of 5 mM p-
nitrophenyl phosphate. The results are presented as means ± S.E of three independent experimental
determinations.
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The /?NPPase activity was not detectable in the absence of K+ ions and only became
detectable at K+ concentrations above 0.2 mM. The maximum catalytic activity was
observed at 5 mM K+ (for 2 ug PA700/100 ul) and 0.5 mM K+ ion (for 0.2 ^g PA700/100
1̂ 1). The K+ ion concentration required for activation is in the same range as that reported
for/?NPPase activities of gastric oxyntic cells (Reenstra and Forte, 1990).
6.3.4 Effect of bovine PA700 on the activity of trypanosomal MCP-Tb
Bovine PA700 increased the activity of the trypanosomal 20S proteasome against Suc-
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Figure 6.4. Effect of PA700 concentration on />NPPase activity and on the hydrolytic activity of the
20S proteasome
Proteasome (0.2 jig), preincubated with increasing amounts of PA700 activator (0-3 jig), was assayed
against Suc-Leu-Leu-Val-Tyr-AMC (50 nM;0). pNPPase activity of PA700 was assayed against pNPP
(5mM;O ). Results are presented as means ± S.E of three independent experiments
Maximal activation was reached at 10 |ig PA700/u.g proteasome (final concentration in the
assay mixture). About 3.5 |ag PA700/|!g proteasome caused 50% activation of proteasome
activity (to •14.5 nmol.min."1mg'1). Maximal velocity was reached at a
proteasome:activator ratio of 1:10 (mol:mol). Saturation of the stimulatory effect by
PA700 indicated that there was no contamination of the activator preparation with bovine
erythrocyte proteasome. The /?NPPase activity increased linearly with an increase in
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concentration of PA700 (Fig. 6.4). PA700 incubated without proteasome did not show
hydrolytic activity against Suc-Leu-Leu-Val-Tyr-AMC.
6.3.5 Effect of PA700 on the kinetics of MCP-Tb hydrolysis
The kinetic parameters of the proteasome-catalysed hydrolysis of different substrates in the
presence and absence of PA700 are presented in Table 6.1. The chymotrypsin-like, trypsin-
like and peptidyl glutamylpeptide hydrolase activities of the trypanosomal proteasome were
determined using Suc-Leu-Leu-Val-Tyr-AMC, Z-Gly-Gly-Arg-AMC and Z-Leu-Leu-Glu-
PNA, respectively. PA700 enhanced the proteasome activities by increasing the apparent VmaX
(maximal reaction velocity) and by decreasing the apparent Km (Michaelis constant). In each
case, the increase in activity (as assessed by the second order rate constants) was about 5-6
fold. No enhancement of proteasome activity was observed in the absence of ATP.
Table 6.1. Effect of the activator PA700 on the catalytic properties of the trypanosomal MCP-Tb.
Activator protein was purified from bovine red blood cells as reported in Section 5.2.2. Proteasome purified from
T. b. brucei was preincubated in the absence and presence of saturating amounts of the activator The proteasome
activity was assayed with increasing concentrations of peptide substrates; Suc-Leu-Leu-Val-Try-AMC (0-500
uM), Z-Gly-Gly-Arg-AMC (0-500 DM), Z-Leu-Leu-Glu-pNA (0-2 mM) and values for the apparent Km (uM)
and V ^ (nmol.min'Vmg"1) estimated by hyperbolic regression using a software package Hyper. The data


































6.3.6 Binding of PA700 to trypanosomal 20S proteasome
The fact that bovine PA700 stimulates proteasome-catalysed peptide hydrolysis suggests
that PA700 is capable of binding to trypanosomal proteasomes. To test this, we performed
binding experiments between PA700 and the proteasome (Fig. 6.5). Rabbit anti-chicken
IgY antibodies were adsorbed to microtitre plates to serve as capture antibody for chicken
anti-proteasome IgY. The anti-proteasome antibodies subsequently bound proteasome
without any obvious impediment. In turn, the immobilised proteasome specifically
interacted with PA700 (Fig. 6.5). Subsequent detection with anti-PA700 antibodies on dot
blots showed that it was possible to dissociate PA700 from the proteasome by using high
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salt concentrations. The similar intensity (Fig. 6.5, column a) of dot blots having different
concentrations (40-4 ng/ml) of PA700 may be interpreted to mean that the proteasome and
PA700 bind strongly to each other. Virtually no PA700 was present in samples obtained
from wells where pre-immune IgY was used instead of anti-proteasome antibodies (Fig.
6.5, column b), or where anti-proteasome antibodies were present but no proteasome was
added (Fig. 6.5, column c). The latter observation implies that anti-proteasome antibodies
immobilised in the microtiter wells were specific for proteasome and did not cross react
with PA700. The specificity of anti-proteasome antibodies for its antigen was confirmed
by immunoblot analysis (Fig. 6.2).
a
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Figure 6.5. Binding assay for PA700-proteasome interaction
MCP-Tb immobilised in the wells of a microplate was incubated with either anti-proteasome antibodies
(column a) or pre-immune IgY (column b). Column c had no MCP-Tb (see details under Section 6.2.5).
This was followed by incubation with 40 (row 1), 20 (row 2), 10 (row 3), 4 (row 4) ng/ml of PA700 regulator
protein. The bound PA700 proteins were eluted with high salt buffer and dot-blotted in duplicate onto
nitrocellulose (columns a- c\ rows 1-4). Presence of PA700 on the nitrocellulose membrane was probed
with chicken anti-PA700 IgY and detected by rabbit anti-chicken alkaline phosphatase conjugate and
BCIP/NBT substrate.
The slight precipitation of proteins in row one of column b and c is interpreted as due to
non-specific interaction between the proteins at high concentration (Fig. 6.5). Duplicate
blots incubated with pre-immune IgY preparations instead of anti-PA700 antibodies were
negative (results not shown).
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6.3.5 Effect of phosphatase inhibitors on PA700 activity
Ouabain (0-125 u,M) had no significant effect on the/?NPPase activity of PA700 (Fig.
6.6). A slight change (corresponding to a change of about 5% from the original activity)
may be due to non-specific interactions between ouabain and PA700. In contrast, sodium
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Figure 6.6. Effect of vanadate and ouabain on/>NPPase activity of PA700.
The PA700 activator (2 ng) was preincubated for 45 min at 37°C with increasing concentrations of vanadate
(0) and ouabain (V) (0-120 yM). Residual activity against pNPP was determined as outlined in Section
3.2.3. The results are presented as means ± S.E for three independent experiments.
Furthermore, vanadate blocked the PA700-induced enhancement of protease activity. This
was observed with each of the protease substrates tested (Fig. 6.7). In the absence of
vanadate, a 1:5 molar ratio of proteasome: PA700 (required for half-maximal activation)
increased the activity (Vmax) against Suc-Leu-Leu-Val-Tyr-AMC 2.1-fold, Z-Gly-Gly-Arg-
AMC 1.6-fold and Z-Leu-Leu-Glu-pNA 2.3-fold. However, none of these proteasomal
activities was stimulated by PA700 when 20 ^M sodium vanadate was present (Fig. 6.7),

























Figure 6. 7. Effect of vanadate on PA700 activation of MCP-Tb
Purified proteasome (0.2 ug) was incubated for 45 min at 37°C with PA700 (1 ug) in the absence or presence
of vanadate (20 JJM). Control experiments contained no PA700 or vanadate. Proteasome activity was assayed
against Suc-Leu-Leu-Val-AMC (50 uM), Z-Gly-Gly-Arg-AMC (50 uM) and Z-Leu-Leu-Glu-AMC (0.2 mM).
The fluorescence resulting from the hydrolysis of the substrates was determined as described under Section
3.4.1. Plots show initial velocity (nmol.min."'.mg"') ± S.E of the means from three independent experimental
determinations.
6.4 Discussion
Proteasomes are multimeric, threonine-proteinases that are found in eukaryotic and
prokaryotic cells. Two classes of eukaryotic proteasomes (called 20S and 26S) have been
identified and these may be isolated from the same cell (Tanaka, 1998). The 26S
proteasome is composed of the 20S proteasome and a 19S particle called PA700. Whereas
the 20S proteasome does not require ATP for activity (Chu-Ping et al., 1994; DeMartino et
al, 1994), the 26S proteasome does require ATP (approximately 60 (iM) for activity. The
bovine 20S proteasome is activated by as much as 15-100-fold when PA700 is added, with
half-maximal activation achieved at a proteasome:activator molar ratio of about 1:3 (Chu-
Ping et al, 1994). In this chapter, we report a 5-6-fold activation of the MCP-Tb by
bovine PA700 at a 1:10 proteasome:activator molar ratio. These differences may be
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attributed to differences between the activators and proteasomes from different species.
Nevertheless, the important point is that bovine PA700, a component of the 26S
proteasome, is able to activate the trypanosomal MCP-Tb. Such cross-species activation
was also seen in the activation of lobster 20S proteasome by bovine PA28 (Mykles, 1996).
In contrast to our studies, however, the activation of the lobster proteasome varied from
0-99-fold depending on the substrate studied.
Like the bovine 20S proteasome, the trypanosomal MCP-Tb only showed PA700-
enhanced protease activity when ATP was present. Apart from showing that ATP is a
necessary component of this activation process, this observation confirmed that the PA700
preparation was not contaminated with another proteasome activator such as PA28. The
need for ATP in the PA700-MCP-Tb activation process is also supported by the inhibition
of both thepNPPase activity of PA700 itself, and the enhancement of MCP-Tb activity in
the presence of PA700 by sodium vanadate (Fig. 6.7). One proposed role of the ATPase is
to supply energy continuously for the selective degradation of target proteins by the active
26S proteasome (Coux et al, 1996). This energy is presumed to be used in the unfolding
of substrate proteins to allow them to penetrate the channel of the a- and p-rings of the 20S
proteasome (Tanaka, 1998). However, peptide substrates were used in the present
experiments, hence peptide unfolding seems an unlikely scenario for the enhancement
observed in this study.
Thus far, neither a PA700-equivalent, nor an intact 26S proteasome, has been reported to
occur in African trypanosomes. However, a molecule equivalent to PA28 (named PA26)
which enhances trypanosomal proteasome activity, has been isolated from T. b. brucei (To
and Wang, 1997). Thus, at least one component of the proteasome regulatory mechanism
is present in these parasites. The present observation of the binding and enhancement of
trypanosomal MCP-Tb activity by bovine PA700 is consistent with the established binding
of bovine PA700 to the bovine 20S proteasome (for review see Coux et al., 1996). This
observation leads us to suggest that the general mechanism(s) of activation of the
trypanosomal MCP-Tb by PA700 is similar to that found in other eukaryotic cells.
Consequently, t it seems likely that an isoform of PA700 is likely to be present in
trypanosomes.
The interaction between PA700 and the 20S core of the 26S proteasome from T. b. brucei
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is possibly weaker than that of other organisms, resulting in the dissociation of the complex
into its regulatory and catalytic sub-complexes during the purification process. Alternatively,
the trypanosome equivalent of PA700 may be sensitive to proteolytic digestion. Considering
the apparent tight binding between PA700 and the MCP-Tb, and the reaction, or lack thereof,
of anti-PA700 antibodies with trypanosome lysates, the latter interpretation seems to be the
more likely possibility. Bloodstream forms of T. brucei possess considerable quantities of
proteolytic activity that, in the absence of exogenously added inhibitors, may degrade any
proteolytically sensitive proteins (Lonsdale-Eccles and Mpimbaza, 1986; Lonsdale-Eccles and
Grab, 1987; Lonsdale-Eccles, 1991).
In order to further analyse the activating effect of PA700 on the MCP-Tb, the trypsin-like,
chymotrypsin-like and peptidyl glutamylpeptide hydrolysing activities need to be considered
separately. These activities do show some overlap, particularly with respect to their reaction
with different protease inhibitors. For example, chymostatin, inhibits the chymotrypsin-like
activity and to a lesser extent the trypsin-like activity of the proteasome (Russo et al., 1993).
Likewise, leupeptin inhibits both trypsin-like and chymotrypsin-like activities of the
proteasome (Chapter 3; Lomo et al., 1997). Proteasome specific inhibitors such as lactacystin
and Z-Leu-Leu-Leu-H block all the peptidase activities of the proteasome (Coux et al., 1996).
Since it has not yet been possible to selectively inhibit each of the different proteasome
activities, kinetics of hydrolysis of peptide substrates by individual activities have only been
estimated based on the assumption that the substrates used are specifically hydrolysed by their
respective proteasome activities. However, peptide substrates are also not absolutely specific
and two or more activities may hydrolyse the same substrate. It is against this background that
the results of the effect of PA700 on the kinetic parameters of the hydrolysis of peptide
substrates must be assessed. PA700 has the general effect of increasing the Vmax and
decreasing the apparent Km for each of the three substrates tested (Table 6.1). Thus, it seems
likely that the effect of PA700 is more complex than a simple alteration of access to the MCP-
Tb active sites.
Because the phosphatase activity of PA700 seems to be essential for the enhancement of the
protease activity of the trypanosomal proteasome, it seems likely that there is interaction
between these different components. Although an equivalent to PA700 has not yet been found
in T. b. brucei itself, the results presented here demonstrate that trypanosomal MCP-Tb
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activity may be subject to similar regulatory mechanisms as mammalian proteasomes. The
results also imply conserved functionality between the proteasomes of trypanosomes and their




Trypanosoma brucei is widespread in Africa. It causes considerable losses in productivity in
domestic animals and the subspecies T. b. rhodesiense and T b. gambiense are responsible for
life-threatening diseases in man (WHO, 1986; Kuzoe, 1993). Currently, control of
trypanosomiasis in domestic livestock involves eradication of the insect vector, the tsetse fly
(Glossina sp.), the exploitation of trypanolerant livestock, and administration of trypanocidal
compounds. Chemotherapy and chemoprophylactic agents are widely used across the African
continent (Wang, 1995). While all the compounds used in domestic livestock have been on
the market for over 30 years, very little is known about their modes of action. [Eflornithine
(DFMO) is the only trypanocide whose mode of action is clearly known—it is an inhibitor of
polyamine synthesis (Fairlamb and Cerami, 1992)]. Unfortunately, the efficiency of many of
these compounds is being impeded by the emergence of drug resistant trypanosomes (Leaches
and Roberts, 1981) and very little is known about the molecular basis of this resistance. In
addition, vaccine development has been impeded by the inherent ability of trypanosomes to
undergo antigenic variation—the primary mechanism for evasion of the host's immune
responses (Cross, 1990). An understanding of the unique biochemical and molecular features
of trypanosomes may allow better use of current trypanocides, may lead to a more informed
approach to the control measures which should be adopted under specific circumstances, and
may aid in the development of vaccines or chemotherapeutic agents.
The present study focussed on a high molecular mass multicatalytic protease (MCP-Tb) from
T. brucei. MCPs (also called proteasomes) have been studied in eukaryotic and
archaebacterial organisms (Coux et al, 1996; Tanaka, 1998) and the 3-dimensional structure
of MCP from Thermoplasma has been determined (Lowe et al, 1995). The 20S proteasome is
a cylindrical particle that contains the active site threonine residue located inside the cylinder
(Seemuller et al, 1995). Access to the interior seems to be regulated by other large (1 IS and
19S) protein complexes (Coux et al, 1996; Tanaka, 1998) that appear to cap the ends of the
cylinders. Association of the proteasome with either of these caps greatly enhances the
hydrolysis of fluorogenic peptides (Chu-Ping et al, 1992; Chu-Ping et al, 1994; DeMartino et
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al, 1996). Whereas complexes of the 20S proteasome with the 1 IS particle (also called
PA28) can only degrade peptides and do not require ATP for activation (Chu-Ping et al,
1992), complexes of the 20S proteasome with the 19S particle (also called PA700) degrade
both peptides and proteins, particularly ubiquitinated proteins, and require ATP for activation
(Coux et al., 1996). Among the Trypanosomatid group of parasitic protozoa, MCP has been
described in T. cruzi (Gonzalez et al, 1996) and T. brucei (Lomo et al, 1997; To and Wang,
1997). Based on its involvement in physiologically important processes in different cell
systems (Tanaka, 1998), MCP appears to be potentially relevant to several aspects of the host-
parasite relationship.
A new purification protocol was developed and used to purify MCP-Tb from bloodstream
forms of T. brucei. Studies on substrate specificity revealed that MCP-Tb has preferences for
peptides with bulky hydrophobic (Leu) or aromatic (Phe, Tyr) residues at Pi as well as polar
residues with either basic (Arg) or acidic (Glu) residues at the same subsite. This is similar to
MCP-rbc, the proteasome from red blood cells. The identity of MCP-Tb as a proteasome was
further demonstrated by its susceptibility to a range of inhibitors. The trypsin-like activity of
MCP-Tb was insensitive to the cysteine and serine protease inhibitor N-Tosyl-Lys-CtfeCl or
the typical cysteine protease inhibitor E-64 (Barret et al, 1986), but was readily inhibited by
leupeptin. Similarly, the chymotrypsin-like activity of MCP-Tb was insensitive to the
classical chymotrypsin-like protease inhibitor N-Tosyl-Phe-CHbCl but readily inhibited by
chymostatin. The peptide aldehyde Z-Leu-Leu-Leu-H readily inhibited all activities of MCP-
Tb. These inhibitor profiles, shared by all other proteasomes examined to date, identify MCP-
Tb as a proteasome and also suggest a common evolutionary origin of the proteasomes.
MCP-Tb has caseinolytic (proteinase) activity. Indeed, it degrades [5-casein at a faster rate
than MCP-rbc. The high rate of casein degradation may be an adaptation for high protein
turnover in the trypanosomes necessitated by rapid parasite multiplication and differentiation.
Indeed, a proteasome specific inhibitor, lactacystin, prevents the intracellular stage-specific
transformation of T. cruzi trypomastigote (non replicative bloodstream forms) into amastigote
(obligate intracellular replicative forms) (Gonzalez et al, 1996). Similar inhibition also
blocks cell cycle progression in bloodstream and procyclic forms of T. brucei (Mutomba et al,
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1997). Thus, proteasome-mediated proteolysis appears to be essential for the transformation
and proliferation of trypanosomes.
Although MCP-Tb and MCP-rbc share important structural features at electron microscopy
level, they also show some significant differences that may represent the products of divergent
evolution. High-resolution transmission electron microscopy showed that individual MCP-Tb
particles have a four-fold symmetry. They have a diameter of about 10 nm and a dark staining
center (the channel) measuring 2.8 nm in diameter. The length of MCP-Tb is about 14.5 nm
long. Thus, the 3-dimensional structures of individual subunits of MCP-Tb are similar to
bovine MCP-rbc. However, MCP-Tb particle preparations also exhibit peculiar end-on
associations in the form of long ribbon-like chains involving ten or more units. This has not
been seen before in proteasomes and its physiological significance is unclear at this time.
The relative molecular mass of MCP-Tb is 590 kDa whereas MCP-rbc is 650 kDa—the basis
of this difference may involve differential glycosylation (Schliephacke et al, 1991) or other
post-translational modifications (Glynne et al, 1993). The subunit proteins of each particle
were in the Mr range 18-27 kDa. However, clear differences were observed upon resolution of
these components on 2D-PAGE gels. MCP-rbc has 28 different components whereas MCP-
Tb has 12 different polypeptide components. The N-terminal sequence of an MCP-Tb subunit
has no obvious sequence similarities with MCP subunits from other species. Although, it is
possible that regions of higher conserved sequences may be found upon obtaining a complete
sequence of the MCP-Tb subunits, this amino acid sequence difference indicates that the
differences in apparent Mr between MCP-Tb and MCP-rbc can probably be explained by
different protein compositions.
Peptide hydrolysis by MCP-Tb was stimulated in an ATP-dependent manner by the presence
of PA700. This is in agreement with earlier reports on the activation of other proteasomes by
PA700 from bovine and rabbit erythrocytes (Chu-Ping et al, 1994; Dahlmann et al., 1995).
PA700 itself has no protease activity but it does have/?-nitrophenyl phosphatase activity that is
stimulated by potassium, unaffected by ouabain, and inhibited by vanadate. PA700 elicits its
ATP-dependent stimulatory activity by associating with the terminal rings of the 20S
proteasome (Coux et al, 1996). In the case of MCP-Tb, PA700 enhanced the various
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proteolytic activities by increasing the second order rate constants of the hydrolysis of Z-Gly-
Gly-Arg-AMC was 5.8 fold, of Suc-Leu-Leu-Val-Tyr-AMC 4.5 fold, and Z-Leu-Leu-Glu-
PNA 6.0 fold. These values are much less than those reported in other system where values as
great as 100-fold have been observed (Chu-Ping et al, 1994). These reduced levels of
activation observed in the present study may be explained by quarternary structures of the
molecules. Electron micrographic analysis of MCP-Tb shows that there is an average of 9
individual MCP-Tb units for each chain of MCP-Tb. If PA700 can only bind to a free, open-
end of a unit, then the reduced level of PA700 activation of MCP-Tb might well be accounted
for by the reduced number of open ends in relation to the total number of catalytic units of
MCP-Tb.
Chicken anti-MCP-Tb IgY recognizes a 590-kDa MCP-Tb on a blot. It also recognises a 27-
kDa component of MCP-Tb. Lack of recognition of the other MCP-Tb components probably
results from epitopes of MCP-Tb being hidden from the chicken's immune system. It is
shown in the present study that anti-MCP-Tb antibodies have an inhibitory effect on the MCP-
Tb protease activity (see also Lomo et al, 1997). Whether MCP-Tb plays a role in the
pathology of trypanosomiasis is not known. However, it is difficult to envisage the use of
inhibitory antibodies to MCP-Tb to offer immuno-protection because MCP-Tb is an
intracellular protease and as such it is unlikely to be accessible to anti-MCP-Tb antibodies.
However, specificity of anti-MCP-Tb to MCP-Tb may be exploited to further the studies of
MCP-Tb (e.g. in structural studies to determine epitope localisation by immunoelectron
microscopy).
Proteasomes have previously been purified from various eukaryotic cells. They have been
localised in the cytoplasm, in association with the endoplasmic reticulum, and in the nucleus
(Akhayat et al, 1987; Tanaka et al, 1989; Peters et al, 1994). The present study, however,
constitutes the first report on the subcellular localisation of proteasomes from a protozoan
parasite. The localisation was based on biochemical as well as immunocytochemical
evidence. The distribution of MCP-Tb activity in the subcellular fractions clearly indicate that
MCP-Tb is most abundant in the cytosol (75%) although some activity is also present in the
nucleus (22%). It is not associated with the mitochondria, glycosomes, lysosome, nor the
Golgi apparatus in the parasite.
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To complement subcellular fractionation studies, immunocytochemical studies were carried
out. These studies also showed the presence of MCP-Tb in the nuclei and the cytoplasm of T.
brucei. This agrees with previous reports showing the presence of other MCPs in nuclei
(Knetch et al, 1991; Rivett et al, 1992; Palmer et al, 1996) but contrasts with reports
showing the presence of MCP in the cytoplasm only and not in the nuclei (Akhayat et al,
1987; Haass et al, 1989; Kamakura et al, 1988; Tanaka et al, 1989).
The present study has unraveled some features of the trypanosomal MCP-Tb but at the same
time new questions have arisen. For instance, a computer-assisted database search showed
that the N-terminal sequence of a 0-type subunit of MCP-Tb does not share an obvious
sequence homology with subunits of other proteasomes from different cells. Such lack of
sequence similarities suggests evolutionary divergence between two functionally related
enzymes. It is envisaged that the protein sequence data of MCP-Tb obtained will be of use in
the design of probes for molecular clone generation. Specific regions of the protein sequence
may be selected for the design of probes such as PCR primers and oligonucleotides. These
probes may be used to screen cDNA or genomic libraries. Recombinant proteins may be
sequenced to verify the authenticity of putative positive clones, monitor the genetic stability of
the clone and the proper processing of recombinant protein products.
Also, recent studies have implicated the proteasome-ubiquitin system in the endocytosis of
several eukaryotic plasma proteins (Hicke, 1997 and Strous and Govers, 1999). Endocytosis
is an important physiological event through which materials are internalized and degraded,
and in trypanosomes, includes the degradation of anti-VSG antibodies (Webster and Grab,
1988; Webster and Fish, 1989; Russo et al, 1993). It would be interesting to investigate a
possible direct or indirect role of MCP-Tb in endocytosis of proteins and peptides by the
parasite. Such a study may involve alternate use of different class-specific protease inhibitors
and proteasome-specific inhibitors (e.g. lactacystin) on live parasites. Such studies may be
extended to unravel the function(s) of MCP-Tb within the parasite, the importance of MCP-Tb
in parasite survival, and the potential of MCP-Tb for drug development.
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Abstract
African trypanosomes are tsetse-transmitted protozoan parasites that cause sleeping sickness in humans and 'Nagana' in
animals. A high relative molecular mass multicatalytic proteinase complex (MCP) was purified and biochemically
characterized from the cytosolic fraction of Trypanosoma brucei brucei. The isolation procedure consisted of fractionation
of the lysate by high speed centrifugation, chromatography on Q-sepharose, molecular sieve filtration on Sephacryl S-300,
chromatography on HA-Ultrogel and glycerol density gradient centrifugation (10-40%). The final enzyme preparation
yielded a single protein band corresponding to a relative molecular mass of 630 kDa on a non-denaturing polyacrylamide
gel. The enzyme hydrolyses a wide range of peptide substrates characteristic of chymotrypsin-like, trypsin-like, peptidylglu-
tamylpeptide-hydrolysing activities determined by fluorogenic peptides, Z-Gly-Gly-Leu-NHMec, Z-Arg-Arg-NHMec and
Z-Leu-Leu-Glu-/3NA. respectively. The enzyme was found to have a wide variation in pH optimal activity profile, with
optimum activity against Z-Gly-Gly-Leu-NHMec at 7.8, Z-Arg-Arg-NHMec at pH 10.5 and Z-Leu-Leu-Glu-/3NA at pH 8.0,
showing that the different activities are distinct. The enzyme hydrolysed oxidized proteins. In addition, the chymotryptic and
trypsin-like activities were susceptible to inhibition by peptide aldehyde inhibitors with variable inhibition effects. The study
demonstrates the presence of a non-lysosomal proteasome pathway of intracellular protein degradation in the bloodstream
form of T. b. brucei. Further, the ability of the enzyme to hydrolyse most oxidized proteins, and the high immunogenicity
exhibited suggests a possible involvement of the enzyme in pathogenesis of the disease.
Keywords: Trypanosomiasis; Multicatalytic proteinase: Antigenicity; Trypanosoma brucei brucei
1. Introduction
Trypanosoma brucei brucei is the flagellated pro-
tozoan parasite that is the aetiological agent of
Abbreviations: NA, 2-naphthylamide; NHMec, 7-amino-4-
methylcoumarin; DTT, dithiothreitol; E-64, trans-epoxysuccinyl-
L-leucylamido (4-guanidino) butane: IgY, immunoglobulin Y: Sue,
succinyl; Z, benzyloxycarbonyl
' Corresponding author. Present address: Department of Bio-
chemistry and Molecular Genetics, University of Alabama at
Birmingham, Birmingham, AL 35294, USA.
African trypanosomiasis in livestock, whose debili-
tating chronic course is characterized by anaemia
and severe endocrinal defects (Lomo et al., 1995).
Proteolysis may have a number of functions in the
parasite including processing of trypanosomal pro-
teins, degradation of proteins involved in the mor-
phological changes occurring during their complex
life cycle and the hydrolysis of host proteins for
nutritional and invasion purposes. Thus, the pro-
teinases of parasitic protozoa are of interest for
several reasons, including their role in pathogenesis
of parasitic diseases such as trypanosomiasis.
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The proteasome (EC 3.4.99.46), also known as
the multicatalytic proteinase complex (MCP), is an
extralysosomal high relative molecular mass pro-
teinase found in eukaryotic cells (Kania et al., 1996).
Proteasomes have also been detected in archaebac-
terium (Seemuller et al., 1995), yeast (Hilt and Wolf,
1992), and trypanosome (Hua et al., 1996), however,
their physiological significance in these micro-
organisms is still unclear. In eukaryotic cells, the
proteasome is thought to be the principal catalyst for
protein degradation within the cytosol. Some of the
suggested functions of the proteasome encompass
processing of antigens (Rock et al., 1994), transcrip-
tion factors (Palombella et al., 1994), regulation of
cell cycle development through degradation of cy-
clins (Glotzer et al., 1991), degrading ubiquitin-pro-
tein conjugates (Hershko and Ciechanover, 1992) as
well as breakdown of short-lived and long-lived
cellular proteins (Rock et al., 1994; Hayashi and
Murakami, 1995).
The present study was designed to purify and
characterise the non-lysosomal MCP from T. b. bru-
cei and attempt to determine its possible role in
host-parasite interaction.
2. Materials and methods
2.1. Chemicals
Chemicals used in this study were purchased from
Sigma, BDH, Merck or Boehringer Mannheim and
were of analytical grade or better. DEAE-cellulose
(DE-53) was from Whatman Biochemical Systems,
Maidstone, U.K. Sephacryl S-300, molecular weight
markers, and Percoll were from Pharmacia. HA-
Ultrogel, Q-sepharose, protease inhibitors, Leu-Leu-
Glu-/3NA and hypoxanthine were purchased from
Sigma Chemicals Co., St. Louis, Mo. All other
peptide substrates used were products of Bachem
Feinchemikalien, Bubendorf, Switzerland.
Horseradish peroxidase (HRPO) was from Seravac.
Freund's complete and incomplete adjuvants were
purchased from Gibco Laboratories, Life Technolo-
gies, Ohio, USA. 2,2 Azino-di-[3-ethylbenzthiazoIine
sulphonate (6)] ABTS was from Boehringer
Mannheim, SA.
2.2. Parasite isolation
Trypanosoma brucei brucei ILTat 1.1 derived
from stock EATRO 795 were used in this study.
Bloodstream forms were grown in 4-month-old
Sprague Dawley rats.
Trypanosome-containing blood was collected at
peak parasitaemia (approximately 108 try-
panosomes/ml) by cardiac puncture into 0.5% (w/v)
citrate. The trypanosomes were separated from blood
cells by a combination of centrifugation on isopycnic
Percoll gradients (Grab and Bwayo, 1982) and chro-
matography on DEAE-cellulose (DE-53) using iso-
tonic phosphate/saline/glucose (PSG) buffer, pH
8.0, prepared as described by Lanham and Godfrey
(1970), containing 0.1 mM hypoxanthine (Lonsdale-
Eccles and Grab, 1987). The trypanosomes recov-
ered from the column effluent were washed three
times in ice-cold PSG buffer, pH 7.4 containing 0.1
mM hypoxanthine and centrifuged at 1000 Xg for
15 min at 4°C. The pelleted cells could be frozen for
subsequent enzyme purification with no appreciable
loss of activity and were stored at - 80°C.
2.3. Enzyme purification
All experimental procedures were carried out at
4°C. The cells (approximately 10'° trypanosomes)
were suspended in 10 mM Tris-HCl, pH 7.0 con-
taining 1 mM dithiothreitol, 0.1 mM EDTA, 2 mM
ATP and ruptured in a French pressure cell (Aminco,
Silver Springs) at approximately 2,500 Psi. The cell
lysate was then centrifuged at 100,000 X g for 1 h in
an angle-fixed 75 Ti rotor. The pellet was washed
and glycerol added to 20% (v/v) of the supernatant.
The supernatant was subsequently loaded onto anion
exchange column Q-sepharose (2.5 X 10 cm) equili-
brated with 5 bed volumes of 10 mM Tris-HCl
buffer pH 7.0 containing 0.1 mM EDTA, 1 mM
DTT, 25 mM KCl, 1.1 mM MgCl2, 20% glycerol
and 0.02% NaN3 (standard buffer). After removal of
unbound proteins by washing with equilibrating
buffer containing 100 mM KCl, bound proteins were
eluted with 6 bed volumes linear gradient of 100-800
mM KCl in the same buffer. The eluted activity was
pooled and concentrated (5-10 fold) by dialysing
(using Mr 12,000 cut-off dialysing tubing) against
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dry poly (ethylene glycol) 20,000. The buffer system
was essentially as described by Dahlmann et al.
(1996). The concentrated active fraction from Q-sep-
harose column was applied to a Sephacryl S-300
(2.5 X 96 cm) in the standard buffer. In this step,
low molecular mass contaminants were removed from
the proteinase. The enzyme eluted as a single peak of
Z-Gly-Gly-Leu-NHMec activity which falls within
the fractionation range of the bead. The active frac-
tion from Sephacryl S-300 was further fractionated
on HA-Ultrogel column of bed volume 12 ml that
had previously been equilibrated with 10 mM potas-
sium phosphate buffer, pH 6.8 containing 1 mM
DTT and 20% glycerol. The MCP associated tightly
with the hydroxylapatite resin. The column was
washed with 60 ml of the equilibrating buffer, then
the adsorbed material was eluted with 150 ml of a
linear gradient of 10-500 mM phosphate in the same
buffer. The enzyme sample was diluted to 5% glyc-
erol then (1-5 mg protein) layered onto a linear
gradient of 10-40% (v/v) glycerol in the standard
buffer. After centrifuging for 22 h at 25,000 rpm in
an SW 40 rotor at 4°C, the gradient was fractionated
into 1 ml aliquots from the top. The gradient-purified
enzyme was finally concentrated by dialysing against
PEG 20,000 using a dialysing membrane of cut-off
limit 12,000. The glycerol concentration was then
brought to 20% and the purified enzyme stored at
- 80°C.
2.4. Assay of protease and caseinolytic activity
The reaction mixture consisted of 50 /xl of 60
mM Tris-HCl buffer, 10 mM KC1, 5 mM MgCl,
and 0.5 mM DTT, pH 8.0, 25 /xl of 200 mM
Z-Gly-Gly-Leu-NHMec or other peptide-NHMec
substrate and 1-5 fig enzyme protein in a total
volume of 100 p.1 of the reaction mixture. Hydro-
lytic rates were measured at 37CC by continuously
monitoring increases in fluorescence (excitation 360
nm; emission 460 nm) on a spectrofluorometer (7620
Microplate Fluorimeter, Cambridge Technology,
Inc.) connected to an IBM compatible PC model
MZ4671. The peptidylglutamyl-hydrolase activity
was measured according to Mykles and Haire (1991).
After incubation for 1 h at 37°C, reaction mixtures
(200 fi\) containing about 5 fig enzyme, 0.2 mM
Z-Leu-Leu-Glu-/3NA, 20 mM Hepes-NaOH (pH 8.0)
were combined with 0.3 ml 1% (w/v) SDS and 1 ml
borate (pH 9.0). The amount of substrate hydrolyzed
was measured with a Hitachi F-200 Fluorescence
Spectrophotometer (excitation 336 nm; emission 410
nm). Various inhibitors were added to the assay
mixtures at desired concentrations when required and
incubated for at least 30 min before the residual
activities were determined. All assays were inspected
for reaction linearity and enzyme concentration were
adjusted to allow measurement of initial velocities
only. The changes in fluoresence intensity were con-
verted to micromoles of NHMec or /3NA by deter-
mining, under the same conditions, the fluoresence
intensity of a standard solution of NHMec or /3NA.
The degration of dephosphorylated /3-casein was
determined by a gel electrophoretic method (Yu et
al., 1991). Briefly, 70 fig of /3-casein were incu-
bated at 37°C with approximately 3 fig of purified
enzyme in a total volume of 175 fi\ of 50 mM
Tris-HCl, pH 8.0. 75 fi\ aliquots of the reaction
mixture were subjected to SDS-PAGE and the gels
stained with Coomassie Blue. After destaining with a
solution containing 50% (v/v) methanol and 10%
(v/v) acetic acid, the band corresponding to the
dephosphorylated /3-casein were excised with a razor
blade transferred to small test tubes and eluted by
shaking overnight with 1.5 ml of 25% pyridine at
room temperature. Blanks were obtained by excising
a band of the same size from the background surface
of each gel and subjecting it to the same treatment.
As controls, 75 fi\ aliquots of each reaction mixture
at time 0 were run in every gel. The absorbance were
measured spectrophotometrically at 605 nm.
2.5. Polyacrylamide gel electrophoresis
Electrophoresis under non-denaturing conditions
was performed on polyacrylamide (3-10% gradient)
gels whereas the SDS-PAGE was conducted on 5%
stacking and 12.5% separating gels as described by
Laemmli (1970). Proteins were detected by either
Coomassie Brilliant Blue. Protein estimation were
done by the method of Bradford (1976) using oval-
bumin as the standard. The chromatographic elution
was monitored at 280 nm.
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Polyclonal antibodies were raised in chickens
against the purified enzyme. Briefly, 50 /xg of the
purified enzyme was emulsified in an equal volume
of complete Freund's adjuvant and injected intra-
muscularly into the breast muscle of chickens. Sub-
sequently, three doses of 50 /xg antigen were given
2, 4 and 6 weeks after the initial injection, in incom-
plete Freund's adjuvant. The IgY antibodies were
then isolated from the chicken egg yolk as described
by Poison et al. (1985). A preimmunization sample
was obtained from the yolk of eggs laid by the same
chickens prior to immunization.
The reactivity of the antibody against the purified
MCP was tested by an enzyme-linked immuno-
sorbent assay procedure. Briefly, the purified en-
zyme was immobilized in 96-well polyvinyl chloride
microtiter plates (0.1 /iig in 100 /J,\ of phosphate
buffered saline, pH 7.2) by an overnight incubation
at 4°C. After washing, 200 /xl of 0.5~.% BSA-PBS
was added to each well (incubated for 1 h at 37°C) to
reduce non-specific binding of antibody. The plates
were washed again in PBS-Tween (0.1% (v/v)
Tween 20 in PBS) and drained. Serial two-fold
dilutions, starting from 1 mg/ml IgY, was prepared
on the plate in 0.5% BSA-PBS and incubated (100
/u.1, 2 h at 37CC). The plates were washed three times
with PBS-Tween and further incubated for 1 h at
37°C with 100 /xl of rabbit anti-chicken IgY conju-




Fig. 1. Non-denaturing polyacrylamide (3-10% gradient) gel elec-
trophoresis of the purified MCP. The gels were stained with
Coomassie Brilliant Blue. The M, markers used were thyro-
globulin (669 kDa), ferritin (440 kDa). catalase (232 kDa) and
LDH (140 kDa).
0.0
0.0 1.0 1.5 2.0 2.5
Log Anti-MCP dilution (Tg/ml)
3.0 3 5
Fig. 2. Determination of antibody titre by enzyme-linked immuno-
sorbent assay (EL1SA). Purified antigens were adsorbed onto a
microtitre plate then incubated with a pre-immune sample (- ° -)
antibody at week 3 (- A - ) and week 6 (- D -) of immunization.
The bound antibody was detected by HRPO-rabbit anti-IgY using
appropriate substrate.
1:300 in 0.5% BSA-PBS. Following washing, the
peroxidase activity was measured with 100 fi\ of
substrate solution (7.5 mg ABTS (chromogen), 7.5
/j,l H,O2 in 15 ml of 0.15 M citrate phosphate








Fig. 3. Immunoblot analysis of purified multicatalytic proteina.se.
Lane 1: Immunoblot analysis with pre-immune sample; lane 2:
incubation with chicken anti-MCP antibody; lane 3: analysis with
chicken anti-variant surface glycoprotein antibody; lane 4: im-













Fig. 4. Effect of anti-MCP antibody on the purified enzyme
activity. The enzyme was incubated for 30 min with various
dilutions of the IgY preparation and the residual activity against
Z-Gly-Gly-Leu-NHMec was determined as outlined in Section 2.
The activity was expressed as arbitrary fluoresence units per min.
allowed to develop against the background of con-
trols. The enzyme reaction was stopped by addition
of 50 /J.\ of 0.1% (m/v) NaN3 in citrate-phosphate.
Absorbance of each well was read at 405 nm on a
Titertek ELISA plate reader. The specificity of the
IgY preparation was assessed by Western blot analy-
sis (Towbin et al., 1979).
To assess the effect of the anti-MCP antibody on
the activity of the purified enzyme, 20 fj.\ of the
enzyme was incubated for 30 min with various dilu-
tions of the IgY preparation. Residual activity was
then measured using 50 /i.M Z-Gly-Gly-Leu-NHMec
at 37°C (Fig. 4).
The steps used for isolating multicatalytic pro-
teinase (MCP) from Trypanosoma brucei are sum-
marized in Table 1. The MCP was purified over
60-fold with an overall recovery of 7%. The Q-sep-
harose chromatography of the high speed supernatant
fraction resulted in a single peak of chymotryptic
activity. The total recovery of the MCP chy-
motrypsin-like activity from the Q-sepharose column
was about 20%. It should be noted that this peak
degraded several oligopeptide substrates including
Z-Phe-Arg-NHMec, Z-Arg-Arg-NHMec, Z-GIy-Gly-
Leu-NHMec and Z-Leu-Leu-Glu-/3NA known to be
respective substrates for cysteine protease, trypsin-
Iike, chymotrypsin-like and peptidylglutamylpeptide
hydrolysing activities, albeit with non-absolute speci-
ficities.
Further purification was achieved by molecular
exclusion chromatography on sephacryl S-300.
Molecular-sieving analysis of the native enzyme on
the same column indicated a high relative molecular
mass protein of 650 kDa. The gel filtration column
effectively eliminated low molecular mass contami-
nants and perhaps higher Mr proteins eluting in the
void volume. The active fractions bound strongly to
the HA-Ultrogel and elute as a sharp peak of activity
that coincided with a small protein peak. The total
recovery from the HA-Ultrogel column was about
10% with about 31-fold purification. The final purifi-
cation was achieved by glycerol density gradient
(10-40%) sedimentation.
Table 1
Purification scheme for trypanosomal multicatalytic proteinase. All activities were determined using substrate Z-Gly-Gly-Leu-NHMec at a











































Specific activity decreased; much of the activity remained in the pellet.
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Table 2
Substrate specificity of purified MCP. The enzyme activity was
determined at 37°C in 30 mM Tris/HCl, pH 8.0, containing 10
mM KCI. 5 mM MgCI, and 0.5 mM DTT with various substrates
























The purity of the final preparation was assessed
by using polyacrylamide gel electrophoresis (Fig. 1).
The enzyme migrated as a single band of about 630
kDa on a non-denaturing (3-10%) gradient gel. The
Mr obtained was slightly less than that for similar
enzyme complexes reported in archaebacterium and
yeast cells (Hilt and Wolf, 1992; Seemuller et al..
1995).
3.2. pH stability and optimum pH
Purified MCP was preincubated at various pH at
room temperature for 30 min. The remaining pro-
teinase activity was then determined with Z-Gly-
Gly-Leu-NHMec at pH 8.0. The enzyme was stable
at between pH 4.0 and 11. The pH optimum for
hydrolysis of Z-Gly-Gly-Leu-NHMec in a four sys-
tem buffer designated AMT (acetate, Tris, MES and
Na2EDTA) was 7.8, Z-Arg-Arg-NHMec pH 10.5,
Z-Leu-Leu-Glu-/3NA pH 8.0. That optimum activi-
ties are distinct points to the fact that these are
different activities on the same enzyme (multicata-
lytic) rather than the same activity hydrolyzing dif-
ferent substrates in a non-specific manner.
The activities of the purified MCP on various
other synthetic substrates are shown in Table 2. The
enzyme hydrolysed substrates with an arginine
residue at the PI position which in general are good
substrates for trypsin-like proteinases. The MCP en-
zyme showed a broad specificity hydrolysing a num-
ber of synthetic substrates with a remarkable prefer-
ence for aromatic or hydrophobic amino acid at PI
position. The substrates with glutaryl or succinyl
blocking groups were not good substrates for MCP.
Table 3
Effect of various proteinase inhibitors on the activity of MCP. Purified enzyme was incubated for 30 min at 25°C with inhibitors in assay
buffer as described in Section 2. The enzyme activity was determined at 37°C against Z-Gly-Gly-Leu-HMec or Z-Arg-Arg-NHMec
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Indeed, the MCP failed to hydrolyse Glu-Gly-Gly-
Phe-NHMec which is a good substrate for classical
chymotrypsin-like enzymes.
3.3. Effect of protease inhibitors
Table 3 shows the effects of protease inhibitors on
trypsin-like and chymotrypsin-like activities of try-
panosomal MCP. The trypsin-like activity assayed
with Z-Arg-Arg-NHMec as the substrate was reason-
ably inhibited by leupeptin and to a lesser extent by
chymostatin. TLCK and TPCK had minimal effects
on the trypsin-like and chymotrypsin-like activities.
Also, the two activities were equally insensitive to
the classical cysteine protease inhibitors such as
cystatin, E-64, or antipain.
Qualititative analysis of the antibody preparation
was done by an enzyme-linked immunosorbent assay
method (Fig. 2). The antibody was then used to
probe a Western blot of a crude lysate and purified
MCP. Fig. 3, lanes 2 and 4 show the antibody
binding to the antigen of size 630 kDa in the crude
lysate and purified sample, respectively.
4. Discussion
In this report we demonstrate the presence of a
trypanosomal proteasome and attempt to elucidate its
properties in the light of its established character-
istics in mammalian (Kuehn and Dahlmann, 1996),
lobster (Mykles and Haire, 1991), yeast (Fujiwara et
al., 1990) and archaebacteria (Seemuller et al., 1995)
sources. It is noted that the trypanosomal proteasome
is highly immunogenic hence may contribute signifi-
cantly to the pathogenesis of the disease. Further, the
ubiquitous existence of the proteasome across the
prokaryotic and eukaryotic organisms no doubt con-
firm its pivotal role in the survival of living organ-
isms.
The established primary function of the protea-
some is to catalyze the non-lysosomal degradation of
the vast majority of cell proteins (Coux et al., 1996).
It also degrades short-lived enzymes such as or-
nithine decarboxylase (ODC), which is rate limiting
in polyamine biosynthesis. Because polyamines are
toxic in high levels, cells have evolved negative
feedback mechanisms, which cause the inactivation
and rapid degradation of ornithine decarboxylase.
Accumulation of polyamines induce the specific in-
hibitory protein, antizyme (Hayashi and Murakami,
1995), which binds to ornithine decarboxylase, inac-
tivates it and triggers its degradation by the 26S
proteasome, provided ATP is present. Recent reports
have indicated that 13 out of the 14 major subunits
of the proteasome are essential for the viability of
yeast cells (Fujiwara et al., 1990; Hilt and Wolf,
1992).
Although the MCP hydrolyzes a wide range of
peptide substrates, its activity appears markedly af-
fected by adjacent blocking groups of succinyl and
glutaryl species at the N-terminal end of the pep-
tides. The two blocking groups may cause steric
hindrance to the S2 and S3 subsites in the peptide
substrate binding cleft. Alternatively, the enzyme
might be sensitive to the multiple negative charges
on these blocking groups. Direct comparisons of this
enzyme with an enzyme recently characterised by
Hua et al. (1996), are difficult because the various
substrates used are not the same. However, Pro-Phe-
Arg-NHMec and H-Ala-Ala-Phe-NHMec are com-
mon to both studies but their relative rates of hydrol-
ysis are considerably different. We observed a 1.5-
fold difference in their rates of hydrolyses while Hua
et al. (1996) observed a 6-fold difference. Hence it
seems likely that the enzymes are different.
A complex group of proteins referred to as cyclins
are involved in regulation of the eukaryotic cell
division via their interaction with cyclin-dependent
kinases (CDKs). The appearance and disappearance
of particular active kinase complexes during differ-
ent phases of the cell cycle is regulated by synthesis
and proteolytic degradation of specific cyclins. There
is evidence that proteasome might be important for
cell cycle regulation by degrading cyclins that act in
different phases of the cell-cycle (Glotzer et al.,
1991). Disruption of either one of the two genes
encoding for subunits of the proteasome has been
reported to arrest the proliferation and viability of
yeast cells (Fujiwara et al., 1990). Consequently, an
attractive hypothesis follows that disruption of try-
panosomal proteasome activity in vivo may arrest
progression of the parasite multiplication and trans-
formation. In bloodstream trypomastigotes, experi-
ments that relate the cyclin levels with the protea-
some activity in different developmental stages,
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namely; the proliferative stages ('long slender") in
which the parasite undergoes binary fission and
non-proliferative stages ('short stumpy') in which it
is incapable of division, should show whether or not
the proteasome catalyzes degradation of proteins
necessary for the transformation or multiplication of
the parasite.
At peak parasitaemia, the antibody response re-
sults in a major trypanolytic crisis in which a whole
range of biologically active factors including pro-
teases are released into the bloodstream of the host.
Immunogenic molecules such as proteasome may
form an antigen-antibody complex, which in turn
activates the complement system leading to damage
of the host tissues (Lomo et al., 1995). Alternatively,
the released trypanosome-borne proteases may accel-
erate the degradation of host proteins. The emacia-
tion and muscular wasting that characterize chronic,
debilitating trypanosome infection may be at least in
part, due to acceleration of this degradative process
in muscle in such a pathological state. This hypothe-
sis will however be verified by immunoblot analysis
of the serum samples from animals chronically in-
fected with T. b. brucei. The observation that try-
panosomal 20S proteasome is 630 kDa as opposed to
the mammalian 20S proteasome which is 700 kDa
(Coux et al., 1996) should enable us to discriminate
between the host and the parasite-derived enzyme in
the likely event of cross-reactivity between the two
enzymes.
In conclusion, the trypanosomal proteasome is of
considerable biological interest because of the myr-
iad functions it is likely to play in the parasite and
host-parasite relationships. This enzyme may be a
promising target for the development of new chemo-
therapy to control trypanosomiasis and our genera-
tion of inhibitory antibody should prove valuable in
dissecting the possible functions of the enzyme.
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